data_1k0h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k0h _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -93.19 138.7 31.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 111.955 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 62.9 m -121.59 124.74 45.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.379 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.43 144.14 50.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 4.0 m -121.11 134.21 55.24 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.478 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.469 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 3.1 mm -99.79 125.28 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.382 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.12 99.14 4.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.558 178.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.442 ' N ' ' HB2' ' A' ' 35' ' ' SER . 15.1 p -108.53 153.69 23.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.58 26.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -89.61 -69.1 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.76 0.314 . . . . 0.0 111.38 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -128.6 71.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.533 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB2' ' N ' ' A' ' 31' ' ' SER . 8.0 t -80.59 114.04 19.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.671 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.09 46.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.373 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 121.19 18.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.69 117.41 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.0 pp -114.09 159.93 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.698 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.699 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 154.55 146.67 4.47 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -115.06 174.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.681 0.753 . . . . 0.0 112.101 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.504 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 6.3 t80 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.618 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.443 ' CD2' HD12 ' A' ' 105' ' ' LEU . 6.0 tp -116.92 140.67 49.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 15.4 t80 -100.3 123.26 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 110.27 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 72' ' ' VAL . 11.2 p -112.46 164.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.542 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.58 41.94 3.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -171.21 -101.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.394 178.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t0 177.95 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -98.42 -34.99 10.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 19.4 m -62.16 -31.17 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.916 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.59 84.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.272 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -69.88 -20.62 63.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.576 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -65.05 61.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.112 178.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -59.38 152.63 20.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -42.02 159.44 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.653 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.91 32.12 61.33 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.187 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 5.6 m-20 -128.62 128.4 44.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 111.015 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 30' ' ' THR . 0.7 OUTLIER -99.98 140.45 34.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.444 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -135.18 159.71 40.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.442 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -123.04 129.53 51.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.499 HD13 ' CZ ' ' A' ' 88' ' ' PHE . 2.3 tt -137.88 135.47 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.47 -95.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.03 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 40.8 mm-40 -50.66 -27.35 6.78 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 98.65 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.813 1.245 . . . . 0.0 111.663 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.5 111.18 5.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CD1' ' HD3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -140.48 139.76 35.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.558 173.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.431 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 7.0 t90 -134.93 142.42 46.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 59.8 t -84.29 108.51 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 121.874 0.845 . . . . 0.0 110.902 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 104' ' ' TRP . 11.9 t70 -85.59 -5.58 59.26 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.864 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 90' ' ' VAL . 9.6 mtm-85 . . . . . 0 C--N 1.339 0.123 0 CA-C-O 121.265 0.555 . . . . 0.0 111.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.095 0.474 . . . . 0.0 111.805 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -99.48 120.34 39.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.528 HD13 ' CD2' ' A' ' 88' ' ' PHE . 10.9 mt -107.75 161.19 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.947 0.879 . . . . 0.0 113.282 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.34 117.21 2.22 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.686 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.552 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mmm180 -98.0 156.68 16.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.448 0.642 . . . . 0.0 112.348 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.076 178.089 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.46 HG23 ' CB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -92.89 138.49 31.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 112.072 -178.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 64.8 m -118.94 124.95 48.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.166 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 39' ' ' ILE . . . -124.98 138.83 54.22 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 5.4 m -115.95 133.9 55.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.331 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.492 HG22 ' HG ' ' A' ' 75' ' ' LEU . 1.9 mm -99.81 131.6 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.132 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -137.35 98.96 3.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.67 178.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -108.1 159.56 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.798 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.08 70.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -75.63 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.886 0.374 . . . . 0.0 111.993 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -137.87 77.16 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.31 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 29.4 p -74.29 123.54 24.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.788 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.5 48.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.17 126.12 29.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -99.71 122.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.436 HG12 ' CD1' ' A' ' 29' ' ' ILE . 2.4 pp -122.01 156.98 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -99.07 140.38 33.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.873 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 159.15 152.57 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.068 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -124.6 178.64 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.284 0.564 . . . . 0.0 111.707 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.502 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 2.4 t80 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.254 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.515 -0.385 0 CA-C-O 121.049 0.452 . . . . 0.0 110.979 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD1' ' CE2' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -115.35 139.72 49.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.996 -177.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -93.82 121.08 34.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.643 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' CG1' HG21 ' A' ' 72' ' ' VAL . 10.0 p -122.18 160.16 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.199 0.524 . . . . 0.0 112.15 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.41 65.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.318 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 167.49 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.002 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -66.36 62.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' THR . 5.6 mt-10 -126.39 -45.82 1.65 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.668 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG21 ' CG1' ' A' ' 67' ' ' VAL . 5.2 m -57.53 -30.29 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.046 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -48.49 77.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.424 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.4 mt-30 -63.29 -19.76 64.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.574 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -67.11 63.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.599 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.8 mmm180 -55.32 160.89 2.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -53.04 146.46 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 77' ' ' ARG . . . 95.88 38.51 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.304 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 2.5 t0 -140.36 150.59 44.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 111.305 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.435 HG22 ' CZ3' ' A' ' 89' ' ' TRP . 4.9 m -118.5 142.98 47.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.688 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -136.1 158.31 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.384 -178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 1.2 p -118.75 129.23 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.674 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -122.7 -136.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.858 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.74 -41.12 97.39 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.592 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -91.0 15.92 10.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.041 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 82' ' ' THR . 4.5 mt-10 57.71 19.78 5.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.399 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 18.1 m120 -144.89 112.66 6.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.537 ' CE1' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -138.98 150.98 46.48 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.435 ' CZ3' HG22 ' A' ' 80' ' ' THR . 30.9 t-105 -135.63 141.92 45.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.439 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.475 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 9.2 t -84.98 107.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.099 0.952 . . . . 0.0 110.532 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' TRP . 33.7 t0 -99.18 -5.89 29.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 3.7 mtm180 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.8 114.15 25.76 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.537 HD11 ' CE1' ' A' ' 88' ' ' PHE . 13.2 mt -107.39 163.31 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -172.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -143.95 122.13 1.77 Allowed Glycine 0 CA--C 1.521 0.461 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.019 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.504 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mtm180 -99.26 140.0 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.347 0.573 . . . . 0.0 111.828 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.504 177.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.846 -0.102 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -92.79 138.6 31.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.519 . . . . 0.0 112.062 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 49.6 m -126.73 124.33 39.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.445 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.47 142.59 51.2 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.8 m -114.34 132.88 56.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.149 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.489 HG22 ' HG ' ' A' ' 75' ' ' LEU . 4.3 mm -102.02 124.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 111.856 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.56 99.11 5.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.363 178.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.436 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -116.95 154.61 30.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.919 -179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.01 -17.7 30.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -88.56 -69.72 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -127.95 72.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 31' ' ' SER . 12.9 p -84.6 146.17 27.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.14 24.73 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.706 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.35 129.97 56.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.945 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 66.7 t -101.84 122.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.025 0.44 . . . . 0.0 111.315 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 29' ' ' ILE . 2.4 pp -116.33 160.09 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.966 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -102.94 147.07 27.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.615 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 150.83 153.32 6.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.014 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -124.03 175.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.556 0.693 . . . . 0.0 112.317 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.503 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 37.1 t80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.57 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.846 0.355 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -113.13 141.08 47.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.067 -177.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 2.2 m-85 -103.98 115.22 30.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.046 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.47 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 12.3 p -102.89 160.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.442 . . . . 0.0 111.523 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.12 -55.88 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.929 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -90.07 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.42 32.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.65 0.262 . . . . 0.0 111.363 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.33 -41.93 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.057 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' CG2' ' CG1' ' A' ' 67' ' ' VAL . 33.5 m -56.57 -33.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.985 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -54.02 -30.78 49.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.5 mt-30 -86.36 -22.71 26.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.624 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 29' ' ' ILE . 6.5 mp -66.51 62.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 12.7 mmt-85 -60.33 158.03 12.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -42.53 157.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.605 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.5 27.56 54.39 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.401 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -125.7 139.91 53.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.471 HG23 ' CZ3' ' A' ' 89' ' ' TRP . 0.5 OUTLIER -108.31 138.87 43.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -140.26 158.58 43.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -121.11 122.28 39.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.237 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.534 HG21 ' CE1' ' A' ' 88' ' ' PHE . 6.4 tt -127.05 137.35 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.323 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 38.88 -92.69 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.946 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 63.0 mm-40 -49.54 -26.36 3.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 3.0 mt-10 101.34 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.619 1.168 . . . . 0.0 111.382 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 16.4 m120 -144.28 110.81 5.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -140.83 119.51 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.626 173.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 9.1 m95 -108.95 142.46 39.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.715 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' CG2' HD22 ' A' ' 81' ' ' LEU . 48.0 t -86.1 107.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.506 0.67 . . . . 0.0 110.348 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 16.4 t0 -89.35 -59.43 2.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.403 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.427 ' N ' ' HB3' ' A' ' 104' ' ' TRP . 5.2 mtp180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.362 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.459 ' CG ' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.484 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.6 t90 -98.04 128.59 44.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.56 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mp -100.29 159.76 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -140.01 110.2 0.67 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.352 172.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.535 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -97.79 156.73 16.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.469 0.652 . . . . 0.0 111.843 -175.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.127 178.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.19 138.93 31.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.579 . . . . 0.0 112.29 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -133.07 123.96 26.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.285 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 83' ' ' ILE . . . -125.76 152.43 45.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.092 0.473 . . . . 0.0 109.977 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' THR . 16.2 m -124.18 133.02 53.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.143 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 HG22 ' HG ' ' A' ' 75' ' ' LEU . 4.0 mm -100.79 122.97 53.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.345 0.593 . . . . 0.0 111.835 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.0 98.75 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.106 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.424 ' N ' ' HB3' ' A' ' 35' ' ' SER . 98.6 p -120.06 160.4 22.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.848 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 -25.65 58.44 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.174 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.91 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 111.569 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 6.3 tt0 -143.44 57.02 1.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.04 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.424 ' HB3' ' N ' ' A' ' 31' ' ' SER . 14.0 p -49.24 118.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.71 46.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.478 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.84 126.06 23.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.9 p -99.48 132.33 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.485 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.23 153.77 24.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 10.6 ttp180 -109.91 142.88 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 66' ' ' PHE . . . 121.28 149.07 8.05 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.48 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG2' ' HB ' ' A' ' 25' ' ' THR . 26.2 t -111.15 -120.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 65' ' ' LEU . 6.1 p90 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -111.71 140.04 46.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.662 0.744 . . . . 0.0 111.194 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.411 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 62.8 t80 -94.63 135.35 36.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.272 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 14.5 p -133.08 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -102.76 37.31 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.95 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 97.5 m -164.32 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.377 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 69' ' ' THR . 51.0 t0 179.0 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.758 0.313 . . . . 0.0 110.879 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.24 -47.01 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.312 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' CG2' ' CG1' ' A' ' 67' ' ' VAL . 27.6 m -52.63 -35.16 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.278 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -30.59 52.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.62 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' ARG . 7.5 mt-30 -89.76 -19.17 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 29' ' ' ILE . 5.6 mp -66.04 67.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.8 mmt85 -62.53 151.79 36.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.078 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -43.92 137.47 3.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.024 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.97 34.74 3.91 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.163 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -140.55 147.79 40.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.188 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 m -111.12 150.36 29.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.778 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.05 152.49 40.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -113.23 120.68 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 5.3 tt -130.38 136.81 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.86 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 41.76 -92.34 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.81 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 4.6 mm-40 -53.12 -33.49 52.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 3.7 mm-40 116.04 19.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.196 1.398 . . . . 0.0 111.745 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.468 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 26.4 t-20 -144.21 121.6 11.66 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 118.845 -1.142 . . . . 0.0 114.03 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CG ' HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -142.94 112.16 6.65 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 8.7 t90 -104.03 141.87 35.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.25 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.437 ' CG2' ' HG3' ' A' ' 92' ' ' ARG . 9.3 p -84.37 109.3 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.892 0.853 . . . . 0.0 111.622 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 104' ' ' TRP . 27.8 t0 -86.93 -4.31 59.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.796 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.437 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 6.3 mtm180 . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 121.232 0.539 . . . . 0.0 112.333 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 9.2 t90 -97.13 123.64 40.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.599 HD13 ' CG ' ' A' ' 88' ' ' PHE . 2.4 mt -104.92 163.3 12.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -171.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.85 121.01 1.41 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.89 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.513 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -98.26 157.58 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.525 0.678 . . . . 0.0 112.217 -175.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.54 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.89 177.8 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.506 ' OG1' ' CD1' ' A' ' 83' ' ' ILE . 1.1 t -92.7 133.18 36.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.135 0.493 . . . . 0.0 111.923 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 83' ' ' ILE . 70.3 m -115.45 123.32 48.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.286 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' A' ' 83' ' ' ILE . . . -122.71 146.94 47.03 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.229 0.538 . . . . 0.0 110.538 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 82' ' ' THR . 5.8 m -120.74 134.15 55.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.718 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG21 ' HG ' ' A' ' 75' ' ' LEU . 8.9 mm -104.58 125.42 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.168 0.509 . . . . 0.0 111.517 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.76 98.96 4.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.378 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.434 ' N ' ' HB3' ' A' ' 35' ' ' SER . 80.0 p -118.22 142.48 47.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.675 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.45 -30.07 1.28 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.855 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.62 -75.9 0.13 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.874 0.369 . . . . 0.0 111.627 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -126.48 64.83 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.434 ' HB3' ' N ' ' A' ' 31' ' ' SER . 93.8 p -77.32 127.68 33.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.675 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 135.97 48.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.78 132.37 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.72 123.41 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.4 pp -119.35 157.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.376 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -99.96 149.74 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.081 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 145.97 150.39 5.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.373 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -120.63 178.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.713 0.768 . . . . 0.0 112.472 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 21.0 t80 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.92 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -114.44 139.66 49.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.8 m-85 -96.38 112.74 24.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' A' ' 72' ' ' VAL . 11.3 p -109.69 163.36 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.717 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.19 -62.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.124 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.5 m -86.02 -110.33 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.415 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -164.82 24.95 0.06 Allowed 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.071 -0.393 . . . . 0.0 111.543 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.84 -35.47 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 109.76 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' A' ' 103' ' ' LEU . 16.6 m -63.12 -39.07 83.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.561 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' N ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.63 -33.08 31.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.304 0.573 . . . . 0.0 110.077 177.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.7 mt-30 -81.99 -23.72 35.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.66 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -63.25 75.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.663 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' GLN . 3.4 mmt180 -71.09 155.26 41.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.855 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -41.82 149.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.916 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.47 35.4 8.65 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.671 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 75' ' ' LEU . 96.7 m-20 -140.66 150.83 44.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.279 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 30' ' ' THR . 1.8 m -116.88 147.36 42.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.335 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -139.22 158.94 43.29 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.802 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -124.99 132.39 53.27 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.506 -0.121 . . . . 0.0 110.903 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.543 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 13.7 tt -152.29 143.11 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 46.18 -94.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.475 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -53.44 -33.73 55.15 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 85' ' ' GLU . 4.9 pt-20 102.56 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.412 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.42 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -142.44 110.19 5.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.288 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -136.55 138.47 41.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.5 t-105 -132.95 144.42 50.12 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.195 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.471 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 7.7 t -84.95 107.47 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.871 0.843 . . . . 0.0 110.041 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 8.1 t70 -96.73 -3.94 41.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.798 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 103' ' ' LEU . 4.4 mtm180 . . . . . 0 N--CA 1.467 0.387 0 C-N-CA 123.657 0.783 . . . . 0.0 112.961 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.454 ' CD1' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.054 0.454 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -98.34 136.88 37.87 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.58 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 3.5 mp -110.03 161.09 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -169.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -147.99 110.52 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 112.99 -1.914 . . . . 0.0 109.814 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.521 ' HD3' ' CE1' ' A' ' 88' ' ' PHE . 2.4 mtm180 -97.98 130.39 44.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.765 0.782 . . . . 0.0 111.796 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.152 175.315 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.809 -0.116 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.464 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -92.41 130.1 38.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.526 . . . . 0.0 111.706 -179.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 69.1 m -115.05 123.24 48.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.633 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 83' ' ' ILE . . . -124.01 145.94 48.86 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 8.4 m -121.13 134.35 55.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.205 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.488 HG21 ' HG ' ' A' ' 75' ' ' LEU . 8.9 mm -102.48 125.33 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.452 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.81 99.22 4.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.813 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.438 ' N ' ' HB2' ' A' ' 35' ' ' SER . 20.1 m -98.07 157.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.49 -18.66 23.55 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -126.1 -40.71 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.615 0.245 . . . . 0.0 111.385 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -112.19 63.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.494 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB2' ' N ' ' A' ' 31' ' ' SER . 17.8 t -104.78 120.3 41.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.654 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.15 42.3 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.35 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.48 127.02 16.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.3 130.53 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 29' ' ' ILE . 1.9 pp -125.57 155.9 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -100.81 144.59 29.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.071 178.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 155.45 154.79 7.06 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.664 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.2 t -128.3 169.87 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.799 . . . . 0.0 111.901 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.505 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 2.4 t80 . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.119 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.851 0.358 . . . . 0.0 110.78 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 105' ' ' LEU . 2.9 tp -112.43 139.51 47.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.687 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -101.53 112.84 25.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.184 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 72' ' ' VAL . 11.4 p -102.87 157.97 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 111.577 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -67.49 -31.55 71.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.433 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.53 -96.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.577 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.57 19.7 0.4 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.674 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -61.15 -48.29 82.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 109.974 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.437 ' HB ' ' CD1' ' A' ' 103' ' ' LEU . 16.0 m -53.78 -35.56 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.469 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -31.96 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.96 -20.93 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.686 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.488 ' HG ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.2 64.21 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.188 0.518 . . . . 0.0 110.664 178.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -55.1 160.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -52.87 145.43 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.407 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.97 6.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.845 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' CB ' HD22 ' A' ' 75' ' ' LEU . 92.8 m-20 -140.55 150.53 43.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 30' ' ' THR . 1.5 m -116.29 145.29 43.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -134.2 159.62 40.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.99 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.94 129.85 52.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.58 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.552 HG22 ' CD1' ' A' ' 88' ' ' PHE . 1.8 tt -126.08 -127.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.45 -71.32 0.77 Allowed Glycine 0 CA--C 1.5 -0.9 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.853 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -55.32 -23.96 26.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.455 ' HA ' ' N ' ' A' ' 83' ' ' ILE . 1.3 pt-20 89.99 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.342 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -142.15 109.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.699 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -138.02 136.55 37.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.767 176.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 7.8 m95 -130.43 143.31 50.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.646 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 33.7 t -85.29 107.11 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.96 0.886 . . . . 0.0 109.905 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.51 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 27.0 t0 -90.35 -3.67 57.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 5.4 mtm180 . . . . . 0 N--CA 1.463 0.192 0 C-N-CA 123.196 0.599 . . . . 0.0 112.58 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.457 0.17 . . . . 0.0 110.899 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.51 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 8.1 t90 -97.56 127.9 43.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.55 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 5.0 mp -100.77 160.77 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -149.0 107.63 0.37 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.054 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.53 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.4 mtm180 -97.25 131.45 43.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.684 0.742 . . . . 0.0 111.392 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.387 176.176 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.491 ' CG2' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.89 138.1 31.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.3 0.572 . . . . 0.0 112.262 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 67.8 m -117.61 123.79 47.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.239 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -126.0 141.24 52.05 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 4.5 m -118.16 132.18 56.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.216 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 5.3 mm -103.52 126.9 57.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.359 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.5 99.22 4.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.282 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.438 ' N ' ' HB3' ' A' ' 35' ' ' SER . 3.0 p -115.31 156.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.05 -18.58 27.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.621 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.38 -70.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 111.247 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -130.65 71.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB3' ' N ' ' A' ' 31' ' ' SER . 66.3 p -81.4 134.55 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.94 49.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.04 127.7 16.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.8 p -99.51 122.56 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.3 pp -112.05 157.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 12.1 ttp180 -100.64 133.15 45.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.887 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 157.24 158.75 9.09 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.789 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.3 t -129.11 167.53 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.828 0.823 . . . . 0.0 111.918 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.527 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 4.8 t80 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.954 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.997 0.427 . . . . 0.0 111.338 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CB ' ' CD1' ' A' ' 105' ' ' LEU . 3.5 tp -113.7 140.93 47.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.435 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 3.7 m-30 -108.49 113.03 25.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.387 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.463 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 12.6 p -98.46 149.54 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.165 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 8.7 mmm180 -96.44 23.69 6.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.794 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.9 m -163.44 -112.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.816 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -161.59 26.25 0.12 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.021 0.373 . . . . 0.0 110.922 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.35 -43.35 19.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.531 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 29.6 m -54.12 -37.94 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -36.58 59.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.884 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.9 mt-30 -77.73 -25.39 49.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.409 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.18 62.85 0.06 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.667 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 1.5 mmt-85 -56.74 158.83 4.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.002 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -49.48 149.76 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.04 37.27 7.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 8.3 m-20 -136.03 148.42 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.8 m -113.55 135.1 54.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.477 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -133.89 160.09 38.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 -179.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 1.2 p -123.03 129.0 50.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 88' ' ' PHE . 3.9 tt -129.71 -139.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.443 ' N ' HG22 ' A' ' 83' ' ' ILE . . . -51.64 -44.68 54.47 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 119.198 0.908 . . . . 0.0 111.628 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' ASN . 1.0 OUTLIER -96.57 28.99 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 173.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.484 ' HA ' ' N ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER 34.54 33.49 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.808 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -141.85 109.87 5.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.221 0.534 . . . . 0.0 111.923 177.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -140.95 142.17 34.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.734 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 2.0 t-105 -134.79 142.62 46.74 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.477 ' CG2' HD21 ' A' ' 81' ' ' LEU . 59.5 t -85.56 107.44 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.126 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 21.4 t0 -90.24 -56.75 3.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.684 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HG3' ' CG1' ' A' ' 90' ' ' VAL . 5.4 mmm180 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.726 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.45 HD11 ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.8 t90 -98.63 128.75 45.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.552 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 4.5 mp -103.1 160.69 14.42 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -171.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -139.08 103.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.749 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.511 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.0 mtm180 -97.46 142.71 28.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.306 0.553 . . . . 0.0 111.17 -176.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.01 177.205 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.759 -0.137 . . . . 0.0 112.759 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.72 138.52 31.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.37 0.605 . . . . 0.0 111.922 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 44.0 m -122.9 128.52 50.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.8 139.99 53.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 4.9 m -114.56 130.89 56.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.493 HG21 ' HG ' ' A' ' 75' ' ' LEU . 4.2 mm -100.06 128.65 51.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -136.88 99.18 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.857 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.438 ' N ' ' HB3' ' A' ' 35' ' ' SER . 4.8 m -95.68 159.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -14.6 39.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.969 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -119.9 -48.04 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.68 68.75 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 111.849 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB3' ' N ' ' A' ' 31' ' ' SER . 40.9 p -98.73 122.69 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.82 41.77 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.424 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . . . -140.72 121.74 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.339 . . . . 0.0 110.799 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 77.5 t -99.5 119.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.148 0.499 . . . . 0.0 111.442 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.5 pp -112.33 159.8 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.374 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.45 146.31 27.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.061 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 153.0 148.86 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.703 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.2 t -119.11 171.98 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 0.0 111.689 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.481 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 36.7 t80 . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.891 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 105' ' ' LEU . 4.9 tp -112.42 138.67 48.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.448 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 27.1 m-85 -101.3 113.3 26.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.474 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 9.1 p -107.38 161.28 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.294 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 46.43 2.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.568 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.7 m -163.97 -108.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.056 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.1 t0 179.75 36.6 0.0 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.887 0.375 . . . . 0.0 110.739 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 tt0 -104.71 -43.4 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.232 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 67' ' ' VAL . 9.9 m -56.88 -37.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -53.99 -41.77 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.814 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -73.9 -18.76 60.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.006 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.493 ' HG ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.07 65.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 110.926 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' HA ' ' NH2' ' A' ' 92' ' ' ARG . 4.1 mmt180 -58.54 156.1 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.03 141.03 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.273 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.38 29.78 5.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.436 ' CB ' HD23 ' A' ' 75' ' ' LEU . 75.2 m-20 -140.37 150.47 43.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.119 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 30' ' ' THR . 0.5 OUTLIER -115.7 145.05 43.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.349 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.458 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -136.27 160.26 39.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.133 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.96 135.8 54.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 3.0 tt -137.58 89.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.9 -68.78 0.19 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 10.6 mm-40 -62.1 -16.74 54.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.386 172.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 84.19 19.13 0.17 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.051 0.54 . . . . 0.0 111.081 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.478 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -142.94 119.05 10.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.546 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -149.44 130.57 14.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.865 169.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -128.49 143.63 51.01 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.518 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.458 ' CG2' HD21 ' A' ' 81' ' ' LEU . 6.3 t -85.2 108.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.664 0.745 . . . . 0.0 110.922 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 9.8 t0 -92.04 -5.43 52.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.506 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' A' ' 76' ' ' ARG . 4.8 mtm-85 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.229 0.537 . . . . 0.0 112.347 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.604 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.486 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 6.5 t90 -96.62 126.55 41.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.546 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 5.3 mp -97.22 160.06 14.56 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -140.86 99.09 0.24 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 87' ' ' ASN . 6.5 ttp180 -99.22 156.77 16.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.435 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.231 177.458 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 40' ' ' ARG . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.451 HG21 ' CA ' ' A' ' 42' ' ' VAL . 14.9 t -93.01 138.7 31.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 54.6 m -105.04 122.97 46.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.573 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.85 145.56 49.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 110.061 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 2.5 m -120.59 133.74 55.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.479 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 8.1 mm -103.63 122.26 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -126.91 99.44 5.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 35' ' ' SER . 6.5 p -115.17 157.98 22.88 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -17.34 32.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.758 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.64 -71.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -132.53 69.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.447 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 68.6 p -73.99 167.04 22.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.76 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 50.76 2.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.597 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.58 132.37 38.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.923 0.392 . . . . 0.0 110.963 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.6 p -99.88 118.28 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.45 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.1 pp -123.52 154.63 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.368 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -100.3 125.39 46.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . -176.91 143.32 6.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.385 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' CA ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -119.26 -162.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.439 -1.015 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.432 -177.514 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 2.3 tt -114.49 139.46 49.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.789 0.328 . . . . 0.0 110.425 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.421 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 84.3 t80 -97.84 111.15 23.56 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.4 ' HB ' HG21 ' A' ' 72' ' ' VAL . 10.6 p -100.68 163.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -71.96 -36.62 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.114 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.63 -96.49 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.616 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -152.47 17.64 0.62 Allowed 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 74' ' ' GLN . 6.8 tt0 -61.56 -46.81 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.418 . . . . 0.0 109.877 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 10.8 m -51.49 -31.67 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.385 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -33.84 68.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' GLU . 3.0 mt-30 -78.71 -20.09 50.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.6 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HG ' ' CG2' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -66.28 62.65 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 178.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.6 mmm-85 -56.04 158.35 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 111.303 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -46.89 161.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.13 37.29 91.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 70.4 m-20 -129.32 131.07 46.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 30' ' ' THR . 54.7 m -100.55 138.78 37.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.552 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.469 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.64 159.51 41.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.298 -178.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 2.8 p -124.43 130.95 53.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.726 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.498 HG21 ' CD2' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -120.99 -130.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.417 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -69.6 -34.08 72.69 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.638 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 9.3 mp0 -101.02 25.23 8.31 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 82' ' ' THR . 10.3 pt-20 38.07 33.88 0.06 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.804 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -144.04 109.15 5.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.54 ' CD1' ' HG2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -140.59 149.68 42.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.491 ' CH2' ' HA3' ' A' ' 108' ' ' GLY . 12.3 m0 -133.23 142.73 48.71 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.901 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.474 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 94.0 t -85.32 106.59 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.821 0.819 . . . . 0.0 109.511 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 7.7 t0 -87.47 -2.11 58.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.668 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.443 ' CD ' ' HA ' ' A' ' 103' ' ' LEU . 3.2 mmp_? . . . . . 0 C--O 1.231 0.109 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.692 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 122.048 0.928 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 2.8 t90 -99.36 122.13 42.06 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.166 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 88' ' ' PHE . 3.5 mp -89.74 156.72 18.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 89' ' ' TRP . . . -133.68 110.47 0.89 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.946 173.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.54 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 1.7 mmm180 -98.91 156.02 17.1 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.491 ' HA3' ' CH2' ' A' ' 89' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.211 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.444 -0.263 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.453 HG21 ' CB ' ' A' ' 42' ' ' VAL . 2.4 t -92.61 138.71 31.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.188 0.518 . . . . 0.0 111.824 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 75.1 m -119.91 129.76 54.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.694 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . . . -123.87 143.6 50.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.344 0.592 . . . . 0.0 110.553 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -119.66 133.71 55.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.84 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -100.6 128.3 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.18 0.514 . . . . 0.0 111.397 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -133.4 98.74 4.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.438 177.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.421 ' N ' ' HB3' ' A' ' 35' ' ' SER . 1.4 p -109.88 151.97 26.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.597 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.57 -39.79 38.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.165 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -75.24 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -139.27 68.45 1.37 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 31.3 p -65.02 128.7 36.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.29 55.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.536 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.72 123.26 14.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.67 117.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.195 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 29' ' ' ILE . 2.3 pp -119.33 159.76 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.688 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -104.03 149.76 24.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.839 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 148.23 146.54 4.36 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -112.41 -168.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.503 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 1.9 t80 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.77 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.467 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.86 139.56 49.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.241 -177.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.42 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.0 m-85 -98.71 112.69 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.414 HG13 ' CG2' ' A' ' 72' ' ' VAL . 12.2 p -106.57 162.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.932 0.396 . . . . 0.0 111.79 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.25 -69.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.86 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.0 p -84.09 -96.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -174.99 31.98 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.292 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -76.5 -46.16 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.082 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.458 ' HB ' ' CD2' ' A' ' 103' ' ' LEU . 17.1 m -53.55 -34.41 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.32 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -54.39 -31.22 54.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.65 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -85.1 -21.91 29.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.718 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 29' ' ' ILE . 3.8 mp -66.85 65.23 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -59.15 155.26 14.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.993 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.03 136.93 13.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.316 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.46 30.18 4.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.838 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD2' ' CG2' ' A' ' 29' ' ' ILE . 16.2 t70 -140.56 144.01 35.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 30' ' ' THR . 2.0 m -112.41 140.12 47.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.561 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -132.16 158.52 41.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.318 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -119.29 130.66 55.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.239 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -117.55 -129.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.382 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.419 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -71.12 -40.38 61.82 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.437 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -90.47 13.32 15.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.108 -0.546 . . . . 0.0 110.099 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 82' ' ' THR . 12.1 mt-10 64.96 20.74 12.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.402 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.07 112.66 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -141.25 126.05 18.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.261 175.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.426 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 12.6 m95 -118.52 144.97 45.68 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.311 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' CG2' ' HG3' ' A' ' 92' ' ' ARG . 11.4 p -83.8 107.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.992 0.901 . . . . 0.0 109.863 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 12.9 t70 -93.53 -5.32 49.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.94 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.44 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 3.6 mtm180 . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 123.409 0.683 . . . . 0.0 112.544 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 72' ' ' VAL . 6.5 tp . . . . . 0 N--CA 1.444 -0.766 0 CA-C-O 121.167 0.508 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -96.6 133.93 40.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.058 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.561 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 1.2 mp -106.07 160.88 14.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -171.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 89' ' ' TRP . . . -137.51 102.67 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.283 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' CZ ' ' CB ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -97.07 155.8 16.64 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.194 -0.592 . . . . 0.0 110.75 -177.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.583 179.155 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.855 0.359 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.17 112.63 13.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -162.27 150.12 14.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.77 66.2 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.804 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -131.28 61.27 1.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.48 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -163.76 -59.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.02 -174.75 4.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.5 60.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.13 -54.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.44 22.97 13.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.1 tt -117.59 -34.95 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.045 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.61 -27.4 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.21 27.23 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 -66.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 68.02 67.88 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.87 146.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.42 76.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mm -112.5 -54.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.82 152.77 15.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.94 56.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.577 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.62 135.64 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.84 -176.48 4.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.71 43.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.368 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -93.19 138.7 31.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 111.955 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 62.9 m -121.59 124.74 45.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.379 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.43 144.14 50.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 4.0 m -121.11 134.21 55.24 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.478 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.469 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 3.1 mm -99.79 125.28 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.382 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.12 99.14 4.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.558 178.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.442 ' N ' ' HB2' ' A' ' 35' ' ' SER . 15.1 p -108.53 153.69 23.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.58 26.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -89.61 -69.1 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.76 0.314 . . . . 0.0 111.38 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -128.6 71.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.533 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB2' ' N ' ' A' ' 31' ' ' SER . 8.0 t -80.59 114.04 19.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.671 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.09 46.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.373 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 121.19 18.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.5 m -99.69 117.41 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.0 pp -114.09 159.93 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.698 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.699 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 154.55 146.67 4.47 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -115.06 174.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.681 0.753 . . . . 0.0 112.101 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.528 ' CE2' ' CG ' ' A' ' 63' ' ' PRO . 6.3 t80 -90.38 141.14 29.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.618 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' SER . 6.5 t0 -128.42 129.42 46.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.611 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.9 109.94 42.43 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.047 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.25 -50.33 8.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.355 2.037 . . . . 0.0 111.806 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -43.17 -40.63 3.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.512 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.9 -73.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -71.94 90.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.207 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.77 25.32 11.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.93 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -100.85 -77.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.04 169.5 8.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.88 57.33 16.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.381 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 13.8 pt20 -113.47 -172.8 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.8 21.23 58.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.3 p -161.09 -46.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 5.7 mmm180 67.76 -64.25 0.28 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.901 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 57' ' ' ARG . 8.5 p 49.29 24.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.309 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 60' ' ' GLY . 13.5 pt-20 -165.09 -49.57 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.523 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' HA3' ' CA ' ' A' ' 47' ' ' GLU . . . -125.46 109.89 1.25 Allowed Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.541 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.5 p -114.38 -30.92 6.42 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.486 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -134.79 141.89 40.3 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.702 0.287 . . . . 0.0 111.622 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.528 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 61.2 Cg_endo -99.97 144.65 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.102 2.535 . . . . 0.0 113.845 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -106.72 161.26 14.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' CD2' HD12 ' A' ' 105' ' ' LEU . 6.0 tp -116.92 140.67 49.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 15.4 t80 -100.3 123.26 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 110.27 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 72' ' ' VAL . 11.2 p -112.46 164.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.542 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' CG2' ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.58 41.94 3.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -171.21 -101.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.394 178.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t0 177.95 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -98.42 -34.99 10.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 19.4 m -62.16 -31.17 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.916 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.59 84.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.272 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -69.88 -20.62 63.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.576 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -65.05 61.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.112 178.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -59.38 152.63 20.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -42.02 159.44 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.653 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.91 32.12 61.33 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.187 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 5.6 m-20 -128.62 128.4 44.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 111.015 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 30' ' ' THR . 0.7 OUTLIER -99.98 140.45 34.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.444 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -135.18 159.71 40.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.442 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -123.04 129.53 51.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.499 HD13 ' CZ ' ' A' ' 88' ' ' PHE . 2.3 tt -137.88 135.47 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.47 -95.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.03 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 40.8 mm-40 -50.66 -27.35 6.78 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 98.65 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.813 1.245 . . . . 0.0 111.663 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.5 111.18 5.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CD1' ' HD3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -140.48 139.76 35.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.558 173.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.431 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 7.0 t90 -134.93 142.42 46.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 59.8 t -84.29 108.51 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 121.874 0.845 . . . . 0.0 110.902 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 104' ' ' TRP . 11.9 t70 -85.59 -5.58 59.26 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.864 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 90' ' ' VAL . 9.6 mtm-85 -44.29 174.15 0.0 OUTLIER 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.265 0.555 . . . . 0.0 111.901 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.74 153.58 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.08 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -161.61 85.02 1.7 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 -25.23 47.46 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.633 2.222 . . . . 0.0 112.407 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -170.72 -52.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.18 77.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.49 157.7 40.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.575 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.92 49.96 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.9 p -103.98 130.71 51.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.938 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.47 55.09 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.574 ' CG ' ' CZ3' ' A' ' 104' ' ' TRP . 1.6 t-80 -108.62 -41.53 4.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.779 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.7 OUTLIER 61.99 77.22 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.805 178.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.574 ' CZ3' ' CG ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -99.48 120.34 39.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.528 HD13 ' CD2' ' A' ' 88' ' ' PHE . 10.9 mt -107.75 161.19 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.947 0.879 . . . . 0.0 113.282 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.34 117.21 2.22 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.686 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.552 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mmm180 -98.0 156.68 16.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.448 0.642 . . . . 0.0 112.348 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.01 39.63 1.05 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.076 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG23 ' CG ' ' A' ' 85' ' ' GLU . 7.4 p -32.08 94.12 0.07 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -90.37 179.34 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.057 2.505 . . . . 0.0 111.675 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.62 -67.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.536 2.157 . . . . 0.0 112.159 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.87 109.78 0.29 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.805 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 113' ' ' VAL . 7.5 p -141.04 25.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.599 . . . . 0.0 110.519 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 48.63 76.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -94.59 148.4 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 127.08 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.058 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.95 179.81 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.813 0.34 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.28 -68.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.56 45.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -108.87 -35.04 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -107.18 60.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.75 62.84 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.9 -54.58 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.817 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.76 117.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -127.42 -51.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.94 -64.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.69 46.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.018 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.8 tt -179.88 161.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.371 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 72.08 23.6 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.161 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -111.33 27.69 9.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.02 -179.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 11.0 p30 -178.6 173.01 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -122.52 42.69 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.918 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m 52.42 91.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.0 mt -87.87 56.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt85 -109.67 32.5 4.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.75 92.67 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 172.28 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mtt -62.87 -81.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.81 47.96 45.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.46 HG23 ' CB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -92.89 138.49 31.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 112.072 -178.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 64.8 m -118.94 124.95 48.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.166 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 39' ' ' ILE . . . -124.98 138.83 54.22 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 5.4 m -115.95 133.9 55.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.331 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.492 HG22 ' HG ' ' A' ' 75' ' ' LEU . 1.9 mm -99.81 131.6 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.132 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -137.35 98.96 3.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.67 178.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.431 ' CB ' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -108.1 159.56 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.798 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.08 70.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -75.63 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.886 0.374 . . . . 0.0 111.993 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -137.87 77.16 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.31 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 29.4 p -74.29 123.54 24.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.788 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.5 48.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.17 126.12 29.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -99.71 122.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.436 HG12 ' CD1' ' A' ' 29' ' ' ILE . 2.4 pp -122.01 156.98 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -99.07 140.38 33.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.873 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 159.15 152.57 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.068 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -124.6 178.64 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.284 0.564 . . . . 0.0 111.707 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 2.4 t80 -89.66 140.78 29.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.254 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' SER . 3.8 t0 -127.53 139.64 52.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -116.75 106.95 47.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.092 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 13.9 Cg_exo -70.04 -38.26 7.41 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.759 2.306 . . . . 0.0 112.24 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.66 48.11 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.52 145.56 55.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 tt -79.4 143.98 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 t 59.86 27.07 16.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.45 63.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 67.21 -67.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.326 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -56.52 4.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.646 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 69.72 136.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.754 0.311 . . . . 0.0 110.796 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.19 36.85 49.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.396 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.17 105.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -86.29 99.52 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.077 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 12.4 p -94.79 37.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 74.96 71.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.62 163.37 24.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.99 -44.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.412 ' OG ' ' CZ2' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -130.69 170.0 12.25 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.676 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 76.7 Cg_endo -98.98 137.99 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.936 2.424 . . . . 0.0 112.996 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -107.13 164.74 11.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.979 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.529 ' CD1' ' CE2' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -115.35 139.72 49.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.996 -177.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -93.82 121.08 34.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.643 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' CG1' HG21 ' A' ' 72' ' ' VAL . 10.0 p -122.18 160.16 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.199 0.524 . . . . 0.0 112.15 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -134.41 65.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.318 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER 167.49 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.002 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -66.36 62.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' THR . 5.6 mt-10 -126.39 -45.82 1.65 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.668 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG21 ' CG1' ' A' ' 67' ' ' VAL . 5.2 m -57.53 -30.29 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.046 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -48.49 77.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.424 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.4 mt-30 -63.29 -19.76 64.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.574 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' HG ' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -67.11 63.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.599 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.8 mmm180 -55.32 160.89 2.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -53.04 146.46 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 77' ' ' ARG . . . 95.88 38.51 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.304 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HB3' ' CD2' ' A' ' 75' ' ' LEU . 2.5 t0 -140.36 150.59 44.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 111.305 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.435 HG22 ' CZ3' ' A' ' 89' ' ' TRP . 4.9 m -118.5 142.98 47.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.688 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -136.1 158.31 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.384 -178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 1.2 p -118.75 129.23 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.674 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 88' ' ' PHE . 0.6 OUTLIER -122.7 -136.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.858 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.74 -41.12 97.39 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.592 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -91.0 15.92 10.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.041 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 82' ' ' THR . 4.5 mt-10 57.71 19.78 5.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.399 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.439 ' ND2' ' CD ' ' A' ' 110' ' ' PRO . 18.1 m120 -144.89 112.66 6.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.537 ' CE1' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -138.98 150.98 46.48 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.435 ' CZ3' HG22 ' A' ' 80' ' ' THR . 30.9 t-105 -135.63 141.92 45.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.439 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.475 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 9.2 t -84.98 107.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.099 0.952 . . . . 0.0 110.532 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' TRP . 33.7 t0 -99.18 -5.89 29.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 3.7 mtm180 -20.04 115.54 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 94' ' ' SER . 1.7 p -49.69 158.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.705 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.31 160.0 74.11 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.96 -169.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.472 2.114 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.24 -65.08 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -97.08 71.04 2.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.06 132.71 3.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.75 15.88 61.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.688 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.91 157.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.5 m 62.46 61.69 1.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -139.28 -48.24 0.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.788 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.438 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 50.68 100.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.49 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.8 114.15 25.76 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.537 HD11 ' CE1' ' A' ' 88' ' ' PHE . 13.2 mt -107.39 163.31 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -172.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -143.95 122.13 1.77 Allowed Glycine 0 CA--C 1.521 0.461 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.019 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.504 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mtm180 -99.26 140.0 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.347 0.573 . . . . 0.0 111.828 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -116.69 -19.73 5.23 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.504 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.451 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 7.1 p 30.09 60.93 0.93 Allowed Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 109' ' ' VAL . 36.8 Cg_endo -95.27 -179.79 0.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.325 2.683 . . . . 0.0 111.784 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 -68.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.545 2.163 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.92 99.76 0.27 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.559 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.3 t -132.83 106.64 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -58.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.21 -29.48 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 54.84 104.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.818 0.342 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.51 167.11 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -152.88 40.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.15 149.24 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -162.69 70.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -116.47 165.37 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.43 132.2 44.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.01 79.81 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.13 82.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.24 84.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.88 53.97 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.3 tp -161.08 -43.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.082 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.56 28.63 3.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -147.24 45.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.019 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.9 39.4 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -119.26 172.17 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.33 -174.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.04 51.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.27 164.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.08 94.28 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.62 -122.34 2.88 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -121.65 157.77 30.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmm 65.27 -165.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.017 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 18.68 5.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.846 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.452 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -92.79 138.6 31.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.519 . . . . 0.0 112.062 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 49.6 m -126.73 124.33 39.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.445 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.47 142.59 51.2 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 3.8 m -114.34 132.88 56.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.149 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.489 HG22 ' HG ' ' A' ' 75' ' ' LEU . 4.3 mm -102.02 124.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 111.856 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.56 99.11 5.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.363 178.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.436 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -116.95 154.61 30.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.919 -179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.01 -17.7 30.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -88.56 -69.72 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -127.95 72.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 31' ' ' SER . 12.9 p -84.6 146.17 27.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.14 24.73 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.706 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.35 129.97 56.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.945 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 66.7 t -101.84 122.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.025 0.44 . . . . 0.0 111.315 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 29' ' ' ILE . 2.4 pp -116.33 160.09 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.966 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -102.94 147.07 27.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.615 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 150.83 153.32 6.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.014 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -124.03 175.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.556 0.693 . . . . 0.0 112.317 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.536 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 37.1 t80 -90.1 140.5 29.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.57 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 64' ' ' SER . 1.1 t70 -124.93 136.91 54.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.106 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 4.1 p30 -123.79 106.74 31.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.799 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.94 -64.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.608 2.205 . . . . 0.0 112.461 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -88.18 -68.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.261 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 44.85 49.58 9.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.576 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.51 -93.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 t 47.88 25.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.697 0.285 . . . . 0.0 111.351 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 -57.75 2.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.839 0.352 . . . . 0.0 110.992 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.91 -26.54 10.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.05 48.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.87 92.47 8.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.059 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.96 24.2 33.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.381 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.26 -29.14 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.336 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 62.78 110.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 13.9 p -94.79 31.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 74.11 37.19 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.76 99.11 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.371 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.04 -26.97 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.983 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.41 175.33 3.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 36.8 Cg_endo -98.68 150.52 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.986 2.458 . . . . 0.0 112.644 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -128.16 165.76 19.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.457 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -113.13 141.08 47.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.067 -177.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 2.2 m-85 -103.98 115.22 30.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.046 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.47 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 12.3 p -102.89 160.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.442 . . . . 0.0 111.523 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.12 -55.88 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.929 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -90.07 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.42 32.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.65 0.262 . . . . 0.0 111.363 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.33 -41.93 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.057 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' CG2' ' CG1' ' A' ' 67' ' ' VAL . 33.5 m -56.57 -33.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.985 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -54.02 -30.78 49.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.5 mt-30 -86.36 -22.71 26.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.624 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.489 ' HG ' HG22 ' A' ' 29' ' ' ILE . 6.5 mp -66.51 62.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 12.7 mmt-85 -60.33 158.03 12.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -42.53 157.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.605 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.5 27.56 54.39 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.401 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -125.7 139.91 53.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.471 HG23 ' CZ3' ' A' ' 89' ' ' TRP . 0.5 OUTLIER -108.31 138.87 43.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -140.26 158.58 43.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -121.11 122.28 39.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.237 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 HG21 ' CE1' ' A' ' 88' ' ' PHE . 6.4 tt -127.05 137.35 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.323 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 38.88 -92.69 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.946 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 63.0 mm-40 -49.54 -26.36 3.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 3.0 mt-10 101.34 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.619 1.168 . . . . 0.0 111.382 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 16.4 m120 -144.28 110.81 5.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.56 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -140.83 119.51 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.626 173.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.476 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 9.1 m95 -108.95 142.46 39.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.715 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' CG2' HD22 ' A' ' 81' ' ' LEU . 48.0 t -86.1 107.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.506 0.67 . . . . 0.0 110.348 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 16.4 t0 -89.35 -59.43 2.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.403 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.427 ' N ' ' HB3' ' A' ' 104' ' ' TRP . 5.2 mtp180 44.8 -177.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.362 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -110.04 30.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.962 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.5 p 61.9 151.77 0.1 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.24 147.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.538 2.159 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.87 100.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -158.5 28.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.55 95.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.47 68.0 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.431 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 m -56.19 95.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.01 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.3 p 174.54 68.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -128.69 -56.03 1.21 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.912 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.459 ' CG ' ' HB ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER 66.09 88.44 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.953 177.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.484 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.6 t90 -98.04 128.59 44.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.56 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 4.9 mp -100.29 159.76 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -140.01 110.2 0.67 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.352 172.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.535 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -97.79 156.73 16.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.469 0.652 . . . . 0.0 111.843 -175.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.42 53.55 0.37 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.127 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -29.91 143.61 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.589 0.756 . . . . 0.0 112.16 -178.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 109' ' ' VAL . 1.3 Cg_endo -43.39 174.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.468 2.779 . . . . 0.0 112.849 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.423 ' HA ' ' CB ' ' A' ' 110' ' ' PRO . 7.0 Cg_exo -72.22 -167.96 5.18 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.441 0.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 70.59 61.77 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.251 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 86' ' ' GLU . 86.5 t -115.14 68.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.899 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 m120 48.24 34.17 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.212 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.56 174.52 7.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -142.94 -77.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.927 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.26 -57.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -175.93 74.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -91.13 171.84 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -119.04 106.99 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -112.0 120.48 42.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.35 -55.2 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.13 126.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -55.58 -62.58 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.94 -53.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.46 33.62 5.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.178 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -144.26 -154.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.988 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . 49.45 50.84 17.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 39.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.815 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 63.11 103.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.63 -176.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.93 67.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 48.92 86.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.105 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.71 95.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -127.84 -175.7 3.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.98 -148.47 19.9 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.48 -179.5 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.13 -79.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.0 47.08 41.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.582 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.494 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.19 138.93 31.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.579 . . . . 0.0 112.29 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -133.07 123.96 26.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.285 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 83' ' ' ILE . . . -125.76 152.43 45.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.092 0.473 . . . . 0.0 109.977 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 82' ' ' THR . 16.2 m -124.18 133.02 53.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.143 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 HG22 ' HG ' ' A' ' 75' ' ' LEU . 4.0 mm -100.79 122.97 53.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.345 0.593 . . . . 0.0 111.835 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.0 98.75 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.106 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.424 ' N ' ' HB3' ' A' ' 35' ' ' SER . 98.6 p -120.06 160.4 22.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.848 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 -25.65 58.44 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.174 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.91 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 111.569 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 6.3 tt0 -143.44 57.02 1.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.04 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.424 ' HB3' ' N ' ' A' ' 31' ' ' SER . 14.0 p -49.24 118.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.71 46.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.478 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.84 126.06 23.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.9 p -99.48 132.33 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.485 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.2 pp -121.23 153.77 24.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 10.6 ttp180 -109.91 142.88 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 66' ' ' PHE . . . 121.28 149.07 8.05 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.48 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' CG2' ' HB ' ' A' ' 25' ' ' THR . 26.2 t -111.15 -120.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 65' ' ' LEU . 6.1 p90 -134.49 141.71 46.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 129.92 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.84 109.63 58.48 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.602 0.239 . . . . 0.0 111.01 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.83 -37.99 14.51 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.912 2.408 . . . . 0.0 112.8 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.01 40.84 1.04 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -103.35 32.15 3.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.813 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 pt -123.19 91.87 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.34 29.3 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.698 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -134.71 -66.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -161.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.006 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.09 153.03 2.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.456 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.07 54.73 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.997 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.79 63.25 0.37 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.24 -89.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.525 0.202 . . . . 0.0 111.123 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 8.9 mpt_? -71.66 -69.69 0.37 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.684 0.278 . . . . 0.0 110.811 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 57' ' ' ARG . 12.9 p 47.67 23.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.835 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER 173.89 35.46 0.0 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.65 54.87 0.27 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.305 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -79.9 123.29 27.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.528 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 141.59 8.95 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.15 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.41 150.74 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.582 2.188 . . . . 0.0 113.155 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -119.82 168.8 10.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.924 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -111.71 140.04 46.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.662 0.744 . . . . 0.0 111.194 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.411 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 62.8 t80 -94.63 135.35 36.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.272 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 14.5 p -133.08 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -102.76 37.31 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.95 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 97.5 m -164.32 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.377 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 69' ' ' THR . 51.0 t0 179.0 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.758 0.313 . . . . 0.0 110.879 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.24 -47.01 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.312 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' CG2' ' CG1' ' A' ' 67' ' ' VAL . 27.6 m -52.63 -35.16 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.278 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -30.59 52.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.62 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 76' ' ' ARG . 7.5 mt-30 -89.76 -19.17 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 29' ' ' ILE . 5.6 mp -66.04 67.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.8 mmt85 -62.53 151.79 36.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.078 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -43.92 137.47 3.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.024 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.97 34.74 3.91 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.163 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -140.55 147.79 40.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.188 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 m -111.12 150.36 29.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.778 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -145.05 152.49 40.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.445 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -113.23 120.68 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 5.3 tt -130.38 136.81 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.86 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 41.76 -92.34 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.81 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 4.6 mm-40 -53.12 -33.49 52.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' A' ' 85' ' ' GLU . 3.7 mm-40 116.04 19.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.196 1.398 . . . . 0.0 111.745 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.468 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 26.4 t-20 -144.21 121.6 11.66 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 118.845 -1.142 . . . . 0.0 114.03 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.599 ' CG ' HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -142.94 112.16 6.65 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 8.7 t90 -104.03 141.87 35.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.25 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.437 ' CG2' ' HG3' ' A' ' 92' ' ' ARG . 9.3 p -84.37 109.3 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.892 0.853 . . . . 0.0 111.622 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 104' ' ' TRP . 27.8 t0 -86.93 -4.31 59.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.796 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.437 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 6.3 mtm180 -37.71 161.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.232 0.539 . . . . 0.0 112.333 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.38 165.45 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.249 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.3 m 58.99 102.55 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.58 -27.52 53.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.451 2.101 . . . . 0.0 112.213 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -177.8 77.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.98 35.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.93 -165.66 13.3 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.15 -103.07 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.82 175.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 110.959 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.75 43.68 27.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' O ' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -116.98 33.99 5.33 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 109.704 178.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.44 HD11 ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -46.62 90.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.747 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 9.2 t90 -97.13 123.64 40.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.599 HD13 ' CG ' ' A' ' 88' ' ' PHE . 2.4 mt -104.92 163.3 12.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -171.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.85 121.01 1.41 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.89 174.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.513 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -98.26 157.58 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.525 0.678 . . . . 0.0 112.217 -175.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.59 39.45 1.09 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.89 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.401 HG23 ' HG3' ' A' ' 85' ' ' GLU . 7.1 p -31.68 103.51 0.21 Allowed Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 77.9 Cg_endo -91.17 171.0 3.16 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.075 2.517 . . . . 0.0 111.566 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.4 175.11 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.694 2.263 . . . . 0.0 112.049 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.24 97.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.438 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.51 131.24 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.515 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.86 113.0 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.025 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -120.74 151.24 39.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.74 146.59 40.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.842 0.353 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.75 94.52 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -127.88 -47.38 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -86.23 -26.25 25.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.004 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -120.87 134.9 55.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -129.9 62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -86.1 88.92 7.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -49.58 161.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -133.22 114.47 13.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.58 -54.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.51 41.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.13 -44.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.88 63.26 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -103.77 58.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.8 69.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.012 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.89 110.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.64 125.82 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.04 164.09 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.9 mt 58.72 74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.17 -39.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.67 158.94 7.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -149.93 88.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.9 ptm -62.08 151.78 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.58 45.4 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.198 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.506 ' OG1' ' CD1' ' A' ' 83' ' ' ILE . 1.1 t -92.7 133.18 36.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.135 0.493 . . . . 0.0 111.923 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 83' ' ' ILE . 70.3 m -115.45 123.32 48.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.286 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' A' ' 83' ' ' ILE . . . -122.71 146.94 47.03 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.229 0.538 . . . . 0.0 110.538 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 82' ' ' THR . 5.8 m -120.74 134.15 55.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.718 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG21 ' HG ' ' A' ' 75' ' ' LEU . 8.9 mm -104.58 125.42 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.168 0.509 . . . . 0.0 111.517 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.76 98.96 4.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.378 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.434 ' N ' ' HB3' ' A' ' 35' ' ' SER . 80.0 p -118.22 142.48 47.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.675 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.45 -30.07 1.28 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.855 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.62 -75.9 0.13 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.874 0.369 . . . . 0.0 111.627 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -126.48 64.83 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.434 ' HB3' ' N ' ' A' ' 31' ' ' SER . 93.8 p -77.32 127.68 33.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.675 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 135.97 48.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.78 132.37 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.72 123.41 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.4 pp -119.35 157.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.376 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -99.96 149.74 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.081 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 145.97 150.39 5.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.373 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.5 OUTLIER -120.63 178.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.713 0.768 . . . . 0.0 112.472 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.536 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 21.0 t80 -93.28 135.99 33.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.92 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -121.24 130.24 53.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.031 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.43 107.04 47.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.1 -33.2 95.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.437 2.091 . . . . 0.0 112.269 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.49 -49.29 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.86 116.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.791 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.12 146.95 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 59.18 30.63 20.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.06 -35.89 74.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.16 82.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.96 22.08 64.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.487 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -66.24 -77.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.24 -54.51 4.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -49.34 119.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.49 103.16 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 58' ' ' VAL . 11.5 p -111.54 28.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 70.17 11.32 7.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 44.73 32.11 2.88 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.12 -74.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 0.0 110.719 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.501 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 1.5 p 172.34 131.08 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.984 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 40.5 Cg_endo -105.7 138.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.764 2.309 . . . . 0.0 113.878 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -108.58 164.33 12.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.87 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -114.44 139.66 49.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.8 m-85 -96.38 112.74 24.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 ' CG1' HG21 ' A' ' 72' ' ' VAL . 11.3 p -109.69 163.36 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.717 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.19 -62.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.124 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.5 m -86.02 -110.33 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.415 -177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -164.82 24.95 0.06 Allowed 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.071 -0.393 . . . . 0.0 111.543 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.84 -35.47 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 109.76 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.454 ' HB ' ' CD1' ' A' ' 103' ' ' LEU . 16.6 m -63.12 -39.07 83.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.561 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' N ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -51.63 -33.08 31.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.304 0.573 . . . . 0.0 110.077 177.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.7 mt-30 -81.99 -23.72 35.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.66 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -63.25 75.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.663 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' GLN . 3.4 mmt180 -71.09 155.26 41.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.855 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -41.82 149.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.916 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.47 35.4 8.65 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.671 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' CB ' HD22 ' A' ' 75' ' ' LEU . 96.7 m-20 -140.66 150.83 44.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.279 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 30' ' ' THR . 1.8 m -116.88 147.36 42.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.335 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' CD2' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -139.22 158.94 43.29 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.802 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -124.99 132.39 53.27 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.506 -0.121 . . . . 0.0 110.903 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.543 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 13.7 tt -152.29 143.11 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 46.18 -94.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.475 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -53.44 -33.73 55.15 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 85' ' ' GLU . 4.9 pt-20 102.56 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.412 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.42 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -142.44 110.19 5.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.288 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.58 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -136.55 138.47 41.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.5 t-105 -132.95 144.42 50.12 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.195 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.471 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 7.7 t -84.95 107.47 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.871 0.843 . . . . 0.0 110.041 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 8.1 t70 -96.73 -3.94 41.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.798 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.422 ' CG ' ' HA ' ' A' ' 103' ' ' LEU . 4.4 mtm180 -29.77 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.657 0.783 . . . . 0.0 112.961 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.84 -65.77 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.143 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -172.83 141.5 1.02 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.38 81.65 2.24 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.593 2.196 . . . . 0.0 112.343 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.09 -175.4 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -73.78 104.6 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.34 -44.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.569 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.28 35.1 4.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.49 132.75 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.826 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.59 50.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CG ' ' CZ3' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -119.35 -40.96 2.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.666 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.454 ' CD1' ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER 49.97 97.89 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.884 -177.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.525 ' CZ3' ' CG ' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -98.34 136.88 37.87 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.58 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 3.5 mp -110.03 161.09 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -169.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -147.99 110.52 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 112.99 -1.914 . . . . 0.0 109.814 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.521 ' HD3' ' CE1' ' A' ' 88' ' ' PHE . 2.4 mtm180 -97.98 130.39 44.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.765 0.782 . . . . 0.0 111.796 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.38 -19.13 75.83 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.152 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 110' ' ' PRO . 61.9 t -123.5 138.11 29.63 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HD2' ' CG1' ' A' ' 109' ' ' VAL . 28.0 Cg_endo -62.4 165.97 14.16 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.59 2.193 . . . . 0.0 112.32 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.18 -154.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.956 2.437 . . . . 0.0 112.185 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 62.95 64.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.032 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.433 HG21 ' CA ' ' A' ' 85' ' ' GLU . 59.5 t -117.97 -21.38 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.573 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.93 -54.18 50.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 50.85 -168.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -106.72 20.53 18.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.982 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.801 0.334 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.12 -177.18 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.033 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -147.12 161.52 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 52.07 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -176.29 148.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.68 -29.91 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.73 -28.86 23.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -126.39 146.94 49.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.27 86.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.51 73.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.176 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.8 30.95 16.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.187 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -134.24 -47.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.75 91.39 4.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.023 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.42 47.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.59 57.26 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.23 86.74 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.99 130.2 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -38.31 -33.49 0.1 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.229 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.421 HD13 HG23 ' A' ' 19' ' ' ILE . 40.6 mt -55.44 136.9 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.015 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.8 mtm-85 66.2 76.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.85 -148.56 8.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -149.62 85.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.328 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.62 -75.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.702 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 19.56 63.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.464 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -92.41 130.1 38.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.526 . . . . 0.0 111.706 -179.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 69.1 m -115.05 123.24 48.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.633 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 83' ' ' ILE . . . -124.01 145.94 48.86 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 8.4 m -121.13 134.35 55.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.205 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.488 HG21 ' HG ' ' A' ' 75' ' ' LEU . 8.9 mm -102.48 125.33 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.452 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.81 99.22 4.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.813 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' N ' ' HB2' ' A' ' 35' ' ' SER . 20.1 m -98.07 157.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.49 -18.66 23.55 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -126.1 -40.71 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.615 0.245 . . . . 0.0 111.385 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -112.19 63.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.494 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB2' ' N ' ' A' ' 31' ' ' SER . 17.8 t -104.78 120.3 41.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.654 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.15 42.3 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.35 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.48 127.02 16.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.3 130.53 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 29' ' ' ILE . 1.9 pp -125.57 155.9 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -100.81 144.59 29.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.071 178.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 155.45 154.79 7.06 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.664 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.2 t -128.3 169.87 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.799 . . . . 0.0 111.901 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.544 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 2.4 t80 -89.93 127.73 36.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.119 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' PRO . 1.6 t0 -113.98 144.57 42.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.609 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.75 108.23 35.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.155 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.35 -29.23 9.65 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.226 . . . . 0.0 112.029 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.66 25.88 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.237 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -68.38 -33.14 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.887 0.375 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 13.8 tt -143.19 95.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.049 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.0 27.94 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.11 -78.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.35 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 106.85 1.49 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -95.63 149.06 21.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.93 15.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.418 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 m -151.49 121.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.015 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -99.0 87.71 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 58' ' ' VAL . 11.6 p -95.03 38.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 68.84 41.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.775 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.43 -83.88 0.97 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.711 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.3 m -114.08 -30.0 6.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.735 0.302 . . . . 0.0 111.252 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.48 166.7 0.12 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.896 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 37.5 Cg_endo -98.33 150.68 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.217 1.945 . . . . 0.0 112.888 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.26 165.97 19.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.78 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 105' ' ' LEU . 2.9 tp -112.43 139.51 47.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.687 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -101.53 112.84 25.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.184 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 72' ' ' VAL . 11.4 p -102.87 157.97 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 111.577 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -67.49 -31.55 71.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.433 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.53 -96.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.577 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.57 19.7 0.4 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.674 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -61.15 -48.29 82.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 109.974 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.437 ' HB ' ' CD1' ' A' ' 103' ' ' LEU . 16.0 m -53.78 -35.56 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.469 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -31.96 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -82.96 -20.93 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.686 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.488 ' HG ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.2 64.21 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.188 0.518 . . . . 0.0 110.664 178.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -55.1 160.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -52.87 145.43 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.407 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.97 6.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.845 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' CB ' HD22 ' A' ' 75' ' ' LEU . 92.8 m-20 -140.55 150.53 43.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.425 ' O ' ' CG2' ' A' ' 30' ' ' THR . 1.5 m -116.29 145.29 43.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -134.2 159.62 40.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.99 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.94 129.85 52.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.58 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.552 HG22 ' CD1' ' A' ' 88' ' ' PHE . 1.8 tt -126.08 -127.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.45 -71.32 0.77 Allowed Glycine 0 CA--C 1.5 -0.9 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.853 -176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -55.32 -23.96 26.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.455 ' HA ' ' N ' ' A' ' 83' ' ' ILE . 1.3 pt-20 89.99 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.342 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -142.15 109.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.699 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -138.02 136.55 37.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.767 176.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 7.8 m95 -130.43 143.31 50.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.646 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 33.7 t -85.29 107.11 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.96 0.886 . . . . 0.0 109.905 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.51 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 27.0 t0 -90.35 -3.67 57.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 5.4 mtm180 -34.7 156.16 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.196 0.599 . . . . 0.0 112.58 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.3 -170.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.584 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.6 91.08 13.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.668 0.271 . . . . 0.0 110.937 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 54.2 Cg_exo -52.52 175.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.715 2.276 . . . . 0.0 112.416 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.04 78.84 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.2 t0 64.91 87.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.75 137.22 7.98 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.468 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' PRO . . . 95.92 112.58 2.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.549 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 p -169.9 36.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 43.3 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -136.55 64.52 1.55 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.287 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -55.87 111.5 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.51 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 8.1 t90 -97.56 127.9 43.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.55 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 5.0 mp -100.77 160.77 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -149.0 107.63 0.37 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.054 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.53 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.4 mtm180 -97.25 131.45 43.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.684 0.742 . . . . 0.0 111.392 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.2 -17.48 52.47 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.387 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.436 ' CG2' ' HD2' ' A' ' 110' ' ' PRO . 14.8 p -74.92 141.34 74.97 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 111.331 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.479 ' CB ' ' CD ' ' A' ' 111' ' ' PRO . 52.2 Cg_exo -54.72 -172.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.483 2.122 . . . . 0.0 111.828 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 110' ' ' PRO . 11.6 Cg_exo -68.38 -41.99 6.0 Favored 'Trans proline' 0 CA--C 1.518 -0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 111.873 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.36 77.94 0.1 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.667 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 113' ' ' VAL . 88.3 t -93.68 48.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.555 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 45.5 69.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.336 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -113.02 141.29 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -152.76 -73.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.69 33.94 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t0 69.84 89.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.99 91.21 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -146.95 43.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.818 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 t30 70.29 171.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.975 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.98 127.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.26 127.22 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.5 t70 68.44 -67.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 78.23 19.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.151 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 13.98 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.324 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -124.89 -40.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 111.062 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.15 120.57 23.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -133.04 31.13 3.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.58 -71.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.84 -60.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.04 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 65.76 122.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.74 154.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.816 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 tt -145.68 144.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -96.4 -62.66 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.17 110.12 2.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.411 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -57.02 123.2 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.51 102.92 14.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.17 38.51 1.79 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.815 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.491 ' CG2' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.89 138.1 31.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.3 0.572 . . . . 0.0 112.262 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 67.8 m -117.61 123.79 47.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.239 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' CB ' HG13 ' A' ' 83' ' ' ILE . . . -126.0 141.24 52.05 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 4.5 m -118.16 132.18 56.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.216 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 5.3 mm -103.52 126.9 57.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.359 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.5 99.22 4.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.282 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' N ' ' HB3' ' A' ' 35' ' ' SER . 3.0 p -115.31 156.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.05 -18.58 27.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.621 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.38 -70.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 111.247 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -130.65 71.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB3' ' N ' ' A' ' 31' ' ' SER . 66.3 p -81.4 134.55 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.94 49.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.04 127.7 16.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.8 p -99.51 122.56 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.3 pp -112.05 157.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 12.1 ttp180 -100.64 133.15 45.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.887 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 157.24 158.75 9.09 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.789 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.3 t -129.11 167.53 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.828 0.823 . . . . 0.0 111.918 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 4.8 t80 -89.22 120.72 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.954 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.53 137.32 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -124.67 107.1 29.24 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.81 -45.87 15.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.459 2.106 . . . . 0.0 111.895 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.05 49.23 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.565 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -46.06 122.4 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.89 25.82 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 m -111.25 27.52 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.34 172.53 7.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 94.51 8.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.74 83.08 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.459 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -82.2 64.33 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.45 51.82 1.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.526 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.03 136.44 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.14 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.003 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 58' ' ' VAL . 13.0 p -105.21 29.11 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.045 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 67.16 24.8 9.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.05 155.19 16.8 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.5 p -158.07 33.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 111.03 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.79 154.32 0.28 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 39.2 Cg_endo -99.14 150.91 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.242 2.628 . . . . 0.0 112.47 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -130.09 164.65 23.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 111.338 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CB ' ' CD1' ' A' ' 105' ' ' LEU . 3.5 tp -113.7 140.93 47.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.435 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 3.7 m-30 -108.49 113.03 25.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.387 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.463 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 12.6 p -98.46 149.54 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.165 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 8.7 mmm180 -96.44 23.69 6.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.794 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.9 m -163.44 -112.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.816 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -161.59 26.25 0.12 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.021 0.373 . . . . 0.0 110.922 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -81.35 -43.35 19.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.531 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.467 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 29.6 m -54.12 -37.94 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -36.58 59.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.884 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.9 mt-30 -77.73 -25.39 49.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.409 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.18 62.85 0.06 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.667 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 1.5 mmt-85 -56.74 158.83 4.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.002 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -49.48 149.76 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.04 37.27 7.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 8.3 m-20 -136.03 148.42 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.8 m -113.55 135.1 54.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.477 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -133.89 160.09 38.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 -179.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 1.2 p -123.03 129.0 50.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.532 HG23 ' CD1' ' A' ' 88' ' ' PHE . 3.9 tt -129.71 -139.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.443 ' N ' HG22 ' A' ' 83' ' ' ILE . . . -51.64 -44.68 54.47 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 119.198 0.908 . . . . 0.0 111.628 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' ASN . 1.0 OUTLIER -96.57 28.99 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 173.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.484 ' HA ' ' N ' ' A' ' 83' ' ' ILE . 0.6 OUTLIER 34.54 33.49 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.808 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -141.85 109.87 5.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.221 0.534 . . . . 0.0 111.923 177.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.552 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -140.95 142.17 34.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.734 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 2.0 t-105 -134.79 142.62 46.74 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.477 ' CG2' HD21 ' A' ' 81' ' ' LEU . 59.5 t -85.56 107.44 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.126 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 21.4 t0 -90.24 -56.75 3.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.684 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.443 ' HG3' ' CG1' ' A' ' 90' ' ' VAL . 5.4 mmm180 42.97 -176.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.726 175.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 m -63.16 173.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.767 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.29 151.69 93.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.735 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -47.16 -33.69 16.14 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.525 2.15 . . . . 0.0 112.365 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.1 76.13 1.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.908 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.86 158.95 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.17 109.0 3.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.541 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.15 -64.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.443 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 p 65.64 130.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 111.016 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.6 m 61.92 46.18 6.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.1 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -128.11 44.35 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.326 0.584 . . . . 0.0 110.297 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD11 ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -46.77 93.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.806 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.8 t90 -98.63 128.75 45.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.552 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 4.5 mp -103.1 160.69 14.42 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -171.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -139.08 103.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.749 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.511 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.0 mtm180 -97.46 142.71 28.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.306 0.553 . . . . 0.0 111.17 -176.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.47 -16.64 63.77 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.01 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.36 75.31 58.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.696 0.284 . . . . 0.0 110.896 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 67.9 Cg_exo -47.97 -44.26 28.07 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.482 2.121 . . . . 0.0 112.618 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 110' ' ' PRO . 6.8 Cg_exo -73.87 -153.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.704 2.269 . . . . 0.0 112.02 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 49.35 98.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -171.42 129.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -75.36 122.36 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.0 111.06 20.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.73 168.04 15.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.02 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.7 27.52 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -166.41 135.75 3.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.7 170.92 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.87 -69.08 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 m120 177.45 158.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.46 76.76 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -110.24 -22.22 11.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 71.3 51.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.81 -44.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.83 50.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.029 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -159.08 -42.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.85 -59.17 2.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.03 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 51.74 31.0 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.02 -171.08 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.008 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 67.23 152.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.52 102.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.2 m 55.78 77.77 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.23 56.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 117.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.94 -176.98 15.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.565 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -91.12 -45.19 8.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 110.946 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.31 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 41.49 47.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.759 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.468 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.72 138.52 31.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.37 0.605 . . . . 0.0 111.922 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 44.0 m -122.9 128.52 50.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.8 139.99 53.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 81' ' ' LEU . 4.9 m -114.56 130.89 56.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.493 HG21 ' HG ' ' A' ' 75' ' ' LEU . 4.2 mm -100.06 128.65 51.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.435 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.4 OUTLIER -136.88 99.18 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.857 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.438 ' N ' ' HB3' ' A' ' 35' ' ' SER . 4.8 m -95.68 159.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -14.6 39.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.969 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -119.9 -48.04 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.68 68.75 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 111.849 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.438 ' HB3' ' N ' ' A' ' 31' ' ' SER . 40.9 p -98.73 122.69 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.82 41.77 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.424 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . . . -140.72 121.74 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.339 . . . . 0.0 110.799 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 77.5 t -99.5 119.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.148 0.499 . . . . 0.0 111.442 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.5 pp -112.33 159.8 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.374 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.45 146.31 27.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.061 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 153.0 148.86 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.703 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 1.2 t -119.11 171.98 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 0.0 111.689 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.542 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 36.7 t80 -90.02 132.91 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -119.4 136.31 54.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.008 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -123.24 106.76 33.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.754 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.41 -45.86 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.669 2.246 . . . . 0.0 112.26 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.75 -83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.053 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.0 t30 64.37 112.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.461 HD13 HG23 ' A' ' 49' ' ' ILE . 15.6 mt -84.74 63.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -108.95 28.97 7.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -137.01 172.13 13.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . . . -92.8 140.59 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.73 -75.24 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.369 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER 58.34 89.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.017 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.32 -28.43 73.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.294 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 m -52.74 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.047 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -73.0 122.21 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.966 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 58' ' ' VAL . 12.7 p -92.98 21.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.24 38.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.48 -32.26 3.73 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.429 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.08 168.15 9.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.939 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -134.8 179.09 1.47 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.542 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 32.5 Cg_endo -98.28 150.71 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.119 2.546 . . . . 0.0 112.374 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -129.32 165.57 21.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 105' ' ' LEU . 4.9 tp -112.42 138.67 48.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.448 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 27.1 m-85 -101.3 113.3 26.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.474 ' CG1' ' CG2' ' A' ' 72' ' ' VAL . 9.1 p -107.38 161.28 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.294 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.87 46.43 2.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.568 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.7 m -163.97 -108.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.056 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 48.1 t0 179.75 36.6 0.0 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.887 0.375 . . . . 0.0 110.739 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 tt0 -104.71 -43.4 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.232 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 67' ' ' VAL . 9.9 m -56.88 -37.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.416 ' N ' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -53.99 -41.77 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.814 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -73.9 -18.76 60.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.006 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.493 ' HG ' HG21 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.07 65.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 110.926 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' HA ' ' NH2' ' A' ' 92' ' ' ARG . 4.1 mmt180 -58.54 156.1 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.03 141.03 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.273 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.38 29.78 5.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.436 ' CB ' HD23 ' A' ' 75' ' ' LEU . 75.2 m-20 -140.37 150.47 43.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.119 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 30' ' ' THR . 0.5 OUTLIER -115.7 145.05 43.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.349 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -136.27 160.26 39.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.133 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.96 135.8 54.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.512 ' CG2' ' CD1' ' A' ' 88' ' ' PHE . 3.0 tt -137.58 89.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.9 -68.78 0.19 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 10.6 mm-40 -62.1 -16.74 54.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.386 172.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER 84.19 19.13 0.17 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.051 0.54 . . . . 0.0 111.081 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -142.94 119.05 10.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.546 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -149.44 130.57 14.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.865 169.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.8 OUTLIER -128.49 143.63 51.01 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.518 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' CG2' HD21 ' A' ' 81' ' ' LEU . 6.3 t -85.2 108.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.664 0.745 . . . . 0.0 110.922 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 9.8 t0 -92.04 -5.43 52.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.506 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.442 ' NH2' ' HA ' ' A' ' 76' ' ' ARG . 4.8 mtm-85 -37.96 161.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.229 0.537 . . . . 0.0 112.347 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.81 -37.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.0 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t 68.16 81.68 0.2 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.059 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.79 -167.45 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -128.65 29.55 5.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -162.65 -177.84 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -48.88 113.64 1.7 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.98 108.91 0.31 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.434 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.72 -169.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.867 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.2 t 76.76 26.9 0.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -115.92 -39.74 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.055 0.455 . . . . 0.0 110.141 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.449 ' CD1' ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER 52.13 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.604 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.486 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 6.5 t90 -96.62 126.55 41.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 5.3 mp -97.22 160.06 14.56 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -140.86 99.09 0.24 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 87' ' ' ASN . 6.5 ttp180 -99.22 156.77 16.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.72 44.81 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.231 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.512 ' CG1' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -25.04 -67.8 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.096 0.958 . . . . 0.0 113.017 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.512 ' HD3' ' CG1' ' A' ' 109' ' ' VAL . 96.1 Cg_endo -79.46 151.32 22.62 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.782 1.655 . . . . 0.0 112.437 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -93.72 -158.77 0.75 Allowed 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.584 -1.006 . . . . 0.0 112.213 0.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 42.16 98.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.102 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.436 ' CG1' ' HA ' ' A' ' 85' ' ' GLU . 94.6 t -139.31 152.61 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 76.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 113' ' ' VAL . 1.1 mtm-85 -82.43 99.16 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -71.41 163.45 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.93 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.55 -77.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.229 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -119.51 177.25 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.029 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.29 -165.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 t70 69.87 42.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 67.45 175.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.4 mt -67.94 -173.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -142.13 142.74 32.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -169.03 175.75 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 77.58 -59.2 0.46 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.936 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.26 30.21 3.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.895 0.379 . . . . 0.0 110.926 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 tt -171.68 161.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.423 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 74.72 92.23 0.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.035 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -102.01 -50.81 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.4 49.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.48 106.35 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.28 122.75 1.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 m 61.7 99.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.789 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.7 tt -89.91 -19.97 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.44 50.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.07 -108.82 0.42 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.5 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 67.0 135.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.171 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -82.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.747 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 40' ' ' ARG . . . 67.61 62.53 4.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.717 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.451 HG21 ' CA ' ' A' ' 42' ' ' VAL . 14.9 t -93.01 138.7 31.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 54.6 m -105.04 122.97 46.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.573 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.85 145.56 49.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 110.061 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 2.5 m -120.59 133.74 55.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.479 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 8.1 mm -103.63 122.26 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.0 OUTLIER -126.91 99.44 5.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.431 ' N ' ' HB3' ' A' ' 35' ' ' SER . 6.5 p -115.17 157.98 22.88 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -17.34 32.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.758 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.64 -71.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -132.53 69.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.447 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 68.6 p -73.99 167.04 22.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.76 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 50.76 2.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.597 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.58 132.37 38.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.923 0.392 . . . . 0.0 110.963 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.6 p -99.88 118.28 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.45 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 27' ' ' ALA . 2.1 pp -123.52 154.63 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.368 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -100.3 125.39 46.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . -176.91 143.32 6.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.385 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' CA ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -119.26 -162.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.29 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 6.6 t80 -122.16 110.15 15.4 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.432 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.83 129.24 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.512 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.36 108.7 62.27 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.14 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.67 -57.17 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.479 2.119 . . . . 0.0 112.269 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -73.27 -25.62 60.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 68.03 86.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.7 mt -76.0 157.55 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.27 27.59 17.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -106.98 154.22 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.22 131.15 32.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 -77.14 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.439 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.81 30.15 12.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.62 49.62 2.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.393 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.72 149.52 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -127.9 99.0 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.429 ' CG2' ' O ' ' A' ' 58' ' ' VAL . 13.7 p -94.05 24.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.2 49.34 5.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.986 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.1 -66.71 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.383 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.7 p 48.78 25.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.209 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.29 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.241 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 37.6 Cg_endo -98.3 139.94 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.086 2.524 . . . . 0.0 113.162 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.48 165.32 12.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.847 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 2.3 tt -114.49 139.46 49.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.789 0.328 . . . . 0.0 110.425 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.421 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 84.3 t80 -97.84 111.15 23.56 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.4 ' HB ' HG21 ' A' ' 72' ' ' VAL . 10.6 p -100.68 163.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -71.96 -36.62 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.114 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.63 -96.49 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.616 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -152.47 17.64 0.62 Allowed 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 74' ' ' GLN . 6.8 tt0 -61.56 -46.81 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.418 . . . . 0.0 109.877 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . 10.8 m -51.49 -31.67 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.385 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -33.84 68.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' GLU . 3.0 mt-30 -78.71 -20.09 50.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.6 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HG ' ' CG2' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -66.28 62.65 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 178.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.6 mmm-85 -56.04 158.35 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 111.303 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -46.89 161.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.13 37.29 91.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 70.4 m-20 -129.32 131.07 46.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 30' ' ' THR . 54.7 m -100.55 138.78 37.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.552 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.469 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.64 159.51 41.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.298 -178.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 2.8 p -124.43 130.95 53.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.726 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.498 HG21 ' CD2' ' A' ' 88' ' ' PHE . 0.9 OUTLIER -120.99 -130.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.417 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -69.6 -34.08 72.69 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.638 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' HA ' ' CG2' ' A' ' 113' ' ' VAL . 9.3 mp0 -101.02 25.23 8.31 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' CG2' ' A' ' 82' ' ' THR . 10.3 pt-20 38.07 33.88 0.06 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.804 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -144.04 109.15 5.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.54 ' CD1' ' HG2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -140.59 149.68 42.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.491 ' CH2' ' HA3' ' A' ' 108' ' ' GLY . 12.3 m0 -133.23 142.73 48.71 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.901 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.474 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 94.0 t -85.32 106.59 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.821 0.819 . . . . 0.0 109.511 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 7.7 t0 -87.47 -2.11 58.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.668 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.443 ' CD ' ' HA ' ' A' ' 103' ' ' LEU . 3.2 mmp_? -36.79 163.78 0.0 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.692 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.1 -51.01 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.909 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.9 p 50.42 67.83 3.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.283 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.63 -28.71 37.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 111.905 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.0 p30 176.68 176.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -70.16 143.6 52.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.978 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.18 -99.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.39 -91.86 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 102' ' ' HIS . 0.2 OUTLIER 59.49 -163.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.6 m 77.34 32.49 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 100' ' ' SER . 0.4 OUTLIER -123.64 -47.67 1.95 Allowed 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.151 0.5 . . . . 0.0 110.479 178.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.497 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 0.2 OUTLIER 60.12 114.94 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.048 0.928 . . . . 0.0 110.129 -177.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.498 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 2.8 t90 -99.36 122.13 42.06 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.166 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.528 HD21 ' CD1' ' A' ' 88' ' ' PHE . 3.5 mp -89.74 156.72 18.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 89' ' ' TRP . . . -133.68 110.47 0.89 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.946 173.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.54 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 1.7 mmm180 -98.91 156.02 17.1 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.491 ' HA3' ' CH2' ' A' ' 89' ' ' TRP . . . -145.94 42.93 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.211 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' A' ' 85' ' ' GLU . 7.4 p -35.62 100.8 0.2 Allowed Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HB2' ' CD ' ' A' ' 111' ' ' PRO . 93.5 Cg_endo -83.46 -179.04 3.99 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.711 2.274 . . . . 0.0 111.598 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 110' ' ' PRO . 12.1 Cg_exo -69.91 -39.85 5.76 Favored 'Trans proline' 0 CA--C 1.519 -0.251 0 C-N-CA 122.481 2.121 . . . . 0.0 112.199 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.5 93.23 6.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.871 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 ' CG2' ' HA ' ' A' ' 85' ' ' GLU . 3.5 p -112.79 -21.32 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.817 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 58.42 69.69 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 110.898 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.83 96.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.26 120.92 12.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.74 113.34 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.84 -63.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -75.99 140.53 42.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -178.28 122.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -100.04 -63.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.163 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.4 mp -118.22 47.14 1.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.12 -73.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -158.5 -83.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.939 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.98 57.71 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.133 0.492 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.23 21.68 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.286 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -179.35 -41.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 111.218 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 169.96 170.32 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.956 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.9 37.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.38 -171.49 2.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -131.04 179.95 5.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.11 166.28 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.08 24.54 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.9 tt -173.32 69.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.032 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 -62.95 1.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 129.71 8.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.622 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 169.88 9.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.834 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.0 71.67 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.995 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.32 42.04 1.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.453 HG21 ' CB ' ' A' ' 42' ' ' VAL . 2.4 t -92.61 138.71 31.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.188 0.518 . . . . 0.0 111.824 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 75.1 m -119.91 129.76 54.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.694 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . . . -123.87 143.6 50.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.344 0.592 . . . . 0.0 110.553 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 m -119.66 133.71 55.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.84 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.485 ' CG2' ' HG ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER -100.6 128.3 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.18 0.514 . . . . 0.0 111.397 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -133.4 98.74 4.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.438 177.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.421 ' N ' ' HB3' ' A' ' 35' ' ' SER . 1.4 p -109.88 151.97 26.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.597 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.57 -39.79 38.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.165 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -75.24 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -139.27 68.45 1.37 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.434 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 31.3 p -65.02 128.7 36.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.29 55.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.536 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.72 123.26 14.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 p -99.67 117.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.195 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.425 HG12 ' CD1' ' A' ' 29' ' ' ILE . 2.3 pp -119.33 159.76 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.688 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -104.03 149.76 24.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.839 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 148.23 146.54 4.36 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -112.41 -168.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 1.9 t80 -115.53 125.05 52.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.77 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 137.72 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.87 106.81 49.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.798 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.77 -36.96 48.48 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.46 42.92 1.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.979 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -84.15 53.0 2.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 47.63 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.093 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.2 p 65.88 33.1 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.5 m-30 -81.2 61.9 4.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 53.69 -87.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.299 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 51' ' ' TYR . . . -109.23 -4.12 31.01 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.979 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 71.02 -170.62 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.935 0.367 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.73 32.06 5.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.412 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 58' ' ' VAL . 2.5 p -159.41 113.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 6.7 mmt180 62.76 -70.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.476 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 56' ' ' VAL . 8.2 p 48.37 26.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.771 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.418 ' OE2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -128.32 -42.79 1.48 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.878 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.28 131.42 2.75 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.663 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -100.88 -68.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.689 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.53 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER 176.84 138.96 0.22 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 42.4 Cg_endo -100.85 139.93 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.763 2.309 . . . . 0.0 114.414 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -107.31 164.19 12.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.2 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.467 ' HB2' ' CD1' ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.86 139.56 49.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.241 -177.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.0 m-85 -98.71 112.69 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.414 HG13 ' CG2' ' A' ' 72' ' ' VAL . 12.2 p -106.57 162.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.932 0.396 . . . . 0.0 111.79 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.25 -69.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.86 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.0 p -84.09 -96.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -174.99 31.98 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.292 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -76.5 -46.16 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.082 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.458 ' HB ' ' CD2' ' A' ' 103' ' ' LEU . 17.1 m -53.55 -34.41 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.32 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -54.39 -31.22 54.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.65 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -85.1 -21.91 29.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.718 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' ' CG2' ' A' ' 29' ' ' ILE . 3.8 mp -66.85 65.23 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 -59.15 155.26 14.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.993 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.03 136.93 13.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.316 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.46 30.18 4.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.838 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' OD2' ' CG2' ' A' ' 29' ' ' ILE . 16.2 t70 -140.56 144.01 35.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 30' ' ' THR . 2.0 m -112.41 140.12 47.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.561 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -132.16 158.52 41.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.318 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -119.29 130.66 55.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.239 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' A' ' 88' ' ' PHE . 1.0 OUTLIER -117.55 -129.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.382 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -71.12 -40.38 61.82 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.437 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -90.47 13.32 15.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.108 -0.546 . . . . 0.0 110.099 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 82' ' ' THR . 12.1 mt-10 64.96 20.74 12.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.402 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.446 ' ND2' ' HD3' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -145.07 112.66 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.561 ' CZ ' ' CD2' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -141.25 126.05 18.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.261 175.094 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.426 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 12.6 m95 -118.52 144.97 45.68 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.311 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' CG2' ' HG3' ' A' ' 92' ' ' ARG . 11.4 p -83.8 107.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.992 0.901 . . . . 0.0 109.863 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 12.9 t70 -93.53 -5.32 49.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.94 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.44 ' HG3' ' CG2' ' A' ' 90' ' ' VAL . 3.6 mtm180 -33.86 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.409 0.683 . . . . 0.0 112.544 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 128.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.159 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 t 54.27 76.64 0.5 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.36 -39.2 86.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.255 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.9 141.67 32.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.043 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.46 105.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.31 -83.34 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.507 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.4 -39.22 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER 50.77 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 72.58 25.88 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.046 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' ' C ' ' A' ' 100' ' ' SER . 1.9 m-70 -119.92 -45.82 2.46 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.458 ' CD2' ' HB ' ' A' ' 72' ' ' VAL . 6.5 tp 53.16 101.4 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.958 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 62' ' ' SER . 0.1 OUTLIER -96.6 133.93 40.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.058 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.561 ' CD2' ' CZ ' ' A' ' 88' ' ' PHE . 1.2 mp -106.07 160.88 14.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -171.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 89' ' ' TRP . . . -137.51 102.67 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.283 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' CZ ' ' CB ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -97.07 155.8 16.64 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.194 -0.592 . . . . 0.0 110.75 -177.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -142.05 1.8 1.76 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.583 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.454 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 7.8 p 26.04 59.99 0.48 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 109' ' ' VAL . 72.6 Cg_endo -94.93 157.54 1.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.217 2.611 . . . . 0.0 112.171 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.79 -67.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.422 2.082 . . . . 0.0 112.203 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -53.13 92.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.884 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 115' ' ' ARG . 47.7 t -158.2 -38.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.862 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -66.28 67.61 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.973 0.416 . . . . 0.0 110.695 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -141.1 120.3 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.086 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -102.8 -179.4 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.877 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.959 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.927 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -93.19 138.7 31.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 111.955 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 62.9 m -121.59 124.74 45.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.379 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.43 144.14 50.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 4.0 m -121.11 134.21 55.24 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.478 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 39' ' ' ILE . 3.1 mm -99.79 125.28 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.382 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.12 99.14 4.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.558 178.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.443 ' N ' ' HB2' ' A' ' 35' ' ' SER . 15.1 p -108.53 153.69 23.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.58 26.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -89.61 -69.1 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.76 0.314 . . . . 0.0 111.38 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -128.6 71.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.533 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.443 ' HB2' ' N ' ' A' ' 31' ' ' SER . 8.0 t -80.59 114.04 19.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.671 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.09 46.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.373 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 121.19 18.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 38' ' ' VAL . 18.5 m -99.69 117.41 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 29' ' ' ILE . 2.0 pp -114.09 159.93 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.698 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.699 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 154.55 146.67 4.47 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.927 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -115.06 174.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.681 0.753 . . . . 0.0 112.101 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.3 t80 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.618 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 105' ' ' LEU . 6.0 tp -116.92 140.67 49.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 15.4 t80 -100.3 123.26 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 110.27 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 68' ' ' ARG . 11.2 p -112.46 164.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.542 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.58 41.94 3.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -171.21 -101.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.394 178.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t0 177.95 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -98.42 -34.99 10.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 103' ' ' LEU . 19.4 m -62.16 -31.17 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.916 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.59 84.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.272 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.9 mt-30 -69.88 -20.62 63.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.576 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.029 HD22 HG21 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -65.05 61.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.112 178.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 74' ' ' GLN . 48.8 mmm-85 -59.38 152.63 20.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -42.02 159.44 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.653 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.91 32.12 61.33 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.187 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 5.6 m-20 -128.62 128.4 44.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 111.015 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.747 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -99.98 140.45 34.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.444 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.883 HD13 HD11 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -135.18 159.71 40.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.442 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -123.04 129.53 51.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.749 HD12 ' CE2' ' A' ' 88' ' ' PHE . 2.3 tt -137.88 135.47 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.47 -95.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.03 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 40.8 mm-40 -50.66 -27.35 6.78 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 98.65 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.813 1.245 . . . . 0.0 111.663 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.5 111.18 5.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.749 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -140.48 139.76 35.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.558 173.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.515 ' HD1' HG23 ' A' ' 80' ' ' THR . 7.0 t90 -134.93 142.42 46.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.029 HG21 HD22 ' A' ' 75' ' ' LEU . 59.8 t -84.29 108.51 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 121.874 0.845 . . . . 0.0 110.902 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 104' ' ' TRP . 11.9 t70 -85.59 -5.58 59.26 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.864 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG3' HG13 ' A' ' 90' ' ' VAL . 9.6 mtm-85 . . . . . 0 C--N 1.339 0.123 0 CA-C-O 121.265 0.555 . . . . 0.0 111.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.757 ' CD1' HG21 ' A' ' 72' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.095 0.474 . . . . 0.0 111.805 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -99.48 120.34 39.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 65' ' ' LEU . 10.9 mt -107.75 161.19 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.947 0.879 . . . . 0.0 113.282 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.34 117.21 2.22 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.686 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.553 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mmm180 -98.0 156.68 16.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.448 0.642 . . . . 0.0 112.348 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.076 178.089 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.963 ' OG1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -92.89 138.49 31.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 112.072 -178.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 64.8 m -118.94 124.95 48.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.166 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -124.98 138.83 54.22 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.45 ' C ' HD13 ' A' ' 29' ' ' ILE . 5.4 m -115.95 133.9 55.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.331 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.965 HD11 HG12 ' A' ' 39' ' ' ILE . 1.9 mm -99.81 131.6 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.132 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -137.35 98.96 3.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.67 178.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -108.1 159.56 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.798 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.08 70.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -75.63 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.886 0.374 . . . . 0.0 111.993 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -137.87 77.16 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.31 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 29.4 p -74.29 123.54 24.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.788 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.5 48.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.17 126.12 29.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 38' ' ' VAL . 13.6 p -99.71 122.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.965 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -122.01 156.98 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -99.07 140.38 33.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.873 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 159.15 152.57 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.068 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.957 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.6 178.64 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.284 0.564 . . . . 0.0 111.707 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.254 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.515 -0.385 0 CA-C-O 121.049 0.452 . . . . 0.0 110.979 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -115.35 139.72 49.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.996 -177.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -93.82 121.08 34.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.643 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 72' ' ' VAL . 10.0 p -122.18 160.16 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.199 0.524 . . . . 0.0 112.15 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' C ' HG22 ' A' ' 69' ' ' THR . 1.8 mpt_? -134.41 65.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.318 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' C ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER 167.49 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.002 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -66.36 62.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' THR . 5.6 mt-10 -126.39 -45.82 1.65 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.668 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 67' ' ' VAL . 5.2 m -57.53 -30.29 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.046 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -48.49 77.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.424 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.4 mt-30 -63.29 -19.76 64.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.574 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.09 HD22 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -67.11 63.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.599 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.8 mmm180 -55.32 160.89 2.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -53.04 146.46 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 77' ' ' ARG . . . 95.88 38.51 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.304 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.695 ' CG ' HD21 ' A' ' 75' ' ' LEU . 2.5 t0 -140.36 150.59 44.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 111.305 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' THR . 4.9 m -118.5 142.98 47.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.688 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.1 158.31 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.384 -178.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.005 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -118.75 129.23 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.674 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.963 HD11 ' OG1' ' A' ' 25' ' ' THR . 0.6 OUTLIER -122.7 -136.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.858 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.555 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -59.74 -41.12 97.39 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.592 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -91.0 15.92 10.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.041 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.005 ' O ' HG22 ' A' ' 82' ' ' THR . 4.5 mt-10 57.71 19.78 5.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.399 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 18.1 m120 -144.89 112.66 6.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.833 ' CD1' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -138.98 150.98 46.48 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.543 ' CE3' HG23 ' A' ' 80' ' ' THR . 30.9 t-105 -135.63 141.92 45.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.439 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.09 HG21 HD22 ' A' ' 75' ' ' LEU . 9.2 t -84.98 107.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.099 0.952 . . . . 0.0 110.532 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' TRP . 33.7 t0 -99.18 -5.89 29.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 3.7 mtm180 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.8 114.15 25.76 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.833 HD13 ' CD1' ' A' ' 88' ' ' PHE . 13.2 mt -107.39 163.31 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -143.95 122.13 1.77 Allowed Glycine 0 CA--C 1.521 0.461 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.019 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mtm180 -99.26 140.0 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.347 0.573 . . . . 0.0 111.828 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.504 177.957 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.846 -0.102 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -92.79 138.6 31.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.519 . . . . 0.0 112.062 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 83' ' ' ILE . 49.6 m -126.73 124.33 39.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.445 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.47 142.59 51.2 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 38' ' ' VAL . 3.8 m -114.34 132.88 56.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.149 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 75' ' ' LEU . 4.3 mm -102.02 124.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 111.856 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.56 99.11 5.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.363 178.322 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.45 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -116.95 154.61 30.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.919 -179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.01 -17.7 30.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -88.56 -69.72 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -127.95 72.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 31' ' ' SER . 12.9 p -84.6 146.17 27.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.14 24.73 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.706 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.35 129.97 56.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.945 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG22 ' OG1' ' A' ' 28' ' ' THR . 66.7 t -101.84 122.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.025 0.44 . . . . 0.0 111.315 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.775 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -116.33 160.09 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.966 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -102.94 147.07 27.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.615 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 150.83 153.32 6.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.014 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.03 175.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.556 0.693 . . . . 0.0 112.317 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.627 ' N ' HG13 ' A' ' 42' ' ' VAL . 37.1 t80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.57 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.846 0.355 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.956 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -113.13 141.08 47.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.067 -177.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 2.2 m-85 -103.98 115.22 30.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.046 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HG22 ' A' ' 72' ' ' VAL . 12.3 p -102.89 160.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.442 . . . . 0.0 111.523 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.12 -55.88 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.929 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -90.07 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.42 32.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.65 0.262 . . . . 0.0 111.363 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.33 -41.93 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.057 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.829 HG11 HD21 ' A' ' 65' ' ' LEU . 33.5 m -56.57 -33.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.985 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -54.02 -30.78 49.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.5 mt-30 -86.36 -22.71 26.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.624 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 29' ' ' ILE . 6.5 mp -66.51 62.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 12.7 mmt-85 -60.33 158.03 12.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -42.53 157.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.605 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.5 27.56 54.39 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.401 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -125.7 139.91 53.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.889 HG22 ' CE3' ' A' ' 89' ' ' TRP . 0.5 OUTLIER -108.31 138.87 43.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -140.26 158.58 43.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -121.11 122.28 39.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.237 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.874 HD11 ' OG1' ' A' ' 25' ' ' THR . 6.4 tt -127.05 137.35 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.323 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 38.88 -92.69 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.946 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 63.0 mm-40 -49.54 -26.36 3.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.975 ' O ' HG22 ' A' ' 82' ' ' THR . 3.0 mt-10 101.34 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.619 1.168 . . . . 0.0 111.382 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 16.4 m120 -144.28 110.81 5.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -140.83 119.51 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.626 173.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.889 ' CE3' HG22 ' A' ' 80' ' ' THR . 9.1 m95 -108.95 142.46 39.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.715 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.866 ' CG2' HD21 ' A' ' 81' ' ' LEU . 48.0 t -86.1 107.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.506 0.67 . . . . 0.0 110.348 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.487 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 16.4 t0 -89.35 -59.43 2.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.403 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.2 mtp180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.362 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.932 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.487 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.6 t90 -98.04 128.59 44.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.956 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.9 mp -100.29 159.76 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -140.01 110.2 0.67 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.352 172.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -97.79 156.73 16.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.469 0.652 . . . . 0.0 111.843 -175.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.127 178.967 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.924 HG21 HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.19 138.93 31.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.579 . . . . 0.0 112.29 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -133.07 123.96 26.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.285 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -125.76 152.43 45.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.092 0.473 . . . . 0.0 109.977 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 16.2 m -124.18 133.02 53.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.143 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD22 ' A' ' 81' ' ' LEU . 4.0 mm -100.79 122.97 53.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.345 0.593 . . . . 0.0 111.835 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -126.0 98.75 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.106 178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.436 ' N ' ' HB3' ' A' ' 35' ' ' SER . 98.6 p -120.06 160.4 22.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.848 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 -25.65 58.44 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.174 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.91 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 111.569 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 6.3 tt0 -143.44 57.02 1.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.04 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 31' ' ' SER . 14.0 p -49.24 118.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.71 46.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.478 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.84 126.06 23.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.9 p -99.48 132.33 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.485 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.587 HG12 HD11 ' A' ' 29' ' ' ILE . 2.2 pp -121.23 153.77 24.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.323 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 10.6 ttp180 -109.91 142.88 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . . . 121.28 149.07 8.05 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.48 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.924 HG23 HG21 ' A' ' 25' ' ' THR . 26.2 t -111.15 -120.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.658 ' N ' HG12 ' A' ' 42' ' ' VAL . 6.1 p90 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -111.71 140.04 46.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.662 0.744 . . . . 0.0 111.194 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 62.8 t80 -94.63 135.35 36.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.272 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.707 HG11 HG22 ' A' ' 72' ' ' VAL . 14.5 p -133.08 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 17.0 mmm180 -102.76 37.31 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.95 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 70' ' ' ASP . 97.5 m -164.32 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.377 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 69' ' ' THR . 51.0 t0 179.0 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.758 0.313 . . . . 0.0 110.879 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.24 -47.01 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.312 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.811 HG11 HD21 ' A' ' 65' ' ' LEU . 27.6 m -52.63 -35.16 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.278 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -30.59 52.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.62 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 76' ' ' ARG . 7.5 mt-30 -89.76 -19.17 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.855 HD11 HG21 ' A' ' 29' ' ' ILE . 5.6 mp -66.04 67.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.8 mmt85 -62.53 151.79 36.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.078 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -43.92 137.47 3.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.024 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.97 34.74 3.91 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.163 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 97.3 m-20 -140.55 147.79 40.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.188 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 81' ' ' LEU . 8.0 m -111.12 150.36 29.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.778 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.977 HD22 HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -145.05 152.49 40.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.962 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -113.23 120.68 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.672 HG21 ' CD1' ' A' ' 88' ' ' PHE . 5.3 tt -130.38 136.81 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.86 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 41.76 -92.34 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.81 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 4.6 mm-40 -53.12 -33.49 52.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.962 ' O ' HG22 ' A' ' 82' ' ' THR . 3.7 mm-40 116.04 19.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.196 1.398 . . . . 0.0 111.745 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.468 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 26.4 t-20 -144.21 121.6 11.66 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 118.845 -1.142 . . . . 0.0 114.03 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -142.94 112.16 6.65 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 8.7 t90 -104.03 141.87 35.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.25 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 90' ' ' VAL . 9.3 p -84.37 109.3 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.892 0.853 . . . . 0.0 111.622 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 104' ' ' TRP . 27.8 t0 -86.93 -4.31 59.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.796 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.656 ' HD3' HD22 ' A' ' 103' ' ' LEU . 6.3 mtm180 . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 121.232 0.539 . . . . 0.0 112.333 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 9.2 t90 -97.13 123.64 40.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.811 HD11 ' CD2' ' A' ' 88' ' ' PHE . 2.4 mt -104.92 163.3 12.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -171.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -145.85 121.01 1.41 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.89 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -98.26 157.58 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.525 0.678 . . . . 0.0 112.217 -175.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.54 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.89 177.8 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 1.005 ' OG1' HD11 ' A' ' 83' ' ' ILE . 1.1 t -92.7 133.18 36.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.135 0.493 . . . . 0.0 111.923 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 83' ' ' ILE . 70.3 m -115.45 123.32 48.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.286 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -122.71 146.94 47.03 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.229 0.538 . . . . 0.0 110.538 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 5.8 m -120.74 134.15 55.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.718 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -104.58 125.42 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.168 0.509 . . . . 0.0 111.517 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.76 98.96 4.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.378 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 80.0 p -118.22 142.48 47.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.675 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.45 -30.07 1.28 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.855 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.62 -75.9 0.13 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.874 0.369 . . . . 0.0 111.627 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -126.48 64.83 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 93.8 p -77.32 127.68 33.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.675 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 135.97 48.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.78 132.37 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 38' ' ' VAL . 14.9 p -99.72 123.41 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -119.35 157.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.376 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -99.96 149.74 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.081 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 145.97 150.39 5.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.373 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -120.63 178.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.713 0.768 . . . . 0.0 112.472 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.647 ' N ' HG13 ' A' ' 42' ' ' VAL . 21.0 t80 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.92 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.899 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -114.44 139.66 49.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.8 m-85 -96.38 112.74 24.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 72' ' ' VAL . 11.3 p -109.69 163.36 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.717 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -93.19 -62.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.124 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 70' ' ' ASP . 60.5 m -86.02 -110.33 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.415 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 69' ' ' THR . 22.5 t70 -164.82 24.95 0.06 Allowed 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.071 -0.393 . . . . 0.0 111.543 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.84 -35.47 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 109.76 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 67' ' ' VAL . 16.6 m -63.12 -39.07 83.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.561 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -33.08 31.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.304 0.573 . . . . 0.0 110.077 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.7 mt-30 -81.99 -23.72 35.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.66 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.054 HD22 HG21 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -63.25 75.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.663 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' GLN . 3.4 mmt180 -71.09 155.26 41.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.855 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -41.82 149.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.916 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.47 35.4 8.65 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.671 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 96.7 m-20 -140.66 150.83 44.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.279 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.792 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.8 m -116.88 147.36 42.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.335 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -139.22 158.94 43.29 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.802 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.977 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -124.99 132.39 53.27 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.506 -0.121 . . . . 0.0 110.903 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 27' ' ' ALA . 13.7 tt -152.29 143.11 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 46.18 -94.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.475 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -53.44 -33.73 55.15 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.977 ' O ' HG22 ' A' ' 82' ' ' THR . 4.9 pt-20 102.56 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.412 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.42 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -142.44 110.19 5.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.288 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.626 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -136.55 138.47 41.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.5 t-105 -132.95 144.42 50.12 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.195 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.054 HG21 HD22 ' A' ' 75' ' ' LEU . 7.7 t -84.95 107.47 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.871 0.843 . . . . 0.0 110.041 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 8.1 t70 -96.73 -3.94 41.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.798 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.4 mtm180 . . . . . 0 N--CA 1.467 0.387 0 C-N-CA 123.657 0.783 . . . . 0.0 112.961 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.851 HD12 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.054 0.454 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -98.34 136.88 37.87 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.899 HD11 ' CB ' ' A' ' 65' ' ' LEU . 3.5 mp -110.03 161.09 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -169.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -147.99 110.52 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 112.99 -1.914 . . . . 0.0 109.814 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.524 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 2.4 mtm180 -97.98 130.39 44.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.765 0.782 . . . . 0.0 111.796 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.152 175.315 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.809 -0.116 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.932 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -92.41 130.1 38.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.526 . . . . 0.0 111.706 -179.189 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 69.1 m -115.05 123.24 48.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.633 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.01 145.94 48.86 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 8.4 m -121.13 134.35 55.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.205 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -102.48 125.33 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.452 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.81 99.22 4.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.813 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 35' ' ' SER . 20.1 m -98.07 157.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.49 -18.66 23.55 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -126.1 -40.71 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.615 0.245 . . . . 0.0 111.385 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -112.19 63.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.494 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 31' ' ' SER . 17.8 t -104.78 120.3 41.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.654 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.15 42.3 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.35 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.48 127.02 16.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 19.2 m -99.3 130.53 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.743 HG12 HD11 ' A' ' 29' ' ' ILE . 1.9 pp -125.57 155.9 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -100.81 144.59 29.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.071 178.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 155.45 154.79 7.06 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.664 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -128.3 169.87 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.799 . . . . 0.0 111.901 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.119 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.851 0.358 . . . . 0.0 110.78 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.08 HD23 HD13 ' A' ' 103' ' ' LEU . 2.9 tp -112.43 139.51 47.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.687 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.776 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.3 m-85 -101.53 112.84 25.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.184 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.913 HG11 HG22 ' A' ' 72' ' ' VAL . 11.4 p -102.87 157.97 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 111.577 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -67.49 -31.55 71.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.433 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.53 -96.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.577 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.57 19.7 0.4 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.674 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -61.15 -48.29 82.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 109.974 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.913 HG22 HG11 ' A' ' 67' ' ' VAL . 16.0 m -53.78 -35.56 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.469 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -31.96 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.4 mt-30 -82.96 -20.93 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.686 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.993 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.2 64.21 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.188 0.518 . . . . 0.0 110.664 178.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLN . 16.2 mmm180 -55.1 160.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -52.87 145.43 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.407 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.97 6.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.845 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 92.8 m-20 -140.55 150.53 43.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.671 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 m -116.29 145.29 43.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.2 159.62 40.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.99 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.94 129.85 52.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.58 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.8 tt -126.08 -127.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 83' ' ' ILE . . . -58.45 -71.32 0.77 Allowed Glycine 0 CA--C 1.5 -0.9 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.853 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -55.32 -23.96 26.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 1.3 pt-20 89.99 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.342 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -142.15 109.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.699 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -138.02 136.55 37.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.767 176.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 7.8 m95 -130.43 143.31 50.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.646 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.993 ' CG2' HD22 ' A' ' 75' ' ' LEU . 33.7 t -85.29 107.11 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.96 0.886 . . . . 0.0 109.905 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 27.0 t0 -90.35 -3.67 57.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HG3' HD23 ' A' ' 103' ' ' LEU . 5.4 mtm180 . . . . . 0 N--CA 1.463 0.192 0 C-N-CA 123.196 0.599 . . . . 0.0 112.58 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.08 HD13 HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.457 0.17 . . . . 0.0 110.899 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 8.1 t90 -97.56 127.9 43.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.0 mp -100.77 160.77 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -149.0 107.63 0.37 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.054 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.536 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.4 mtm180 -97.25 131.45 43.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.684 0.742 . . . . 0.0 111.392 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.387 176.176 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.88 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.89 138.1 31.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.3 0.572 . . . . 0.0 112.262 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 67.8 m -117.61 123.79 47.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.239 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -126.0 141.24 52.05 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' THR . 4.5 m -118.16 132.18 56.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.216 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.876 HD12 HD11 ' A' ' 75' ' ' LEU . 5.3 mm -103.52 126.9 57.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.359 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.5 99.22 4.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.282 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.456 ' N ' ' HB3' ' A' ' 35' ' ' SER . 3.0 p -115.31 156.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.05 -18.58 27.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.621 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.38 -70.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 111.247 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -130.65 71.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.456 ' HB3' ' N ' ' A' ' 31' ' ' SER . 66.3 p -81.4 134.55 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.94 49.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.04 127.7 16.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 38' ' ' VAL . 12.8 p -99.51 122.56 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' OE1' ' A' ' 71' ' ' GLU . 2.3 pp -112.05 157.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 12.1 ttp180 -100.64 133.15 45.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.887 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 157.24 158.75 9.09 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.789 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.88 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.3 t -129.11 167.53 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.828 0.823 . . . . 0.0 111.918 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' HB2' HD22 ' A' ' 105' ' ' LEU . 4.8 t80 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.954 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.997 0.427 . . . . 0.0 111.338 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.013 HD23 HD12 ' A' ' 103' ' ' LEU . 3.5 tp -113.7 140.93 47.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.674 ' N ' HD12 ' A' ' 65' ' ' LEU . 3.7 m-30 -108.49 113.03 25.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.387 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.791 HG11 HG22 ' A' ' 72' ' ' VAL . 12.6 p -98.46 149.54 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.165 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.428 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 8.7 mmm180 -96.44 23.69 6.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.794 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 70' ' ' ASP . 43.9 m -163.44 -112.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.816 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 6.3 m-20 -161.59 26.25 0.12 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.021 0.373 . . . . 0.0 110.922 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.768 ' OE1' HG22 ' A' ' 39' ' ' ILE . 42.5 mt-10 -81.35 -43.35 19.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.531 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.791 HG22 HG11 ' A' ' 67' ' ' VAL . 29.6 m -54.12 -37.94 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -36.58 59.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.884 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.9 mt-30 -77.73 -25.39 49.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.409 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.948 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.18 62.85 0.06 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.667 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 1.5 mmt-85 -56.74 158.83 4.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.002 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -49.48 149.76 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.04 37.27 7.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 8.3 m-20 -136.03 148.42 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.757 ' C ' HD23 ' A' ' 81' ' ' LEU . 6.8 m -113.55 135.1 54.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.815 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -133.89 160.09 38.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 -179.041 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -123.03 129.0 50.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.859 HD12 ' CE2' ' A' ' 88' ' ' PHE . 3.9 tt -129.71 -139.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -51.64 -44.68 54.47 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 119.198 0.908 . . . . 0.0 111.628 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' ASN . 1.0 OUTLIER -96.57 28.99 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 173.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.995 ' O ' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER 34.54 33.49 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.808 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -141.85 109.87 5.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.221 0.534 . . . . 0.0 111.923 177.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -140.95 142.17 34.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.734 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 2.0 t-105 -134.79 142.62 46.74 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.948 ' CG2' HD22 ' A' ' 75' ' ' LEU . 59.5 t -85.56 107.44 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.126 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 21.4 t0 -90.24 -56.75 3.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.684 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.768 ' HD3' HD22 ' A' ' 103' ' ' LEU . 5.4 mmm180 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.726 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.013 HD12 HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.8 t90 -98.63 128.75 45.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.985 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.5 mp -103.1 160.69 14.42 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -171.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -139.08 103.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.749 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.0 mtm180 -97.46 142.71 28.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.306 0.553 . . . . 0.0 111.17 -176.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.01 177.205 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.759 -0.137 . . . . 0.0 112.759 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.72 138.52 31.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.37 0.605 . . . . 0.0 111.922 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 44.0 m -122.9 128.52 50.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.8 139.99 53.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.53 ' OG1' HG22 ' A' ' 38' ' ' VAL . 4.9 m -114.56 130.89 56.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 75' ' ' LEU . 4.2 mm -100.06 128.65 51.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -136.88 99.18 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.857 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 4.8 m -95.68 159.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -14.6 39.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.969 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -119.9 -48.04 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.68 68.75 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 111.849 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 40.9 p -98.73 122.69 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.82 41.77 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.424 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . . . -140.72 121.74 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.339 . . . . 0.0 110.799 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG22 ' OG1' ' A' ' 28' ' ' THR . 77.5 t -99.5 119.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.148 0.499 . . . . 0.0 111.442 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.652 HG12 HD11 ' A' ' 29' ' ' ILE . 2.5 pp -112.33 159.8 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.374 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.45 146.31 27.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.061 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 153.0 148.86 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.703 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -119.11 171.98 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 0.0 111.689 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HD2' HD22 ' A' ' 105' ' ' LEU . 36.7 t80 . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.891 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.048 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 tp -112.42 138.67 48.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.598 ' N ' HD12 ' A' ' 65' ' ' LEU . 27.1 m-85 -101.3 113.3 26.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.81 HG11 ' CG2' ' A' ' 72' ' ' VAL . 9.1 p -107.38 161.28 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.294 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -127.87 46.43 2.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.568 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 70' ' ' ASP . 87.7 m -163.97 -108.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.056 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 69' ' ' THR . 48.1 t0 179.75 36.6 0.0 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.887 0.375 . . . . 0.0 110.739 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 tt0 -104.71 -43.4 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.232 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.81 ' CG2' HG11 ' A' ' 67' ' ' VAL . 9.9 m -56.88 -37.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -41.77 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.814 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -73.9 -18.76 60.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.006 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.01 HD11 HG23 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.07 65.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 110.926 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.439 ' HA ' ' NH2' ' A' ' 92' ' ' ARG . 4.1 mmt180 -58.54 156.1 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.03 141.03 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.273 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.38 29.78 5.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 75.2 m-20 -140.37 150.47 43.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.119 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -115.7 145.05 43.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.349 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -136.27 160.26 39.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.133 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.96 135.8 54.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.735 HG21 ' CD1' ' A' ' 88' ' ' PHE . 3.0 tt -137.58 89.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.9 -68.78 0.19 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 10.6 mm-40 -62.1 -16.74 54.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.386 172.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.002 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 84.19 19.13 0.17 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.051 0.54 . . . . 0.0 111.081 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.505 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -142.94 119.05 10.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.735 ' CD1' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -149.44 130.57 14.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.865 169.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.544 ' CD2' HG23 ' A' ' 80' ' ' THR . 0.8 OUTLIER -128.49 143.63 51.01 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.518 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.99 HG21 HD22 ' A' ' 75' ' ' LEU . 6.3 t -85.2 108.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.664 0.745 . . . . 0.0 110.922 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 9.8 t0 -92.04 -5.43 52.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.506 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.537 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mtm-85 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.229 0.537 . . . . 0.0 112.347 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.048 HD13 HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.604 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.493 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 6.5 t90 -96.62 126.55 41.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.3 mp -97.22 160.06 14.56 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -140.86 99.09 0.24 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' ASN . 6.5 ttp180 -99.22 156.77 16.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.435 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.231 177.458 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 40' ' ' ARG . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.746 ' OG1' HD11 ' A' ' 83' ' ' ILE . 14.9 t -93.01 138.7 31.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 54.6 m -105.04 122.97 46.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.573 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.015 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.85 145.56 49.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 110.061 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 2.5 m -120.59 133.74 55.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.581 HD12 HD11 ' A' ' 75' ' ' LEU . 8.1 mm -103.63 122.26 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -126.91 99.44 5.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' HB3' ' A' ' 35' ' ' SER . 6.5 p -115.17 157.98 22.88 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -17.34 32.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.758 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.64 -71.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -132.53 69.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 68.6 p -73.99 167.04 22.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.76 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 50.76 2.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.597 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.58 132.37 38.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.923 0.392 . . . . 0.0 110.963 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 38' ' ' VAL . 12.6 p -99.88 118.28 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.45 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.666 HG22 ' CD ' ' A' ' 71' ' ' GLU . 2.1 pp -123.52 154.63 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.368 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -100.3 125.39 46.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -176.91 143.32 6.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.385 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -119.26 -162.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.29 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.439 -1.015 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.432 -177.514 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.823 ' CD2' HD21 ' A' ' 103' ' ' LEU . 2.3 tt -114.49 139.46 49.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.789 0.328 . . . . 0.0 110.425 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.438 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 84.3 t80 -97.84 111.15 23.56 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 72' ' ' VAL . 10.6 p -100.68 163.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 67' ' ' VAL . 4.2 tpt85 -71.96 -36.62 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.114 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.63 -96.49 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.616 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -152.47 17.64 0.62 Allowed 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.666 ' CD ' HG22 ' A' ' 39' ' ' ILE . 6.8 tt0 -61.56 -46.81 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.418 . . . . 0.0 109.877 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.78 ' CG2' HD22 ' A' ' 103' ' ' LEU . 10.8 m -51.49 -31.67 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.385 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -33.84 68.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 3.0 mt-30 -78.71 -20.09 50.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.6 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.021 HD22 HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -66.28 62.65 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 178.182 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 29.6 mmm-85 -56.04 158.35 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 111.303 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -46.89 161.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.13 37.29 91.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 70.4 m-20 -129.32 131.07 46.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.626 ' C ' HD23 ' A' ' 81' ' ' LEU . 54.7 m -100.55 138.78 37.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.552 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.719 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.64 159.51 41.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.298 -178.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 86' ' ' GLU . 2.8 p -124.43 130.95 53.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.726 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.015 HD12 ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -120.99 -130.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -69.6 -34.08 72.69 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.638 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 9.3 mp0 -101.02 25.23 8.31 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.007 ' O ' HG22 ' A' ' 82' ' ' THR . 10.3 pt-20 38.07 33.88 0.06 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.804 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -144.04 109.15 5.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.775 ' HE2' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -140.59 149.68 42.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.506 ' CH2' ' HA3' ' A' ' 108' ' ' GLY . 12.3 m0 -133.23 142.73 48.71 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.901 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.021 HG21 HD22 ' A' ' 75' ' ' LEU . 94.0 t -85.32 106.59 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.821 0.819 . . . . 0.0 109.511 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 7.7 t0 -87.47 -2.11 58.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.668 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.614 ' HG3' HG13 ' A' ' 90' ' ' VAL . 3.2 mmp_? . . . . . 0 C--O 1.231 0.109 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.692 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 122.048 0.928 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.507 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 2.8 t90 -99.36 122.13 42.06 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.166 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.787 HD21 ' HB2' ' A' ' 65' ' ' LEU . 3.5 mp -89.74 156.72 18.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 89' ' ' TRP . . . -133.68 110.47 0.89 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.946 173.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 1.7 mmm180 -98.91 156.02 17.1 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CH2' ' A' ' 89' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.211 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.444 -0.263 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.825 ' OG1' HD11 ' A' ' 83' ' ' ILE . 2.4 t -92.61 138.71 31.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.188 0.518 . . . . 0.0 111.824 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 75.1 m -119.91 129.76 54.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.694 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.052 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -123.87 143.6 50.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.344 0.592 . . . . 0.0 110.553 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.597 ' C ' HD13 ' A' ' 29' ' ' ILE . 4.4 m -119.66 133.71 55.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.84 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.004 HD11 HG12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -100.6 128.3 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.18 0.514 . . . . 0.0 111.397 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -133.4 98.74 4.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.438 177.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 35' ' ' SER . 1.4 p -109.88 151.97 26.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.597 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.57 -39.79 38.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.165 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -75.24 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -139.27 68.45 1.37 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 31.3 p -65.02 128.7 36.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.29 55.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.536 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.72 123.26 14.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 38' ' ' VAL . 12.4 p -99.67 117.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.004 HG12 HD11 ' A' ' 29' ' ' ILE . 2.3 pp -119.33 159.76 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.688 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -104.03 149.76 24.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.839 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 148.23 146.54 4.36 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.768 ' CB ' HG21 ' A' ' 25' ' ' THR . 0.4 OUTLIER -112.41 -168.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.71 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.9 t80 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.77 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.806 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.86 139.56 49.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.241 -177.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.0 m-85 -98.71 112.69 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 65' ' ' LEU . 12.2 p -106.57 162.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.932 0.396 . . . . 0.0 111.79 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.25 -69.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.86 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.0 p -84.09 -96.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -174.99 31.98 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.292 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.666 ' OE1' HG22 ' A' ' 39' ' ' ILE . 1.9 tt0 -76.5 -46.16 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.082 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.715 ' HB ' HD22 ' A' ' 103' ' ' LEU . 17.1 m -53.55 -34.41 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.32 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -54.39 -31.22 54.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.65 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.0 mt-30 -85.1 -21.91 29.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.718 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HG21 ' A' ' 29' ' ' ILE . 3.8 mp -66.85 65.23 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.5 mmm-85 -59.15 155.26 14.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.03 136.93 13.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.316 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.46 30.18 4.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.838 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 90' ' ' VAL . 16.2 t70 -140.56 144.01 35.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 30' ' ' THR . 2.0 m -112.41 140.12 47.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.561 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.868 HD12 ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -132.16 158.52 41.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.318 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.999 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -119.29 130.66 55.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.239 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -117.55 -129.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.382 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.433 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -71.12 -40.38 61.82 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.437 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -90.47 13.32 15.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.108 -0.546 . . . . 0.0 110.099 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.999 ' O ' HG22 ' A' ' 82' ' ' THR . 12.1 mt-10 64.96 20.74 12.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.402 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.07 112.66 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.936 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -141.25 126.05 18.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.261 175.094 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 12.6 m95 -118.52 144.97 45.68 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.311 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 90' ' ' VAL . 11.4 p -83.8 107.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.992 0.901 . . . . 0.0 109.863 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 12.9 t70 -93.53 -5.32 49.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.94 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.609 ' HD3' HD12 ' A' ' 103' ' ' LEU . 3.6 mtm180 . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 123.409 0.683 . . . . 0.0 112.544 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HB ' ' A' ' 72' ' ' VAL . 6.5 tp . . . . . 0 N--CA 1.444 -0.766 0 CA-C-O 121.167 0.508 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -96.6 133.93 40.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.058 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.806 HD11 ' CB ' ' A' ' 65' ' ' LEU . 1.2 mp -106.07 160.88 14.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -171.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 89' ' ' TRP . . . -137.51 102.67 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.283 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -97.07 155.8 16.64 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.194 -0.592 . . . . 0.0 110.75 -177.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.583 179.155 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.855 0.359 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.17 112.63 13.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -162.27 150.12 14.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.77 66.2 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.804 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -131.28 61.27 1.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.48 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -163.76 -59.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.02 -174.75 4.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.5 60.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.13 -54.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.44 22.97 13.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.1 tt -117.59 -34.95 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.045 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.61 -27.4 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.21 27.23 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 -66.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 68.02 67.88 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.87 146.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.42 76.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mm -112.5 -54.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.82 152.77 15.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.94 56.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.577 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.62 135.64 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.84 -176.48 4.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.71 43.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.368 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.927 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -93.19 138.7 31.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 111.955 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 62.9 m -121.59 124.74 45.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.379 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.43 144.14 50.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 4.0 m -121.11 134.21 55.24 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.478 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 39' ' ' ILE . 3.1 mm -99.79 125.28 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.382 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.12 99.14 4.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.558 178.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.443 ' N ' ' HB2' ' A' ' 35' ' ' SER . 15.1 p -108.53 153.69 23.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.58 26.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -89.61 -69.1 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.76 0.314 . . . . 0.0 111.38 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -128.6 71.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.533 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.443 ' HB2' ' N ' ' A' ' 31' ' ' SER . 8.0 t -80.59 114.04 19.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.671 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.09 46.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.373 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 121.19 18.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 38' ' ' VAL . 18.5 m -99.69 117.41 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 29' ' ' ILE . 2.0 pp -114.09 159.93 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.698 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.699 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 154.55 146.67 4.47 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.927 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -115.06 174.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.681 0.753 . . . . 0.0 112.101 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.3 t80 -90.38 141.14 29.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.618 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' SER . 6.5 t0 -128.42 129.42 46.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.611 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.9 109.94 42.43 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.047 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.25 -50.33 8.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.355 2.037 . . . . 0.0 111.806 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -43.17 -40.63 3.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.512 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.9 -73.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -71.94 90.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.207 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.77 25.32 11.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.93 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -100.85 -77.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.04 169.5 8.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.88 57.33 16.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.381 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 13.8 pt20 -113.47 -172.8 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.8 21.23 58.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 57' ' ' ARG . 6.3 p -161.09 -46.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 58' ' ' VAL . 5.7 mmm180 67.76 -64.25 0.28 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.901 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 57' ' ' ARG . 8.5 p 49.29 24.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.309 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 60' ' ' GLY . 13.5 pt-20 -165.09 -49.57 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.523 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' HA3' ' CA ' ' A' ' 47' ' ' GLU . . . -125.46 109.89 1.25 Allowed Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.541 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.5 p -114.38 -30.92 6.42 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.489 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -134.79 141.89 40.3 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.702 0.287 . . . . 0.0 111.622 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.528 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 61.2 Cg_endo -99.97 144.65 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.102 2.535 . . . . 0.0 113.845 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -106.72 161.26 14.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 105' ' ' LEU . 6.0 tp -116.92 140.67 49.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 15.4 t80 -100.3 123.26 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 110.27 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 68' ' ' ARG . 11.2 p -112.46 164.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.542 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.58 41.94 3.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -171.21 -101.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.394 178.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t0 177.95 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -98.42 -34.99 10.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 103' ' ' LEU . 19.4 m -62.16 -31.17 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.916 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.59 84.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.272 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.9 mt-30 -69.88 -20.62 63.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.576 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.029 HD22 HG21 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -65.05 61.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.112 178.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 74' ' ' GLN . 48.8 mmm-85 -59.38 152.63 20.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -42.02 159.44 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.653 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.91 32.12 61.33 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.187 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 5.6 m-20 -128.62 128.4 44.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 111.015 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.747 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -99.98 140.45 34.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.444 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.883 HD13 HD11 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -135.18 159.71 40.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.442 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -123.04 129.53 51.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.749 HD12 ' CE2' ' A' ' 88' ' ' PHE . 2.3 tt -137.88 135.47 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.47 -95.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.03 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.764 ' HB3' HG23 ' A' ' 109' ' ' VAL . 40.8 mm-40 -50.66 -27.35 6.78 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 98.65 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.813 1.245 . . . . 0.0 111.663 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -143.5 111.18 5.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.749 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -140.48 139.76 35.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.558 173.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.515 ' HD1' HG23 ' A' ' 80' ' ' THR . 7.0 t90 -134.93 142.42 46.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.029 HG21 HD22 ' A' ' 75' ' ' LEU . 59.8 t -84.29 108.51 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 121.874 0.845 . . . . 0.0 110.902 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 104' ' ' TRP . 11.9 t70 -85.59 -5.58 59.26 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.864 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG3' HG13 ' A' ' 90' ' ' VAL . 9.6 mtm-85 -44.29 174.15 0.0 OUTLIER 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.265 0.555 . . . . 0.0 111.901 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.74 153.58 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.08 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -161.61 85.02 1.7 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 -25.23 47.46 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.633 2.222 . . . . 0.0 112.407 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -170.72 -52.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.18 77.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.49 157.7 40.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.575 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.92 49.96 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.9 p -103.98 130.71 51.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.938 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.47 55.09 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.574 ' CG ' ' CZ3' ' A' ' 104' ' ' TRP . 1.6 t-80 -108.62 -41.53 4.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.779 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.757 ' CD1' HG21 ' A' ' 72' ' ' VAL . 0.7 OUTLIER 61.99 77.22 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.805 178.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.574 ' CZ3' ' CG ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -99.48 120.34 39.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 65' ' ' LEU . 10.9 mt -107.75 161.19 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.947 0.879 . . . . 0.0 113.282 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.34 117.21 2.22 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.686 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.553 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mmm180 -98.0 156.68 16.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.448 0.642 . . . . 0.0 112.348 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.01 39.63 1.05 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.076 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.764 HG23 ' HB3' ' A' ' 85' ' ' GLU . 7.4 p -32.08 94.12 0.07 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 96.2 Cg_endo -90.37 179.34 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.057 2.505 . . . . 0.0 111.675 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.62 -67.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.536 2.157 . . . . 0.0 112.159 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.87 109.78 0.29 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.805 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 113' ' ' VAL . 7.5 p -141.04 25.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.599 . . . . 0.0 110.519 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 48.63 76.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.54 ' HG3' HG13 ' A' ' 113' ' ' VAL . 1.5 mtp180 -94.59 148.4 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 127.08 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.058 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.95 179.81 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.813 0.34 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 69.28 -68.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.56 45.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -108.87 -35.04 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -107.18 60.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.75 62.84 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.9 -54.58 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.817 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.76 117.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -127.42 -51.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.94 -64.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.69 46.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.018 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.8 tt -179.88 161.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.371 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 72.08 23.6 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.161 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -111.33 27.69 9.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.02 -179.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 11.0 p30 -178.6 173.01 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -122.52 42.69 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.918 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m 52.42 91.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 19' ' ' ILE . 23.0 mt -87.87 56.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt85 -109.67 32.5 4.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.75 92.67 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 172.28 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mtt -62.87 -81.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.81 47.96 45.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.963 ' OG1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -92.89 138.49 31.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 112.072 -178.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 64.8 m -118.94 124.95 48.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.166 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -124.98 138.83 54.22 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.45 ' C ' HD13 ' A' ' 29' ' ' ILE . 5.4 m -115.95 133.9 55.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.331 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.965 HD11 HG12 ' A' ' 39' ' ' ILE . 1.9 mm -99.81 131.6 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.132 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -137.35 98.96 3.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.67 178.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -108.1 159.56 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.798 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.08 70.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -75.63 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.886 0.374 . . . . 0.0 111.993 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -137.87 77.16 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.31 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 29.4 p -74.29 123.54 24.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.788 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.5 48.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.17 126.12 29.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 38' ' ' VAL . 13.6 p -99.71 122.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.965 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -122.01 156.98 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -99.07 140.38 33.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.873 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 159.15 152.57 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.068 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.957 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.6 178.64 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.284 0.564 . . . . 0.0 111.707 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 -89.66 140.78 29.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.254 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' SER . 3.8 t0 -127.53 139.64 52.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -116.75 106.95 47.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.092 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 13.9 Cg_exo -70.04 -38.26 7.41 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.759 2.306 . . . . 0.0 112.24 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.66 48.11 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.52 145.56 55.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 tt -79.4 143.98 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 t 59.86 27.07 16.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 10.0 t80 -68.45 63.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' TYR . . . 67.21 -67.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.326 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -56.52 4.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.646 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 69.72 136.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.754 0.311 . . . . 0.0 110.796 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.19 36.85 49.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.396 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.17 105.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -86.29 99.52 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.077 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 58' ' ' VAL . 12.4 p -94.79 37.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 74.96 71.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.62 163.37 24.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.99 -44.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.69 170.0 12.25 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.676 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 76.7 Cg_endo -98.98 137.99 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.936 2.424 . . . . 0.0 112.996 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -107.13 164.74 11.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.979 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -115.35 139.72 49.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.996 -177.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -93.82 121.08 34.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.643 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 72' ' ' VAL . 10.0 p -122.18 160.16 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.199 0.524 . . . . 0.0 112.15 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' C ' HG22 ' A' ' 69' ' ' THR . 1.8 mpt_? -134.41 65.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.318 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' C ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER 167.49 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.002 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -66.36 62.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' THR . 5.6 mt-10 -126.39 -45.82 1.65 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.668 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 67' ' ' VAL . 5.2 m -57.53 -30.29 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.046 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -48.49 77.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.424 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.4 mt-30 -63.29 -19.76 64.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.574 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.09 HD22 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -67.11 63.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.599 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.8 mmm180 -55.32 160.89 2.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -53.04 146.46 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 77' ' ' ARG . . . 95.88 38.51 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.304 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.695 ' CG ' HD21 ' A' ' 75' ' ' LEU . 2.5 t0 -140.36 150.59 44.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 111.305 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' THR . 4.9 m -118.5 142.98 47.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.688 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.1 158.31 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.384 -178.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.005 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -118.75 129.23 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.674 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.963 HD11 ' OG1' ' A' ' 25' ' ' THR . 0.6 OUTLIER -122.7 -136.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.858 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.555 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -59.74 -41.12 97.39 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.592 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -91.0 15.92 10.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.041 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.005 ' O ' HG22 ' A' ' 82' ' ' THR . 4.5 mt-10 57.71 19.78 5.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.399 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.439 ' ND2' ' CD ' ' A' ' 110' ' ' PRO . 18.1 m120 -144.89 112.66 6.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.833 ' CD1' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -138.98 150.98 46.48 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.543 ' CE3' HG23 ' A' ' 80' ' ' THR . 30.9 t-105 -135.63 141.92 45.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.439 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.09 HG21 HD22 ' A' ' 75' ' ' LEU . 9.2 t -84.98 107.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.099 0.952 . . . . 0.0 110.532 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' TRP . 33.7 t0 -99.18 -5.89 29.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 3.7 mtm180 -20.04 115.54 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 94' ' ' SER . 1.7 p -49.69 158.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.705 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.31 160.0 74.11 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.96 -169.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.472 2.114 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.24 -65.08 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -97.08 71.04 2.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.06 132.71 3.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.75 15.88 61.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.688 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.91 157.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.5 m 62.46 61.69 1.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -139.28 -48.24 0.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.788 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 50.68 100.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.49 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.8 114.15 25.76 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.833 HD13 ' CD1' ' A' ' 88' ' ' PHE . 13.2 mt -107.39 163.31 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -143.95 122.13 1.77 Allowed Glycine 0 CA--C 1.521 0.461 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.019 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mtm180 -99.26 140.0 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.347 0.573 . . . . 0.0 111.828 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -116.69 -19.73 5.23 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.504 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 109' ' ' VAL . 7.1 p 30.09 60.93 0.93 Allowed Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 109' ' ' VAL . 36.8 Cg_endo -95.27 -179.79 0.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.325 2.683 . . . . 0.0 111.784 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 -68.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.545 2.163 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.92 99.76 0.27 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.559 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 86' ' ' GLU . 84.3 t -132.83 106.64 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -58.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.21 -29.48 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 54.84 104.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.818 0.342 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.51 167.11 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -152.88 40.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.15 149.24 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -162.69 70.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -116.47 165.37 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.43 132.2 44.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.01 79.81 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.13 82.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.24 84.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.88 53.97 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 13' ' ' ALA . 5.3 tp -161.08 -43.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.082 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -96.56 28.63 3.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -147.24 45.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.019 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.9 39.4 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -119.26 172.17 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.33 -174.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.04 51.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.27 164.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.08 94.28 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.62 -122.34 2.88 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -121.65 157.77 30.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmm 65.27 -165.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.017 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 18.68 5.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.846 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -92.79 138.6 31.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.519 . . . . 0.0 112.062 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 83' ' ' ILE . 49.6 m -126.73 124.33 39.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.445 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.47 142.59 51.2 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 38' ' ' VAL . 3.8 m -114.34 132.88 56.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.149 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 75' ' ' LEU . 4.3 mm -102.02 124.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 111.856 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.56 99.11 5.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.363 178.322 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.45 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -116.95 154.61 30.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.919 -179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.01 -17.7 30.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -88.56 -69.72 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -127.95 72.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 31' ' ' SER . 12.9 p -84.6 146.17 27.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.14 24.73 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.706 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.35 129.97 56.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.945 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG22 ' OG1' ' A' ' 28' ' ' THR . 66.7 t -101.84 122.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.025 0.44 . . . . 0.0 111.315 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.775 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -116.33 160.09 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.966 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -102.94 147.07 27.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.615 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 150.83 153.32 6.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.014 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.03 175.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.556 0.693 . . . . 0.0 112.317 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.627 ' N ' HG13 ' A' ' 42' ' ' VAL . 37.1 t80 -90.1 140.5 29.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.57 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 64' ' ' SER . 1.1 t70 -124.93 136.91 54.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.106 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 4.1 p30 -123.79 106.74 31.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.799 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.422 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 19.6 Cg_exo -67.94 -64.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.608 2.205 . . . . 0.0 112.461 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . 1.5 mt-10 -88.18 -68.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.261 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 6.7 p-10 44.85 49.58 9.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.576 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -149.51 -93.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.403 ' H ' HD12 ' A' ' 49' ' ' ILE . 3.7 t 47.88 25.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.697 0.285 . . . . 0.0 111.351 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 -57.75 2.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.839 0.352 . . . . 0.0 110.992 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.91 -26.54 10.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.05 48.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.87 92.47 8.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.059 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.96 24.2 33.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.381 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.26 -29.14 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.336 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 62.78 110.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 58' ' ' VAL . 13.9 p -94.79 31.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 74.11 37.19 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 46' ' ' PRO . . . -130.76 99.11 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.371 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.04 -26.97 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.983 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.41 175.33 3.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 36.8 Cg_endo -98.68 150.52 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.986 2.458 . . . . 0.0 112.644 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -128.16 165.76 19.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.956 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -113.13 141.08 47.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.067 -177.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 2.2 m-85 -103.98 115.22 30.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.046 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HG22 ' A' ' 72' ' ' VAL . 12.3 p -102.89 160.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.442 . . . . 0.0 111.523 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.12 -55.88 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.929 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -90.07 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.42 32.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.65 0.262 . . . . 0.0 111.363 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.33 -41.93 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.057 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.829 HG11 HD21 ' A' ' 65' ' ' LEU . 33.5 m -56.57 -33.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.985 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -54.02 -30.78 49.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.5 mt-30 -86.36 -22.71 26.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.624 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 29' ' ' ILE . 6.5 mp -66.51 62.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 12.7 mmt-85 -60.33 158.03 12.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -42.53 157.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.605 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.5 27.56 54.39 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.401 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -125.7 139.91 53.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.889 HG22 ' CE3' ' A' ' 89' ' ' TRP . 0.5 OUTLIER -108.31 138.87 43.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -140.26 158.58 43.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -121.11 122.28 39.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.237 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.874 HD11 ' OG1' ' A' ' 25' ' ' THR . 6.4 tt -127.05 137.35 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.323 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 38.88 -92.69 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.946 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 63.0 mm-40 -49.54 -26.36 3.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.975 ' O ' HG22 ' A' ' 82' ' ' THR . 3.0 mt-10 101.34 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.619 1.168 . . . . 0.0 111.382 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 16.4 m120 -144.28 110.81 5.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -140.83 119.51 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.626 173.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.889 ' CE3' HG22 ' A' ' 80' ' ' THR . 9.1 m95 -108.95 142.46 39.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.715 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.866 ' CG2' HD21 ' A' ' 81' ' ' LEU . 48.0 t -86.1 107.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.506 0.67 . . . . 0.0 110.348 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.487 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 16.4 t0 -89.35 -59.43 2.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.403 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.2 mtp180 44.8 -177.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.362 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -110.04 30.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.962 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.5 p 61.9 151.77 0.1 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.24 147.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.538 2.159 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.87 100.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -158.5 28.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.55 95.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.47 68.0 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.431 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 m -56.19 95.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.01 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.3 p 174.54 68.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -128.69 -56.03 1.21 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.912 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.932 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 66.09 88.44 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.953 177.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.487 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.6 t90 -98.04 128.59 44.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.956 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.9 mp -100.29 159.76 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -140.01 110.2 0.67 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.352 172.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -97.79 156.73 16.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.469 0.652 . . . . 0.0 111.843 -175.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.42 53.55 0.37 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.127 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.545 HG23 ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -29.91 143.61 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.589 0.756 . . . . 0.0 112.16 -178.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.545 ' HD2' HG23 ' A' ' 109' ' ' VAL . 1.3 Cg_endo -43.39 174.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.468 2.779 . . . . 0.0 112.849 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 7.0 Cg_exo -72.22 -167.96 5.18 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.441 0.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . 70.59 61.77 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.251 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 86' ' ' GLU . 86.5 t -115.14 68.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.899 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 m120 48.24 34.17 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.212 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.56 174.52 7.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -142.94 -77.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.927 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.26 -57.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -175.93 74.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -91.13 171.84 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -119.04 106.99 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -112.0 120.48 42.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.35 -55.2 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.13 126.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' A' ' 12' ' ' ILE . 12.0 m-20 -55.58 -62.58 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.94 -53.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.46 33.62 5.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.178 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.709 HG23 ' N ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -144.26 -154.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.988 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.709 ' N ' HG23 ' A' ' 12' ' ' ILE . . . 49.45 50.84 17.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 39.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.815 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 63.11 103.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.63 -176.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.93 67.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 48.92 86.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.105 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.71 95.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -127.84 -175.7 3.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.98 -148.47 19.9 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.48 -179.5 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.13 -79.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.0 47.08 41.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.582 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.924 HG21 HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.19 138.93 31.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.579 . . . . 0.0 112.29 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -133.07 123.96 26.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.285 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -125.76 152.43 45.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.092 0.473 . . . . 0.0 109.977 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 16.2 m -124.18 133.02 53.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.143 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD22 ' A' ' 81' ' ' LEU . 4.0 mm -100.79 122.97 53.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.345 0.593 . . . . 0.0 111.835 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -126.0 98.75 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.106 178.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.436 ' N ' ' HB3' ' A' ' 35' ' ' SER . 98.6 p -120.06 160.4 22.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.848 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 -25.65 58.44 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.174 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.91 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 111.569 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 6.3 tt0 -143.44 57.02 1.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.04 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 31' ' ' SER . 14.0 p -49.24 118.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.71 46.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.478 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.84 126.06 23.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.9 p -99.48 132.33 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.485 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.587 HG12 HD11 ' A' ' 29' ' ' ILE . 2.2 pp -121.23 153.77 24.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.323 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 10.6 ttp180 -109.91 142.88 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . . . 121.28 149.07 8.05 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.48 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.924 HG23 HG21 ' A' ' 25' ' ' THR . 26.2 t -111.15 -120.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.658 ' N ' HG12 ' A' ' 42' ' ' VAL . 6.1 p90 -134.49 141.71 46.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 129.92 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -100.84 109.63 58.48 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.602 0.239 . . . . 0.0 111.01 -178.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.83 -37.99 14.51 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.912 2.408 . . . . 0.0 112.8 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.01 40.84 1.04 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.0 p-10 -103.35 32.15 3.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.813 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 pt -123.19 91.87 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.34 29.3 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.698 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -134.71 -66.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -161.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.006 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.09 153.03 2.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.456 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.07 54.73 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.997 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.79 63.25 0.37 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -139.24 -89.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.525 0.202 . . . . 0.0 111.123 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' HG12 ' A' ' 58' ' ' VAL . 8.9 mpt_? -71.66 -69.69 0.37 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.684 0.278 . . . . 0.0 110.811 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 58' ' ' VAL . 12.9 p 47.67 23.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.835 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 173.89 35.46 0.0 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.65 54.87 0.27 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.305 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -79.9 123.29 27.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.528 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 141.59 8.95 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.15 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.41 150.74 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.582 2.188 . . . . 0.0 113.155 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -119.82 168.8 10.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.924 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -111.71 140.04 46.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.662 0.744 . . . . 0.0 111.194 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 62.8 t80 -94.63 135.35 36.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.272 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.707 HG11 HG22 ' A' ' 72' ' ' VAL . 14.5 p -133.08 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 17.0 mmm180 -102.76 37.31 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.95 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 70' ' ' ASP . 97.5 m -164.32 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.377 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 69' ' ' THR . 51.0 t0 179.0 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.758 0.313 . . . . 0.0 110.879 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.24 -47.01 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.312 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.811 HG11 HD21 ' A' ' 65' ' ' LEU . 27.6 m -52.63 -35.16 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.278 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -30.59 52.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.62 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 76' ' ' ARG . 7.5 mt-30 -89.76 -19.17 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.855 HD11 HG21 ' A' ' 29' ' ' ILE . 5.6 mp -66.04 67.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.8 mmt85 -62.53 151.79 36.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.078 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -43.92 137.47 3.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.024 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.97 34.74 3.91 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.163 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 97.3 m-20 -140.55 147.79 40.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.188 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 81' ' ' LEU . 8.0 m -111.12 150.36 29.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.778 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.977 HD22 HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -145.05 152.49 40.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.962 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -113.23 120.68 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.672 HG21 ' CD1' ' A' ' 88' ' ' PHE . 5.3 tt -130.38 136.81 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.86 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 41.76 -92.34 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.81 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.897 ' HB3' HG23 ' A' ' 109' ' ' VAL . 4.6 mm-40 -53.12 -33.49 52.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.962 ' O ' HG22 ' A' ' 82' ' ' THR . 3.7 mm-40 116.04 19.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.196 1.398 . . . . 0.0 111.745 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.474 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 26.4 t-20 -144.21 121.6 11.66 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 118.845 -1.142 . . . . 0.0 114.03 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -142.94 112.16 6.65 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 8.7 t90 -104.03 141.87 35.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.25 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 90' ' ' VAL . 9.3 p -84.37 109.3 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.892 0.853 . . . . 0.0 111.622 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 104' ' ' TRP . 27.8 t0 -86.93 -4.31 59.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.796 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.656 ' HD3' HD22 ' A' ' 103' ' ' LEU . 6.3 mtm180 -37.71 161.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.232 0.539 . . . . 0.0 112.333 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 94' ' ' SER . 1.7 t -135.38 165.45 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.249 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 93' ' ' VAL . 42.3 m 58.99 102.55 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.58 -27.52 53.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.451 2.101 . . . . 0.0 112.213 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -177.8 77.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.98 35.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.93 -165.66 13.3 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.15 -103.07 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.82 175.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 110.959 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.75 43.68 27.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' O ' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -116.98 33.99 5.33 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 109.704 178.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -46.62 90.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.747 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 9.2 t90 -97.13 123.64 40.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.811 HD11 ' CD2' ' A' ' 88' ' ' PHE . 2.4 mt -104.92 163.3 12.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -171.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -145.85 121.01 1.41 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.89 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -98.26 157.58 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.525 0.678 . . . . 0.0 112.217 -175.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.59 39.45 1.09 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.89 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 85' ' ' GLU . 7.1 p -31.68 103.51 0.21 Allowed Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 77.9 Cg_endo -91.17 171.0 3.16 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.075 2.517 . . . . 0.0 111.566 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.4 175.11 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.694 2.263 . . . . 0.0 112.049 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.24 97.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.438 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG23 ' HG2' ' A' ' 86' ' ' GLU . 2.7 p -134.51 131.24 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.515 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.86 113.0 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.025 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HD3' HG13 ' A' ' 113' ' ' VAL . 1.6 mtm180 -120.74 151.24 39.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.74 146.59 40.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.842 0.353 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.75 94.52 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -127.88 -47.38 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -86.23 -26.25 25.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.004 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.637 ' OD1' HD23 ' A' ' 7' ' ' LEU . 34.7 t0 -120.87 134.9 55.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -129.9 62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD23 ' OD1' ' A' ' 5' ' ' ASP . 2.2 mm? -86.1 88.92 7.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -49.58 161.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -133.22 114.47 13.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.58 -54.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.51 41.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 13' ' ' ALA . 16.6 tt -150.13 -44.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -93.88 63.26 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -103.77 58.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.8 69.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.012 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.89 110.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.64 125.82 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.04 164.09 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.9 mt 58.72 74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.17 -39.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.67 158.94 7.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -149.93 88.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.9 ptm -62.08 151.78 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.58 45.4 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.198 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 1.005 ' OG1' HD11 ' A' ' 83' ' ' ILE . 1.1 t -92.7 133.18 36.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.135 0.493 . . . . 0.0 111.923 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 83' ' ' ILE . 70.3 m -115.45 123.32 48.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.286 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -122.71 146.94 47.03 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.229 0.538 . . . . 0.0 110.538 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 5.8 m -120.74 134.15 55.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.718 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -104.58 125.42 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.168 0.509 . . . . 0.0 111.517 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.76 98.96 4.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.378 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 80.0 p -118.22 142.48 47.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.675 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.45 -30.07 1.28 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.855 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.62 -75.9 0.13 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.874 0.369 . . . . 0.0 111.627 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -126.48 64.83 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 93.8 p -77.32 127.68 33.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.675 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 135.97 48.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.78 132.37 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 38' ' ' VAL . 14.9 p -99.72 123.41 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -119.35 157.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.376 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -99.96 149.74 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.081 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 145.97 150.39 5.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.373 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -120.63 178.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.713 0.768 . . . . 0.0 112.472 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.647 ' N ' HG13 ' A' ' 42' ' ' VAL . 21.0 t80 -93.28 135.99 33.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.92 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 130.24 53.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.031 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.43 107.04 47.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.1 -33.2 95.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.437 2.091 . . . . 0.0 112.269 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.49 -49.29 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.86 116.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.791 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.12 146.95 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 59.18 30.63 20.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.06 -35.89 74.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.16 82.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.96 22.08 64.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.487 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -66.24 -77.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.24 -54.51 4.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 56' ' ' VAL . 15.9 m -49.34 119.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.49 103.16 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 58' ' ' VAL . 11.5 p -111.54 28.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 70.17 11.32 7.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 44.73 32.11 2.88 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.12 -74.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 0.0 110.719 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.508 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 1.5 p 172.34 131.08 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.984 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 40.5 Cg_endo -105.7 138.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.764 2.309 . . . . 0.0 113.878 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -108.58 164.33 12.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.87 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.899 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -114.44 139.66 49.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.8 m-85 -96.38 112.74 24.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 72' ' ' VAL . 11.3 p -109.69 163.36 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.717 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -93.19 -62.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.124 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 70' ' ' ASP . 60.5 m -86.02 -110.33 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.415 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 69' ' ' THR . 22.5 t70 -164.82 24.95 0.06 Allowed 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.071 -0.393 . . . . 0.0 111.543 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.84 -35.47 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 109.76 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 67' ' ' VAL . 16.6 m -63.12 -39.07 83.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.561 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -33.08 31.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.304 0.573 . . . . 0.0 110.077 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.7 mt-30 -81.99 -23.72 35.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.66 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.054 HD22 HG21 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -63.25 75.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.663 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' GLN . 3.4 mmt180 -71.09 155.26 41.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.855 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -41.82 149.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.916 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.47 35.4 8.65 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.671 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 96.7 m-20 -140.66 150.83 44.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.279 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.792 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.8 m -116.88 147.36 42.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.335 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -139.22 158.94 43.29 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.802 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.977 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -124.99 132.39 53.27 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.506 -0.121 . . . . 0.0 110.903 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 27' ' ' ALA . 13.7 tt -152.29 143.11 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 46.18 -94.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.475 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.655 ' CA ' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -53.44 -33.73 55.15 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.977 ' O ' HG22 ' A' ' 82' ' ' THR . 4.9 pt-20 102.56 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.412 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.426 ' OD1' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -142.44 110.19 5.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.288 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.626 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -136.55 138.47 41.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.5 t-105 -132.95 144.42 50.12 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.195 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.054 HG21 HD22 ' A' ' 75' ' ' LEU . 7.7 t -84.95 107.47 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.871 0.843 . . . . 0.0 110.041 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 8.1 t70 -96.73 -3.94 41.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.798 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.4 mtm180 -29.77 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.657 0.783 . . . . 0.0 112.961 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.84 -65.77 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.143 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -172.83 141.5 1.02 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.38 81.65 2.24 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.593 2.196 . . . . 0.0 112.343 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.09 -175.4 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -73.78 104.6 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.34 -44.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.569 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.28 35.1 4.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.49 132.75 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.826 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.59 50.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CG ' ' CZ3' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -119.35 -40.96 2.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.666 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.851 HD12 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 49.97 97.89 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.884 -177.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.525 ' CZ3' ' CG ' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -98.34 136.88 37.87 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.899 HD11 ' CB ' ' A' ' 65' ' ' LEU . 3.5 mp -110.03 161.09 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -169.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -147.99 110.52 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 112.99 -1.914 . . . . 0.0 109.814 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.524 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 2.4 mtm180 -97.98 130.39 44.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.765 0.782 . . . . 0.0 111.796 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.38 -19.13 75.83 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.152 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 110' ' ' PRO . 61.9 t -123.5 138.11 29.63 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 109' ' ' VAL . 28.0 Cg_endo -62.4 165.97 14.16 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.59 2.193 . . . . 0.0 112.32 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.18 -154.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.956 2.437 . . . . 0.0 112.185 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 62.95 64.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.032 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.655 HG21 ' CA ' ' A' ' 85' ' ' GLU . 59.5 t -117.97 -21.38 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.573 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.93 -54.18 50.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 50.85 -168.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -106.72 20.53 18.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.982 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.801 0.334 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.12 -177.18 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.033 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -147.12 161.52 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 52.07 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -176.29 148.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.68 -29.91 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.73 -28.86 23.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -126.39 146.94 49.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.27 86.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.51 73.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.176 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.8 30.95 16.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.187 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 13' ' ' ALA . 6.5 tp -134.24 -47.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -99.75 91.39 4.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.023 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.42 47.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.59 57.26 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.23 86.74 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.99 130.2 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -38.31 -33.49 0.1 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.229 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.501 HG22 ' CG ' ' A' ' 20' ' ' ARG . 40.6 mt -55.44 136.9 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.015 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' CG ' HG22 ' A' ' 19' ' ' ILE . 11.8 mtm-85 66.2 76.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.85 -148.56 8.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -149.62 85.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.328 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.62 -75.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.702 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 19.56 63.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.932 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -92.41 130.1 38.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.526 . . . . 0.0 111.706 -179.189 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 69.1 m -115.05 123.24 48.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.633 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.01 145.94 48.86 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 8.4 m -121.13 134.35 55.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.205 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -102.48 125.33 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.452 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.81 99.22 4.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.813 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 35' ' ' SER . 20.1 m -98.07 157.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.49 -18.66 23.55 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -126.1 -40.71 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.615 0.245 . . . . 0.0 111.385 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -112.19 63.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.494 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 31' ' ' SER . 17.8 t -104.78 120.3 41.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.654 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.15 42.3 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.35 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.48 127.02 16.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 19.2 m -99.3 130.53 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.743 HG12 HD11 ' A' ' 29' ' ' ILE . 1.9 pp -125.57 155.9 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -100.81 144.59 29.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.071 178.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 155.45 154.79 7.06 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.664 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -128.3 169.87 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.799 . . . . 0.0 111.901 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 -89.93 127.73 36.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.119 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' PRO . 1.6 t0 -113.98 144.57 42.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.609 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.75 108.23 35.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.155 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HG2' ' O ' ' A' ' 62' ' ' SER . 3.3 Cg_exo -74.35 -29.23 9.65 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.226 . . . . 0.0 112.029 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.66 25.88 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.237 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -68.38 -33.14 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.887 0.375 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.669 ' O ' HG23 ' A' ' 49' ' ' ILE . 13.8 tt -143.19 95.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.049 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.0 27.94 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.11 -78.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.35 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 106.85 1.49 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -95.63 149.06 21.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.93 15.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.418 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 m -151.49 121.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.015 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -99.0 87.71 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 58' ' ' VAL . 11.6 p -95.03 38.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 68.84 41.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.775 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.43 -83.88 0.97 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.711 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' SER . 24.3 m -114.08 -30.0 6.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.735 0.302 . . . . 0.0 111.252 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 75.48 166.7 0.12 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.896 -178.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 37.5 Cg_endo -98.33 150.68 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.217 1.945 . . . . 0.0 112.888 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.26 165.97 19.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.78 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.08 HD23 HD13 ' A' ' 103' ' ' LEU . 2.9 tp -112.43 139.51 47.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.687 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.776 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.3 m-85 -101.53 112.84 25.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.184 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.913 HG11 HG22 ' A' ' 72' ' ' VAL . 11.4 p -102.87 157.97 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 111.577 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -67.49 -31.55 71.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.433 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.53 -96.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.577 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.57 19.7 0.4 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.674 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -61.15 -48.29 82.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 109.974 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.913 HG22 HG11 ' A' ' 67' ' ' VAL . 16.0 m -53.78 -35.56 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.469 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -31.96 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.4 mt-30 -82.96 -20.93 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.686 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.993 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.2 64.21 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.188 0.518 . . . . 0.0 110.664 178.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLN . 16.2 mmm180 -55.1 160.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -52.87 145.43 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.407 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.97 6.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.845 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 92.8 m-20 -140.55 150.53 43.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.671 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 m -116.29 145.29 43.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.2 159.62 40.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.99 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.94 129.85 52.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.58 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.8 tt -126.08 -127.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 83' ' ' ILE . . . -58.45 -71.32 0.77 Allowed Glycine 0 CA--C 1.5 -0.9 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.853 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.824 ' HG3' HG11 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -55.32 -23.96 26.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 1.3 pt-20 89.99 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.342 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -142.15 109.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.699 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -138.02 136.55 37.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.767 176.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 7.8 m95 -130.43 143.31 50.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.646 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.993 ' CG2' HD22 ' A' ' 75' ' ' LEU . 33.7 t -85.29 107.11 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.96 0.886 . . . . 0.0 109.905 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 27.0 t0 -90.35 -3.67 57.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HG3' HD23 ' A' ' 103' ' ' LEU . 5.4 mtm180 -34.7 156.16 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.196 0.599 . . . . 0.0 112.58 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -106.3 -170.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.584 -178.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.56 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -111.6 91.08 13.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.668 0.271 . . . . 0.0 110.937 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 54.2 Cg_exo -52.52 175.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.715 2.276 . . . . 0.0 112.416 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.04 78.84 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.2 t0 64.91 87.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.75 137.22 7.98 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.468 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' PRO . . . 95.92 112.58 2.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.549 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 p -169.9 36.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 43.3 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -136.55 64.52 1.55 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.287 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.08 HD13 HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -55.87 111.5 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 8.1 t90 -97.56 127.9 43.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.0 mp -100.77 160.77 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -149.0 107.63 0.37 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.054 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.857 ' HB3' HG12 ' A' ' 109' ' ' VAL . 4.4 mtm180 -97.25 131.45 43.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.684 0.742 . . . . 0.0 111.392 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.2 -17.48 52.47 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.387 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 107' ' ' ARG . 14.8 p -74.92 141.34 74.97 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 111.331 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.479 ' CB ' ' CD ' ' A' ' 111' ' ' PRO . 52.2 Cg_exo -54.72 -172.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.483 2.122 . . . . 0.0 111.828 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 110' ' ' PRO . 11.6 Cg_exo -68.38 -41.99 6.0 Favored 'Trans proline' 0 CA--C 1.518 -0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 111.873 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.36 77.94 0.1 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.667 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.786 HG13 ' CD ' ' A' ' 85' ' ' GLU . 88.3 t -93.68 48.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.555 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 45.5 69.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.336 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -113.02 141.29 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -152.76 -73.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.69 33.94 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t0 69.84 89.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.99 91.21 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -146.95 43.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.818 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 t30 70.29 171.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.975 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.98 127.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.26 127.22 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.577 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 15.5 t70 68.44 -67.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 9' ' ' ASP . . . 78.23 19.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.151 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 13.98 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.324 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 13' ' ' ALA . 8.0 tp -124.89 -40.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 111.062 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -79.15 120.57 23.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.5 ptt180 -133.04 31.13 3.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 14' ' ' ARG . . . 177.58 -71.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.84 -60.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.04 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 65.76 122.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.74 154.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.816 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 tt -145.68 144.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -96.4 -62.66 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.17 110.12 2.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.411 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -57.02 123.2 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.51 102.92 14.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.17 38.51 1.79 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.815 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.88 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.89 138.1 31.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.3 0.572 . . . . 0.0 112.262 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 67.8 m -117.61 123.79 47.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.239 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -126.0 141.24 52.05 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' THR . 4.5 m -118.16 132.18 56.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.216 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.876 HD12 HD11 ' A' ' 75' ' ' LEU . 5.3 mm -103.52 126.9 57.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.359 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.5 99.22 4.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.282 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.456 ' N ' ' HB3' ' A' ' 35' ' ' SER . 3.0 p -115.31 156.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.05 -18.58 27.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.621 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.38 -70.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 111.247 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -130.65 71.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.456 ' HB3' ' N ' ' A' ' 31' ' ' SER . 66.3 p -81.4 134.55 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.94 49.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.04 127.7 16.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 38' ' ' VAL . 12.8 p -99.51 122.56 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' OE1' ' A' ' 71' ' ' GLU . 2.3 pp -112.05 157.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 12.1 ttp180 -100.64 133.15 45.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.887 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 157.24 158.75 9.09 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.789 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.88 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.3 t -129.11 167.53 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.828 0.823 . . . . 0.0 111.918 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' HB2' HD22 ' A' ' 105' ' ' LEU . 4.8 t80 -89.22 120.72 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.954 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.53 137.32 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -124.67 107.1 29.24 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.81 -45.87 15.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.459 2.106 . . . . 0.0 111.895 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.05 49.23 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.565 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -46.06 122.4 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.89 25.82 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 m -111.25 27.52 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.34 172.53 7.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 94.51 8.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.74 83.08 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.459 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -82.2 64.33 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.45 51.82 1.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.526 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.03 136.44 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.14 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.003 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 58' ' ' VAL . 13.0 p -105.21 29.11 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.045 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 67.16 24.8 9.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.05 155.19 16.8 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.5 p -158.07 33.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 111.03 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.79 154.32 0.28 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 39.2 Cg_endo -99.14 150.91 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.242 2.628 . . . . 0.0 112.47 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -130.09 164.65 23.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 111.338 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.013 HD23 HD12 ' A' ' 103' ' ' LEU . 3.5 tp -113.7 140.93 47.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.674 ' N ' HD12 ' A' ' 65' ' ' LEU . 3.7 m-30 -108.49 113.03 25.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.387 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.791 HG11 HG22 ' A' ' 72' ' ' VAL . 12.6 p -98.46 149.54 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.165 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.428 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 8.7 mmm180 -96.44 23.69 6.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.794 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 70' ' ' ASP . 43.9 m -163.44 -112.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.816 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 6.3 m-20 -161.59 26.25 0.12 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.021 0.373 . . . . 0.0 110.922 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.768 ' OE1' HG22 ' A' ' 39' ' ' ILE . 42.5 mt-10 -81.35 -43.35 19.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.531 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.791 HG22 HG11 ' A' ' 67' ' ' VAL . 29.6 m -54.12 -37.94 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -36.58 59.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.884 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.9 mt-30 -77.73 -25.39 49.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.409 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.948 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.18 62.85 0.06 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.667 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 1.5 mmt-85 -56.74 158.83 4.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.002 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -49.48 149.76 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.04 37.27 7.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 8.3 m-20 -136.03 148.42 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.757 ' C ' HD23 ' A' ' 81' ' ' LEU . 6.8 m -113.55 135.1 54.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.815 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -133.89 160.09 38.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 -179.041 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -123.03 129.0 50.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.859 HD12 ' CE2' ' A' ' 88' ' ' PHE . 3.9 tt -129.71 -139.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -51.64 -44.68 54.47 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 119.198 0.908 . . . . 0.0 111.628 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' ASN . 1.0 OUTLIER -96.57 28.99 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 173.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.995 ' O ' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER 34.54 33.49 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.808 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -141.85 109.87 5.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.221 0.534 . . . . 0.0 111.923 177.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -140.95 142.17 34.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.734 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 2.0 t-105 -134.79 142.62 46.74 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.948 ' CG2' HD22 ' A' ' 75' ' ' LEU . 59.5 t -85.56 107.44 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.126 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 21.4 t0 -90.24 -56.75 3.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.684 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.768 ' HD3' HD22 ' A' ' 103' ' ' LEU . 5.4 mmm180 42.97 -176.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.726 175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 m -63.16 173.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.767 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.29 151.69 93.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.735 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -47.16 -33.69 16.14 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.525 2.15 . . . . 0.0 112.365 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.1 76.13 1.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.908 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.86 158.95 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.17 109.0 3.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.541 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.15 -64.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.443 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 p 65.64 130.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 111.016 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.6 m 61.92 46.18 6.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.1 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -128.11 44.35 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.326 0.584 . . . . 0.0 110.297 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.013 HD12 HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -46.77 93.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.806 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.8 t90 -98.63 128.75 45.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.985 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.5 mp -103.1 160.69 14.42 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -171.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -139.08 103.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.749 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.0 mtm180 -97.46 142.71 28.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.306 0.553 . . . . 0.0 111.17 -176.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.47 -16.64 63.77 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.01 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.36 75.31 58.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.696 0.284 . . . . 0.0 110.896 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 67.9 Cg_exo -47.97 -44.26 28.07 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.482 2.121 . . . . 0.0 112.618 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 110' ' ' PRO . 6.8 Cg_exo -73.87 -153.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.704 2.269 . . . . 0.0 112.02 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 49.35 98.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -171.42 129.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -75.36 122.36 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.0 111.06 20.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.73 168.04 15.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.02 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.7 27.52 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -166.41 135.75 3.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.7 170.92 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.87 -69.08 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 m120 177.45 158.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.46 76.76 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -110.24 -22.22 11.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 71.3 51.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.81 -44.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.83 50.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.029 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -159.08 -42.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -76.85 -59.17 2.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.03 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 51.74 31.0 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.02 -171.08 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.008 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 67.23 152.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.52 102.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.2 m 55.78 77.77 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.23 56.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 117.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.94 -176.98 15.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.565 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -91.12 -45.19 8.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 110.946 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.31 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 41.49 47.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.759 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.72 138.52 31.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.37 0.605 . . . . 0.0 111.922 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 44.0 m -122.9 128.52 50.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.8 139.99 53.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.53 ' OG1' HG22 ' A' ' 38' ' ' VAL . 4.9 m -114.56 130.89 56.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 75' ' ' LEU . 4.2 mm -100.06 128.65 51.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -136.88 99.18 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.857 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 4.8 m -95.68 159.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -14.6 39.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.969 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -119.9 -48.04 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.68 68.75 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 111.849 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 40.9 p -98.73 122.69 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.82 41.77 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.424 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . . . -140.72 121.74 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.339 . . . . 0.0 110.799 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG22 ' OG1' ' A' ' 28' ' ' THR . 77.5 t -99.5 119.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.148 0.499 . . . . 0.0 111.442 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.652 HG12 HD11 ' A' ' 29' ' ' ILE . 2.5 pp -112.33 159.8 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.374 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.45 146.31 27.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.061 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 153.0 148.86 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.703 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -119.11 171.98 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 0.0 111.689 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HD2' HD22 ' A' ' 105' ' ' LEU . 36.7 t80 -90.02 132.91 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -119.4 136.31 54.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.008 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -123.24 106.76 33.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.754 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.41 -45.86 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.669 2.246 . . . . 0.0 112.26 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.75 -83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.053 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 64.37 112.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.74 63.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -108.95 28.97 7.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -137.01 172.13 13.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . . . -92.8 140.59 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.73 -75.24 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.369 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER 58.34 89.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.017 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.32 -28.43 73.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.294 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 m -52.74 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.047 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -73.0 122.21 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.966 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 58' ' ' VAL . 12.7 p -92.98 21.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.24 38.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.48 -32.26 3.73 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.429 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.08 168.15 9.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.939 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -134.8 179.09 1.47 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.542 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 32.5 Cg_endo -98.28 150.71 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.119 2.546 . . . . 0.0 112.374 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -129.32 165.57 21.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.048 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 tp -112.42 138.67 48.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.598 ' N ' HD12 ' A' ' 65' ' ' LEU . 27.1 m-85 -101.3 113.3 26.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.81 HG11 ' CG2' ' A' ' 72' ' ' VAL . 9.1 p -107.38 161.28 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.294 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -127.87 46.43 2.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.568 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 70' ' ' ASP . 87.7 m -163.97 -108.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.056 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 69' ' ' THR . 48.1 t0 179.75 36.6 0.0 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.887 0.375 . . . . 0.0 110.739 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 tt0 -104.71 -43.4 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.232 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.81 ' CG2' HG11 ' A' ' 67' ' ' VAL . 9.9 m -56.88 -37.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -41.77 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.814 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -73.9 -18.76 60.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.006 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.01 HD11 HG23 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.07 65.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 110.926 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.439 ' HA ' ' NH2' ' A' ' 92' ' ' ARG . 4.1 mmt180 -58.54 156.1 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.03 141.03 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.273 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.38 29.78 5.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 75.2 m-20 -140.37 150.47 43.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.119 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -115.7 145.05 43.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.349 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -136.27 160.26 39.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.133 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.96 135.8 54.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.735 HG21 ' CD1' ' A' ' 88' ' ' PHE . 3.0 tt -137.58 89.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.9 -68.78 0.19 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.754 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.6 mm-40 -62.1 -16.74 54.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.386 172.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.002 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 84.19 19.13 0.17 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.051 0.54 . . . . 0.0 111.081 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -142.94 119.05 10.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.735 ' CD1' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -149.44 130.57 14.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.865 169.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.544 ' CD2' HG23 ' A' ' 80' ' ' THR . 0.8 OUTLIER -128.49 143.63 51.01 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.518 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.99 HG21 HD22 ' A' ' 75' ' ' LEU . 6.3 t -85.2 108.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.664 0.745 . . . . 0.0 110.922 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 9.8 t0 -92.04 -5.43 52.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.506 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.537 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mtm-85 -37.96 161.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.229 0.537 . . . . 0.0 112.347 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.81 -37.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.0 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t 68.16 81.68 0.2 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.059 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.79 -167.45 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -128.65 29.55 5.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -162.65 -177.84 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -48.88 113.64 1.7 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.98 108.91 0.31 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.434 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.72 -169.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.867 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.2 t 76.76 26.9 0.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -115.92 -39.74 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.055 0.455 . . . . 0.0 110.141 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.048 HD13 HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 52.13 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.604 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.493 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 6.5 t90 -96.62 126.55 41.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.3 mp -97.22 160.06 14.56 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -140.86 99.09 0.24 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' ASN . 6.5 ttp180 -99.22 156.77 16.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.72 44.81 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.231 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.848 HG13 ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -25.04 -67.8 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.096 0.958 . . . . 0.0 113.017 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.848 ' CD ' HG13 ' A' ' 109' ' ' VAL . 96.1 Cg_endo -79.46 151.32 22.62 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.782 1.655 . . . . 0.0 112.437 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -93.72 -158.77 0.75 Allowed 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.584 -1.006 . . . . 0.0 112.213 0.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 42.16 98.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.102 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' GLU . 94.6 t -139.31 152.61 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 76.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 113' ' ' VAL . 1.1 mtm-85 -82.43 99.16 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -71.41 163.45 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.93 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.225 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 71.55 -77.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.229 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -119.51 177.25 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.029 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.29 -165.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 t70 69.87 42.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 67.45 175.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.4 mt -67.94 -173.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -142.13 142.74 32.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.561 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -169.03 175.75 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 9' ' ' ASP . . . 77.58 -59.2 0.46 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.936 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.26 30.21 3.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.895 0.379 . . . . 0.0 110.926 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 19.9 tt -171.68 161.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.423 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 74.72 92.23 0.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.035 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 97.2 mtt180 -102.01 -50.81 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' ARG . . . 178.4 49.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.48 106.35 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.28 122.75 1.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 m 61.7 99.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.789 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.7 tt -89.91 -19.97 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.44 50.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.07 -108.82 0.42 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.5 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 67.0 135.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.171 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.572 ' SD ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.69 -82.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.747 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 40' ' ' ARG . . . 67.61 62.53 4.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.717 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.746 ' OG1' HD11 ' A' ' 83' ' ' ILE . 14.9 t -93.01 138.7 31.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 54.6 m -105.04 122.97 46.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.573 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.015 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.85 145.56 49.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 110.061 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 2.5 m -120.59 133.74 55.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.581 HD12 HD11 ' A' ' 75' ' ' LEU . 8.1 mm -103.63 122.26 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -126.91 99.44 5.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' HB3' ' A' ' 35' ' ' SER . 6.5 p -115.17 157.98 22.88 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -17.34 32.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.758 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.64 -71.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -132.53 69.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 68.6 p -73.99 167.04 22.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.76 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 50.76 2.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.597 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.58 132.37 38.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.923 0.392 . . . . 0.0 110.963 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 38' ' ' VAL . 12.6 p -99.88 118.28 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.45 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.666 HG22 ' CD ' ' A' ' 71' ' ' GLU . 2.1 pp -123.52 154.63 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.368 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -100.3 125.39 46.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -176.91 143.32 6.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.385 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -119.26 -162.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.29 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 6.6 t80 -122.16 110.15 15.4 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.432 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.83 129.24 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.512 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.36 108.7 62.27 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.14 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.67 -57.17 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.479 2.119 . . . . 0.0 112.269 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -73.27 -25.62 60.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 68.03 86.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 50' ' ' SER . 53.7 mt -76.0 157.55 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.491 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER 61.27 27.59 17.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -106.98 154.22 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.22 131.15 32.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 -77.14 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.439 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.81 30.15 12.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.62 49.62 2.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.393 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.72 149.52 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -127.9 99.0 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 58' ' ' VAL . 13.7 p -94.05 24.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.2 49.34 5.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.986 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.1 -66.71 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.383 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.7 p 48.78 25.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.209 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.29 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.241 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 37.6 Cg_endo -98.3 139.94 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.086 2.524 . . . . 0.0 113.162 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.48 165.32 12.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.847 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.823 ' CD2' HD21 ' A' ' 103' ' ' LEU . 2.3 tt -114.49 139.46 49.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.789 0.328 . . . . 0.0 110.425 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.438 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 84.3 t80 -97.84 111.15 23.56 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 72' ' ' VAL . 10.6 p -100.68 163.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 67' ' ' VAL . 4.2 tpt85 -71.96 -36.62 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.114 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.63 -96.49 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.616 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -152.47 17.64 0.62 Allowed 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.666 ' CD ' HG22 ' A' ' 39' ' ' ILE . 6.8 tt0 -61.56 -46.81 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.418 . . . . 0.0 109.877 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.78 ' CG2' HD22 ' A' ' 103' ' ' LEU . 10.8 m -51.49 -31.67 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.385 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -33.84 68.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 3.0 mt-30 -78.71 -20.09 50.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.6 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.021 HD22 HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -66.28 62.65 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 178.182 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 29.6 mmm-85 -56.04 158.35 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 111.303 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -46.89 161.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.13 37.29 91.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 70.4 m-20 -129.32 131.07 46.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.626 ' C ' HD23 ' A' ' 81' ' ' LEU . 54.7 m -100.55 138.78 37.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.552 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.719 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.64 159.51 41.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.298 -178.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 86' ' ' GLU . 2.8 p -124.43 130.95 53.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.726 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.015 HD12 ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -120.99 -130.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -69.6 -34.08 72.69 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.638 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.773 ' HA ' HG23 ' A' ' 113' ' ' VAL . 9.3 mp0 -101.02 25.23 8.31 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.007 ' O ' HG22 ' A' ' 82' ' ' THR . 10.3 pt-20 38.07 33.88 0.06 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.804 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -144.04 109.15 5.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.775 ' HE2' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -140.59 149.68 42.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.506 ' CH2' ' HA3' ' A' ' 108' ' ' GLY . 12.3 m0 -133.23 142.73 48.71 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.901 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.021 HG21 HD22 ' A' ' 75' ' ' LEU . 94.0 t -85.32 106.59 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.821 0.819 . . . . 0.0 109.511 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 7.7 t0 -87.47 -2.11 58.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.668 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.614 ' HG3' HG13 ' A' ' 90' ' ' VAL . 3.2 mmp_? -36.79 163.78 0.0 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.692 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.1 -51.01 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.909 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.9 p 50.42 67.83 3.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.283 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.63 -28.71 37.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 111.905 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.0 p30 176.68 176.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -70.16 143.6 52.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.978 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.18 -99.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.39 -91.86 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 102' ' ' HIS . 0.2 OUTLIER 59.49 -163.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.6 m 77.34 32.49 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.468 ' O ' HD23 ' A' ' 103' ' ' LEU . 0.4 OUTLIER -123.64 -47.67 1.95 Allowed 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.151 0.5 . . . . 0.0 110.479 178.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 60.12 114.94 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.048 0.928 . . . . 0.0 110.129 -177.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.507 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 2.8 t90 -99.36 122.13 42.06 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.166 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.787 HD21 ' HB2' ' A' ' 65' ' ' LEU . 3.5 mp -89.74 156.72 18.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 89' ' ' TRP . . . -133.68 110.47 0.89 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.946 173.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 1.7 mmm180 -98.91 156.02 17.1 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CH2' ' A' ' 89' ' ' TRP . . . -145.94 42.93 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.211 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 109' ' ' VAL . 7.4 p -35.62 100.8 0.2 Allowed Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HB2' ' CD ' ' A' ' 111' ' ' PRO . 93.5 Cg_endo -83.46 -179.04 3.99 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.711 2.274 . . . . 0.0 111.598 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 110' ' ' PRO . 12.1 Cg_exo -69.91 -39.85 5.76 Favored 'Trans proline' 0 CA--C 1.519 -0.251 0 C-N-CA 122.481 2.121 . . . . 0.0 112.199 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.5 93.23 6.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.871 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.773 HG23 ' HA ' ' A' ' 85' ' ' GLU . 3.5 p -112.79 -21.32 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.817 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 58.42 69.69 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 110.898 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 0.6 OUTLIER -67.83 96.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.26 120.92 12.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 2.8 ptp180 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.74 113.34 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.84 -63.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -75.99 140.53 42.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -178.28 122.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -100.04 -63.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.163 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.4 mp -118.22 47.14 1.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.12 -73.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -158.5 -83.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.939 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -83.98 57.71 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.133 0.492 . . . . 0.0 111.134 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.23 21.68 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.286 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -179.35 -41.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 111.218 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 169.96 170.32 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.9 37.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.38 -171.49 2.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -131.04 179.95 5.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.11 166.28 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.08 24.54 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 19' ' ' ILE . 2.9 tt -173.32 69.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 -62.95 1.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 129.71 8.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.622 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 169.88 9.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.834 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.0 71.67 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.995 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.32 42.04 1.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.825 ' OG1' HD11 ' A' ' 83' ' ' ILE . 2.4 t -92.61 138.71 31.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.188 0.518 . . . . 0.0 111.824 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 75.1 m -119.91 129.76 54.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.694 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.052 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -123.87 143.6 50.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.344 0.592 . . . . 0.0 110.553 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.597 ' C ' HD13 ' A' ' 29' ' ' ILE . 4.4 m -119.66 133.71 55.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.84 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.004 HD11 HG12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -100.6 128.3 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.18 0.514 . . . . 0.0 111.397 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -133.4 98.74 4.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.438 177.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 35' ' ' SER . 1.4 p -109.88 151.97 26.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.597 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.57 -39.79 38.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.165 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -75.24 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -139.27 68.45 1.37 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 31.3 p -65.02 128.7 36.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.29 55.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.536 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.72 123.26 14.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' HG13 ' A' ' 38' ' ' VAL . 12.4 p -99.67 117.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.004 HG12 HD11 ' A' ' 29' ' ' ILE . 2.3 pp -119.33 159.76 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.688 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -104.03 149.76 24.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.839 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 148.23 146.54 4.36 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.768 ' CB ' HG21 ' A' ' 25' ' ' THR . 0.4 OUTLIER -112.41 -168.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.71 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.9 t80 -115.53 125.05 52.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.77 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 137.72 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.87 106.81 49.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.798 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 25.2 Cg_exo -63.77 -36.96 48.48 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.46 42.92 1.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.979 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -84.15 53.0 2.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER 47.63 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.093 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 49' ' ' ILE . 2.2 p 65.88 33.1 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.5 m-30 -81.2 61.9 4.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 53.69 -87.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.299 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 51' ' ' TYR . . . -109.23 -4.12 31.01 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.979 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 71.02 -170.62 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.935 0.367 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.73 32.06 5.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.412 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 58' ' ' VAL . 2.5 p -159.41 113.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.581 ' O ' HG12 ' A' ' 58' ' ' VAL . 6.7 mmt180 62.76 -70.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.476 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 57' ' ' ARG . 8.2 p 48.37 26.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.771 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.418 ' OE2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -128.32 -42.79 1.48 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.878 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.28 131.42 2.75 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.663 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -100.88 -68.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.689 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.539 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER 176.84 138.96 0.22 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 42.4 Cg_endo -100.85 139.93 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.763 2.309 . . . . 0.0 114.414 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -107.31 164.19 12.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.2 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.806 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.86 139.56 49.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.241 -177.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.0 m-85 -98.71 112.69 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 65' ' ' LEU . 12.2 p -106.57 162.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.932 0.396 . . . . 0.0 111.79 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.25 -69.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.86 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.0 p -84.09 -96.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -174.99 31.98 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.292 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.666 ' OE1' HG22 ' A' ' 39' ' ' ILE . 1.9 tt0 -76.5 -46.16 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.082 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.715 ' HB ' HD22 ' A' ' 103' ' ' LEU . 17.1 m -53.55 -34.41 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.32 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -54.39 -31.22 54.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.65 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.0 mt-30 -85.1 -21.91 29.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.718 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HG21 ' A' ' 29' ' ' ILE . 3.8 mp -66.85 65.23 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.5 mmm-85 -59.15 155.26 14.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.03 136.93 13.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.316 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.46 30.18 4.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.838 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 90' ' ' VAL . 16.2 t70 -140.56 144.01 35.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 30' ' ' THR . 2.0 m -112.41 140.12 47.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.561 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.868 HD12 ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -132.16 158.52 41.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.318 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.999 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -119.29 130.66 55.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.239 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -117.55 -129.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.382 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.433 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -71.12 -40.38 61.82 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.437 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.864 ' HB3' HG23 ' A' ' 109' ' ' VAL . 19.7 mm-40 -90.47 13.32 15.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.108 -0.546 . . . . 0.0 110.099 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.999 ' O ' HG22 ' A' ' 82' ' ' THR . 12.1 mt-10 64.96 20.74 12.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.402 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.07 112.66 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.936 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -141.25 126.05 18.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.261 175.094 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 12.6 m95 -118.52 144.97 45.68 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.311 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 90' ' ' VAL . 11.4 p -83.8 107.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.992 0.901 . . . . 0.0 109.863 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 12.9 t70 -93.53 -5.32 49.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.94 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.609 ' HD3' HD12 ' A' ' 103' ' ' LEU . 3.6 mtm180 -33.86 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.409 0.683 . . . . 0.0 112.544 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 128.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.159 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 t 54.27 76.64 0.5 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.36 -39.2 86.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.255 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.9 141.67 32.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.043 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.46 105.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.31 -83.34 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.507 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.4 -39.22 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER 50.77 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 72.58 25.88 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.046 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' ' C ' ' A' ' 100' ' ' SER . 1.9 m-70 -119.92 -45.82 2.46 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HB ' ' A' ' 72' ' ' VAL . 6.5 tp 53.16 101.4 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.958 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.539 ' CD1' ' HB2' ' A' ' 62' ' ' SER . 0.1 OUTLIER -96.6 133.93 40.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.058 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.806 HD11 ' CB ' ' A' ' 65' ' ' LEU . 1.2 mp -106.07 160.88 14.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -171.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 89' ' ' TRP . . . -137.51 102.67 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.283 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -97.07 155.8 16.64 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.194 -0.592 . . . . 0.0 110.75 -177.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -142.05 1.8 1.76 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.583 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.864 HG23 ' HB3' ' A' ' 85' ' ' GLU . 7.8 p 26.04 59.99 0.48 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 109' ' ' VAL . 72.6 Cg_endo -94.93 157.54 1.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.217 2.611 . . . . 0.0 112.171 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.79 -67.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.422 2.082 . . . . 0.0 112.203 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -53.13 92.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.884 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' 86' ' ' GLU . 47.7 t -158.2 -38.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.862 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -66.28 67.61 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.973 0.416 . . . . 0.0 110.695 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -141.1 120.3 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.086 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -102.8 -179.4 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.877 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.959 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.368 -0.293 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.927 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -93.19 138.7 31.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 111.955 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 62.9 m -121.59 124.74 45.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.379 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.43 144.14 50.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 4.0 m -121.11 134.21 55.24 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.478 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 39' ' ' ILE . 3.1 mm -99.79 125.28 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.382 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.12 99.14 4.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.558 178.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.443 ' N ' ' HB2' ' A' ' 35' ' ' SER . 15.1 p -108.53 153.69 23.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.58 26.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -89.61 -69.1 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.76 0.314 . . . . 0.0 111.38 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -128.6 71.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.533 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.443 ' HB2' ' N ' ' A' ' 31' ' ' SER . 8.0 t -80.59 114.04 19.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.671 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.09 46.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.373 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 121.19 18.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 38' ' ' VAL . 18.5 m -99.69 117.41 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 29' ' ' ILE . 2.0 pp -114.09 159.93 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.698 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.699 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 154.55 146.67 4.47 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.927 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -115.06 174.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.681 0.753 . . . . 0.0 112.101 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.3 t80 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.618 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 105' ' ' LEU . 6.0 tp -116.92 140.67 49.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 15.4 t80 -100.3 123.26 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 110.27 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 68' ' ' ARG . 11.2 p -112.46 164.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.542 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.58 41.94 3.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -171.21 -101.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.394 178.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t0 177.95 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -98.42 -34.99 10.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 103' ' ' LEU . 19.4 m -62.16 -31.17 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.916 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.59 84.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.272 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.9 mt-30 -69.88 -20.62 63.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.576 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.029 HD22 HG21 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -65.05 61.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.112 178.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 74' ' ' GLN . 48.8 mmm-85 -59.38 152.63 20.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -42.02 159.44 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.653 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.91 32.12 61.33 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.187 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 5.6 m-20 -128.62 128.4 44.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 111.015 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.747 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -99.98 140.45 34.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.444 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.883 HD13 HD11 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -135.18 159.71 40.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.442 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -123.04 129.53 51.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.749 HD12 ' CE2' ' A' ' 88' ' ' PHE . 2.3 tt -137.88 135.47 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.47 -95.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.03 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.486 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 40.8 mm-40 -50.66 -27.35 6.78 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 98.65 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.813 1.245 . . . . 0.0 111.663 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.5 111.18 5.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.749 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -140.48 139.76 35.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.558 173.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.515 ' HD1' HG23 ' A' ' 80' ' ' THR . 7.0 t90 -134.93 142.42 46.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.029 HG21 HD22 ' A' ' 75' ' ' LEU . 59.8 t -84.29 108.51 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 121.874 0.845 . . . . 0.0 110.902 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 104' ' ' TRP . 11.9 t70 -85.59 -5.58 59.26 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.864 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG3' HG13 ' A' ' 90' ' ' VAL . 9.6 mtm-85 . . . . . 0 C--N 1.339 0.123 0 CA-C-O 121.265 0.555 . . . . 0.0 111.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.757 ' CD1' HG21 ' A' ' 72' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.095 0.474 . . . . 0.0 111.805 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -99.48 120.34 39.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 65' ' ' LEU . 10.9 mt -107.75 161.19 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.947 0.879 . . . . 0.0 113.282 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.34 117.21 2.22 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.686 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.553 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mmm180 -98.0 156.68 16.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.448 0.642 . . . . 0.0 112.348 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.076 178.089 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 N-CA-C 112.399 -0.28 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.963 ' OG1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -92.89 138.49 31.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 112.072 -178.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 64.8 m -118.94 124.95 48.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.166 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -124.98 138.83 54.22 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.45 ' C ' HD13 ' A' ' 29' ' ' ILE . 5.4 m -115.95 133.9 55.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.331 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.965 HD11 HG12 ' A' ' 39' ' ' ILE . 1.9 mm -99.81 131.6 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.132 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -137.35 98.96 3.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.67 178.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -108.1 159.56 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.798 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.08 70.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -75.63 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.886 0.374 . . . . 0.0 111.993 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -137.87 77.16 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.31 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 29.4 p -74.29 123.54 24.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.788 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.5 48.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.17 126.12 29.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.6 p -99.71 122.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.965 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -122.01 156.98 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -99.07 140.38 33.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.873 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 159.15 152.57 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.068 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.957 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.6 178.64 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.284 0.564 . . . . 0.0 111.707 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.254 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER . . . . . 0 CA--C 1.515 -0.385 0 CA-C-O 121.049 0.452 . . . . 0.0 110.979 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -115.35 139.72 49.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.996 -177.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -93.82 121.08 34.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.643 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 72' ' ' VAL . 10.0 p -122.18 160.16 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.199 0.524 . . . . 0.0 112.15 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.534 ' C ' HG22 ' A' ' 69' ' ' THR . 1.8 mpt_? -134.41 65.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.318 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' C ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER 167.49 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.002 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -66.36 62.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' THR . 5.6 mt-10 -126.39 -45.82 1.65 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.668 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 67' ' ' VAL . 5.2 m -57.53 -30.29 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.046 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -48.49 77.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.424 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.4 mt-30 -63.29 -19.76 64.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.574 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.09 HD22 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -67.11 63.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.599 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.8 mmm180 -55.32 160.89 2.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -53.04 146.46 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 77' ' ' ARG . . . 95.88 38.51 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.304 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.695 ' CG ' HD21 ' A' ' 75' ' ' LEU . 2.5 t0 -140.36 150.59 44.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 111.305 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' THR . 4.9 m -118.5 142.98 47.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.688 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.1 158.31 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.384 -178.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.005 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -118.75 129.23 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.674 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.963 HD11 ' OG1' ' A' ' 25' ' ' THR . 0.6 OUTLIER -122.7 -136.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.858 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.555 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -59.74 -41.12 97.39 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.592 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -91.0 15.92 10.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.041 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.005 ' O ' HG22 ' A' ' 82' ' ' THR . 4.5 mt-10 57.71 19.78 5.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.399 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.425 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 18.1 m120 -144.89 112.66 6.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.833 ' CD1' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -138.98 150.98 46.48 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.543 ' CE3' HG23 ' A' ' 80' ' ' THR . 30.9 t-105 -135.63 141.92 45.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.439 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.09 HG21 HD22 ' A' ' 75' ' ' LEU . 9.2 t -84.98 107.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.099 0.952 . . . . 0.0 110.532 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' TRP . 33.7 t0 -99.18 -5.89 29.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 3.7 mtm180 . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.8 114.15 25.76 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.833 HD13 ' CD1' ' A' ' 88' ' ' PHE . 13.2 mt -107.39 163.31 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -143.95 122.13 1.77 Allowed Glycine 0 CA--C 1.521 0.461 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.019 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mtm180 -99.26 140.0 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.347 0.573 . . . . 0.0 111.828 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.504 177.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.846 -0.102 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -92.79 138.6 31.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.519 . . . . 0.0 112.062 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 83' ' ' ILE . 49.6 m -126.73 124.33 39.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.445 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.47 142.59 51.2 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 38' ' ' VAL . 3.8 m -114.34 132.88 56.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.149 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 75' ' ' LEU . 4.3 mm -102.02 124.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 111.856 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.56 99.11 5.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.363 178.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.45 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -116.95 154.61 30.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.919 -179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.01 -17.7 30.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -88.56 -69.72 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -127.95 72.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 31' ' ' SER . 12.9 p -84.6 146.17 27.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.14 24.73 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.706 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.35 129.97 56.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.945 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG22 ' OG1' ' A' ' 28' ' ' THR . 66.7 t -101.84 122.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.025 0.44 . . . . 0.0 111.315 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.775 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -116.33 160.09 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.966 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -102.94 147.07 27.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.615 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 150.83 153.32 6.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.014 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.03 175.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.556 0.693 . . . . 0.0 112.317 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.627 ' N ' HG13 ' A' ' 42' ' ' VAL . 37.1 t80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.57 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.846 0.355 . . . . 0.0 110.92 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.956 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -113.13 141.08 47.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.067 -177.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.427 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 2.2 m-85 -103.98 115.22 30.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.046 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HG22 ' A' ' 72' ' ' VAL . 12.3 p -102.89 160.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.442 . . . . 0.0 111.523 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.12 -55.88 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.929 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -90.07 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.42 32.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.65 0.262 . . . . 0.0 111.363 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.33 -41.93 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.057 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.829 HG11 HD21 ' A' ' 65' ' ' LEU . 33.5 m -56.57 -33.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.985 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -54.02 -30.78 49.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.5 mt-30 -86.36 -22.71 26.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.624 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 29' ' ' ILE . 6.5 mp -66.51 62.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 12.7 mmt-85 -60.33 158.03 12.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -42.53 157.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.605 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.5 27.56 54.39 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.401 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -125.7 139.91 53.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.889 HG22 ' CE3' ' A' ' 89' ' ' TRP . 0.5 OUTLIER -108.31 138.87 43.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -140.26 158.58 43.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -121.11 122.28 39.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.237 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.874 HD11 ' OG1' ' A' ' 25' ' ' THR . 6.4 tt -127.05 137.35 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.323 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 38.88 -92.69 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.946 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 63.0 mm-40 -49.54 -26.36 3.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.975 ' O ' HG22 ' A' ' 82' ' ' THR . 3.0 mt-10 101.34 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.619 1.168 . . . . 0.0 111.382 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 16.4 m120 -144.28 110.81 5.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -140.83 119.51 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.626 173.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.889 ' CE3' HG22 ' A' ' 80' ' ' THR . 9.1 m95 -108.95 142.46 39.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.715 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.866 ' CG2' HD21 ' A' ' 81' ' ' LEU . 48.0 t -86.1 107.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.506 0.67 . . . . 0.0 110.348 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.487 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 16.4 t0 -89.35 -59.43 2.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.403 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.2 mtp180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.362 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.932 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.487 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.6 t90 -98.04 128.59 44.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.956 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.9 mp -100.29 159.76 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -140.01 110.2 0.67 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.352 172.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -97.79 156.73 16.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.469 0.652 . . . . 0.0 111.843 -175.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.127 178.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.924 HG21 HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.19 138.93 31.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.579 . . . . 0.0 112.29 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -133.07 123.96 26.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.285 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -125.76 152.43 45.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.092 0.473 . . . . 0.0 109.977 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 16.2 m -124.18 133.02 53.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.143 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD22 ' A' ' 81' ' ' LEU . 4.0 mm -100.79 122.97 53.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.345 0.593 . . . . 0.0 111.835 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -126.0 98.75 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.106 178.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.436 ' N ' ' HB3' ' A' ' 35' ' ' SER . 98.6 p -120.06 160.4 22.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.848 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 -25.65 58.44 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.174 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.91 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 111.569 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 6.3 tt0 -143.44 57.02 1.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.04 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 31' ' ' SER . 14.0 p -49.24 118.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.71 46.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.478 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.84 126.06 23.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.9 p -99.48 132.33 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.485 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.587 HG12 HD11 ' A' ' 29' ' ' ILE . 2.2 pp -121.23 153.77 24.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.323 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 10.6 ttp180 -109.91 142.88 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . . . 121.28 149.07 8.05 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.48 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.924 HG23 HG21 ' A' ' 25' ' ' THR . 26.2 t -111.15 -120.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.658 ' N ' HG12 ' A' ' 42' ' ' VAL . 6.1 p90 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -111.71 140.04 46.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.662 0.744 . . . . 0.0 111.194 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 62.8 t80 -94.63 135.35 36.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.272 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.707 HG11 HG22 ' A' ' 72' ' ' VAL . 14.5 p -133.08 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 17.0 mmm180 -102.76 37.31 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.95 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 70' ' ' ASP . 97.5 m -164.32 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.377 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 69' ' ' THR . 51.0 t0 179.0 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.758 0.313 . . . . 0.0 110.879 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.24 -47.01 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.312 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.811 HG11 HD21 ' A' ' 65' ' ' LEU . 27.6 m -52.63 -35.16 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.278 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -30.59 52.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.62 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 76' ' ' ARG . 7.5 mt-30 -89.76 -19.17 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.855 HD11 HG21 ' A' ' 29' ' ' ILE . 5.6 mp -66.04 67.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.8 mmt85 -62.53 151.79 36.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.078 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -43.92 137.47 3.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.024 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.97 34.74 3.91 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.163 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 97.3 m-20 -140.55 147.79 40.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.188 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 81' ' ' LEU . 8.0 m -111.12 150.36 29.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.778 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.977 HD22 HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -145.05 152.49 40.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.962 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -113.23 120.68 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.672 HG21 ' CD1' ' A' ' 88' ' ' PHE . 5.3 tt -130.38 136.81 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.86 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 41.76 -92.34 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.81 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 86' ' ' GLU . 4.6 mm-40 -53.12 -33.49 52.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.962 ' O ' HG22 ' A' ' 82' ' ' THR . 3.7 mm-40 116.04 19.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.196 1.398 . . . . 0.0 111.745 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.468 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 26.4 t-20 -144.21 121.6 11.66 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 118.845 -1.142 . . . . 0.0 114.03 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -142.94 112.16 6.65 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 8.7 t90 -104.03 141.87 35.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.25 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 90' ' ' VAL . 9.3 p -84.37 109.3 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.892 0.853 . . . . 0.0 111.622 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 104' ' ' TRP . 27.8 t0 -86.93 -4.31 59.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.796 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.656 ' HD3' HD22 ' A' ' 103' ' ' LEU . 6.3 mtm180 . . . . . 0 N--CA 1.462 0.156 0 CA-C-O 121.232 0.539 . . . . 0.0 112.333 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 9.2 t90 -97.13 123.64 40.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.811 HD11 ' CD2' ' A' ' 88' ' ' PHE . 2.4 mt -104.92 163.3 12.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -171.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -145.85 121.01 1.41 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.89 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -98.26 157.58 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.525 0.678 . . . . 0.0 112.217 -175.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.54 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.89 177.8 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 1.005 ' OG1' HD11 ' A' ' 83' ' ' ILE . 1.1 t -92.7 133.18 36.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.135 0.493 . . . . 0.0 111.923 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 83' ' ' ILE . 70.3 m -115.45 123.32 48.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.286 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -122.71 146.94 47.03 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.229 0.538 . . . . 0.0 110.538 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 5.8 m -120.74 134.15 55.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.718 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -104.58 125.42 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.168 0.509 . . . . 0.0 111.517 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.76 98.96 4.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.378 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 80.0 p -118.22 142.48 47.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.675 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.45 -30.07 1.28 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.855 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.62 -75.9 0.13 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.874 0.369 . . . . 0.0 111.627 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -126.48 64.83 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 93.8 p -77.32 127.68 33.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.675 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 135.97 48.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.78 132.37 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.9 p -99.72 123.41 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -119.35 157.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.376 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -99.96 149.74 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.081 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 145.97 150.39 5.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.373 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -120.63 178.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.713 0.768 . . . . 0.0 112.472 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.647 ' N ' HG13 ' A' ' 42' ' ' VAL . 21.0 t80 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.92 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.947 0.403 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.899 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -114.44 139.66 49.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.8 m-85 -96.38 112.74 24.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 72' ' ' VAL . 11.3 p -109.69 163.36 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.717 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -93.19 -62.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.124 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 70' ' ' ASP . 60.5 m -86.02 -110.33 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.415 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 69' ' ' THR . 22.5 t70 -164.82 24.95 0.06 Allowed 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.071 -0.393 . . . . 0.0 111.543 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.84 -35.47 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 109.76 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 67' ' ' VAL . 16.6 m -63.12 -39.07 83.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.561 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -33.08 31.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.304 0.573 . . . . 0.0 110.077 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.7 mt-30 -81.99 -23.72 35.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.66 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.054 HD22 HG21 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -63.25 75.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.663 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' GLN . 3.4 mmt180 -71.09 155.26 41.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.855 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -41.82 149.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.916 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.47 35.4 8.65 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.671 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 96.7 m-20 -140.66 150.83 44.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.279 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.792 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.8 m -116.88 147.36 42.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.335 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -139.22 158.94 43.29 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.802 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.977 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -124.99 132.39 53.27 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.506 -0.121 . . . . 0.0 110.903 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 27' ' ' ALA . 13.7 tt -152.29 143.11 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 46.18 -94.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.475 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -53.44 -33.73 55.15 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.977 ' O ' HG22 ' A' ' 82' ' ' THR . 4.9 pt-20 102.56 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.412 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.42 ' N ' ' OE1' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -142.44 110.19 5.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.288 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.626 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -136.55 138.47 41.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.5 t-105 -132.95 144.42 50.12 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.195 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.054 HG21 HD22 ' A' ' 75' ' ' LEU . 7.7 t -84.95 107.47 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.871 0.843 . . . . 0.0 110.041 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 8.1 t70 -96.73 -3.94 41.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.798 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.4 mtm180 . . . . . 0 N--CA 1.467 0.387 0 C-N-CA 123.657 0.783 . . . . 0.0 112.961 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.851 HD12 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.054 0.454 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -98.34 136.88 37.87 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.899 HD11 ' CB ' ' A' ' 65' ' ' LEU . 3.5 mp -110.03 161.09 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -169.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -147.99 110.52 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 112.99 -1.914 . . . . 0.0 109.814 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.524 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 2.4 mtm180 -97.98 130.39 44.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.765 0.782 . . . . 0.0 111.796 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.152 175.315 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.809 -0.116 . . . . 0.0 112.809 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.932 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -92.41 130.1 38.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.526 . . . . 0.0 111.706 -179.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 69.1 m -115.05 123.24 48.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.633 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.01 145.94 48.86 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 8.4 m -121.13 134.35 55.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.205 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -102.48 125.33 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.452 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.81 99.22 4.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.813 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 35' ' ' SER . 20.1 m -98.07 157.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.49 -18.66 23.55 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -126.1 -40.71 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.615 0.245 . . . . 0.0 111.385 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -112.19 63.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.494 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 31' ' ' SER . 17.8 t -104.78 120.3 41.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.654 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.15 42.3 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.35 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.48 127.02 16.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 19.2 m -99.3 130.53 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.743 HG12 HD11 ' A' ' 29' ' ' ILE . 1.9 pp -125.57 155.9 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -100.81 144.59 29.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.071 178.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 155.45 154.79 7.06 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.664 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -128.3 169.87 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.799 . . . . 0.0 111.901 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.561 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 . . . . . 0 N--CA 1.448 -0.573 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.119 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.851 0.358 . . . . 0.0 110.78 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.08 HD23 HD13 ' A' ' 103' ' ' LEU . 2.9 tp -112.43 139.51 47.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.687 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.776 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.3 m-85 -101.53 112.84 25.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.184 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.913 HG11 HG22 ' A' ' 72' ' ' VAL . 11.4 p -102.87 157.97 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 111.577 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -67.49 -31.55 71.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.433 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.53 -96.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.577 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.57 19.7 0.4 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.674 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -61.15 -48.29 82.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 109.974 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.913 HG22 HG11 ' A' ' 67' ' ' VAL . 16.0 m -53.78 -35.56 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.469 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -31.96 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.4 mt-30 -82.96 -20.93 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.686 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.993 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.2 64.21 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.188 0.518 . . . . 0.0 110.664 178.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLN . 16.2 mmm180 -55.1 160.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -52.87 145.43 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.407 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.97 6.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.845 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 92.8 m-20 -140.55 150.53 43.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.671 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 m -116.29 145.29 43.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.2 159.62 40.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.99 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.94 129.85 52.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.58 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.8 tt -126.08 -127.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 83' ' ' ILE . . . -58.45 -71.32 0.77 Allowed Glycine 0 CA--C 1.5 -0.9 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.853 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -55.32 -23.96 26.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 1.3 pt-20 89.99 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.342 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -142.15 109.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.699 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -138.02 136.55 37.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.767 176.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 7.8 m95 -130.43 143.31 50.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.646 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.993 ' CG2' HD22 ' A' ' 75' ' ' LEU . 33.7 t -85.29 107.11 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.96 0.886 . . . . 0.0 109.905 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.516 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 27.0 t0 -90.35 -3.67 57.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HG3' HD23 ' A' ' 103' ' ' LEU . 5.4 mtm180 . . . . . 0 N--CA 1.463 0.192 0 C-N-CA 123.196 0.599 . . . . 0.0 112.58 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.08 HD13 HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.457 0.17 . . . . 0.0 110.899 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 8.1 t90 -97.56 127.9 43.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.0 mp -100.77 160.77 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -149.0 107.63 0.37 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.054 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.536 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.4 mtm180 -97.25 131.45 43.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.684 0.742 . . . . 0.0 111.392 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.672 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.387 176.176 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.421 0 N-CA-C 112.815 -0.114 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.88 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.89 138.1 31.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.3 0.572 . . . . 0.0 112.262 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 67.8 m -117.61 123.79 47.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.239 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -126.0 141.24 52.05 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' THR . 4.5 m -118.16 132.18 56.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.216 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.876 HD12 HD11 ' A' ' 75' ' ' LEU . 5.3 mm -103.52 126.9 57.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.359 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.5 99.22 4.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.282 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.456 ' N ' ' HB3' ' A' ' 35' ' ' SER . 3.0 p -115.31 156.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.05 -18.58 27.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.621 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.38 -70.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 111.247 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -130.65 71.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.456 ' HB3' ' N ' ' A' ' 31' ' ' SER . 66.3 p -81.4 134.55 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.94 49.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.04 127.7 16.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.8 p -99.51 122.56 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' OE1' ' A' ' 71' ' ' GLU . 2.3 pp -112.05 157.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 12.1 ttp180 -100.64 133.15 45.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.887 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 157.24 158.75 9.09 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.789 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.88 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.3 t -129.11 167.53 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.828 0.823 . . . . 0.0 111.918 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' HB2' HD22 ' A' ' 105' ' ' LEU . 4.8 t80 . . . . . 0 N--CA 1.449 -0.508 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.954 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.997 0.427 . . . . 0.0 111.338 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.013 HD23 HD12 ' A' ' 103' ' ' LEU . 3.5 tp -113.7 140.93 47.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.674 ' N ' HD12 ' A' ' 65' ' ' LEU . 3.7 m-30 -108.49 113.03 25.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.387 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.791 HG11 HG22 ' A' ' 72' ' ' VAL . 12.6 p -98.46 149.54 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.165 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.428 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 8.7 mmm180 -96.44 23.69 6.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.794 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 70' ' ' ASP . 43.9 m -163.44 -112.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.816 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 6.3 m-20 -161.59 26.25 0.12 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.021 0.373 . . . . 0.0 110.922 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.768 ' OE1' HG22 ' A' ' 39' ' ' ILE . 42.5 mt-10 -81.35 -43.35 19.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.531 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.791 HG22 HG11 ' A' ' 67' ' ' VAL . 29.6 m -54.12 -37.94 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -36.58 59.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.884 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.9 mt-30 -77.73 -25.39 49.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.409 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.948 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.18 62.85 0.06 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.667 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 1.5 mmt-85 -56.74 158.83 4.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.002 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -49.48 149.76 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.04 37.27 7.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.477 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 8.3 m-20 -136.03 148.42 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.757 ' C ' HD23 ' A' ' 81' ' ' LEU . 6.8 m -113.55 135.1 54.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.815 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -133.89 160.09 38.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 -179.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -123.03 129.0 50.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.859 HD12 ' CE2' ' A' ' 88' ' ' PHE . 3.9 tt -129.71 -139.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -51.64 -44.68 54.47 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 119.198 0.908 . . . . 0.0 111.628 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' ASN . 1.0 OUTLIER -96.57 28.99 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 173.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.995 ' O ' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER 34.54 33.49 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.808 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -141.85 109.87 5.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.221 0.534 . . . . 0.0 111.923 177.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -140.95 142.17 34.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.734 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 2.0 t-105 -134.79 142.62 46.74 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.948 ' CG2' HD22 ' A' ' 75' ' ' LEU . 59.5 t -85.56 107.44 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.126 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.496 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 21.4 t0 -90.24 -56.75 3.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.684 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.768 ' HD3' HD22 ' A' ' 103' ' ' LEU . 5.4 mmm180 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.726 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.013 HD12 HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.8 t90 -98.63 128.75 45.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.985 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.5 mp -103.1 160.69 14.42 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -171.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -139.08 103.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.749 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.0 mtm180 -97.46 142.71 28.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.306 0.553 . . . . 0.0 111.17 -176.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.44 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.01 177.205 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.759 -0.137 . . . . 0.0 112.759 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.72 138.52 31.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.37 0.605 . . . . 0.0 111.922 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 44.0 m -122.9 128.52 50.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.8 139.99 53.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.53 ' OG1' HG22 ' A' ' 38' ' ' VAL . 4.9 m -114.56 130.89 56.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 75' ' ' LEU . 4.2 mm -100.06 128.65 51.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -136.88 99.18 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.857 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 4.8 m -95.68 159.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -14.6 39.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.969 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -119.9 -48.04 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.68 68.75 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 111.849 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 40.9 p -98.73 122.69 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.82 41.77 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.424 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . . . -140.72 121.74 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.339 . . . . 0.0 110.799 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG22 ' OG1' ' A' ' 28' ' ' THR . 77.5 t -99.5 119.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.148 0.499 . . . . 0.0 111.442 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.652 HG12 HD11 ' A' ' 29' ' ' ILE . 2.5 pp -112.33 159.8 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.374 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.45 146.31 27.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.061 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 153.0 148.86 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.703 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -119.11 171.98 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 0.0 111.689 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HD2' HD22 ' A' ' 105' ' ' LEU . 36.7 t80 . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.891 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.94 0.4 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.048 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 tp -112.42 138.67 48.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.598 ' N ' HD12 ' A' ' 65' ' ' LEU . 27.1 m-85 -101.3 113.3 26.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.81 HG11 ' CG2' ' A' ' 72' ' ' VAL . 9.1 p -107.38 161.28 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.294 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -127.87 46.43 2.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.568 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 70' ' ' ASP . 87.7 m -163.97 -108.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.056 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 69' ' ' THR . 48.1 t0 179.75 36.6 0.0 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.887 0.375 . . . . 0.0 110.739 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 tt0 -104.71 -43.4 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.232 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.81 ' CG2' HG11 ' A' ' 67' ' ' VAL . 9.9 m -56.88 -37.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -41.77 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.814 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -73.9 -18.76 60.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.006 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.01 HD11 HG23 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.07 65.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 110.926 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.439 ' HA ' ' NH2' ' A' ' 92' ' ' ARG . 4.1 mmt180 -58.54 156.1 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.03 141.03 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.273 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.38 29.78 5.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 75.2 m-20 -140.37 150.47 43.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.119 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -115.7 145.05 43.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.349 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -136.27 160.26 39.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.133 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.96 135.8 54.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.735 HG21 ' CD1' ' A' ' 88' ' ' PHE . 3.0 tt -137.58 89.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.9 -68.78 0.19 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 10.6 mm-40 -62.1 -16.74 54.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.386 172.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.002 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 84.19 19.13 0.17 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.051 0.54 . . . . 0.0 111.081 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.505 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -142.94 119.05 10.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.735 ' CD1' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -149.44 130.57 14.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.865 169.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.544 ' CD2' HG23 ' A' ' 80' ' ' THR . 0.8 OUTLIER -128.49 143.63 51.01 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.518 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.99 HG21 HD22 ' A' ' 75' ' ' LEU . 6.3 t -85.2 108.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.664 0.745 . . . . 0.0 110.922 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 9.8 t0 -92.04 -5.43 52.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.506 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.537 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mtm-85 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.229 0.537 . . . . 0.0 112.347 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.048 HD13 HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 120.821 0.344 . . . . 0.0 110.604 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.493 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 6.5 t90 -96.62 126.55 41.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.3 mp -97.22 160.06 14.56 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -140.86 99.09 0.24 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' ASN . 6.5 ttp180 -99.22 156.77 16.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.435 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.231 177.458 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 40' ' ' ARG . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.717 -0.153 . . . . 0.0 112.717 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.746 ' OG1' HD11 ' A' ' 83' ' ' ILE . 14.9 t -93.01 138.7 31.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 54.6 m -105.04 122.97 46.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.573 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.015 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.85 145.56 49.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 110.061 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 2.5 m -120.59 133.74 55.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.581 HD12 HD11 ' A' ' 75' ' ' LEU . 8.1 mm -103.63 122.26 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -126.91 99.44 5.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' HB3' ' A' ' 35' ' ' SER . 6.5 p -115.17 157.98 22.88 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -17.34 32.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.758 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.64 -71.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -132.53 69.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 68.6 p -73.99 167.04 22.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.76 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 50.76 2.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.597 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.58 132.37 38.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.923 0.392 . . . . 0.0 110.963 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.6 p -99.88 118.28 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.45 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.666 HG22 ' CD ' ' A' ' 71' ' ' GLU . 2.1 pp -123.52 154.63 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.368 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -100.3 125.39 46.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -176.91 143.32 6.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.385 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -119.26 -162.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.439 -1.015 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.432 -177.514 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.255 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.823 ' CD2' HD21 ' A' ' 103' ' ' LEU . 2.3 tt -114.49 139.46 49.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.789 0.328 . . . . 0.0 110.425 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.438 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 84.3 t80 -97.84 111.15 23.56 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 72' ' ' VAL . 10.6 p -100.68 163.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 67' ' ' VAL . 4.2 tpt85 -71.96 -36.62 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.114 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.63 -96.49 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.616 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -152.47 17.64 0.62 Allowed 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.666 ' CD ' HG22 ' A' ' 39' ' ' ILE . 6.8 tt0 -61.56 -46.81 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.418 . . . . 0.0 109.877 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.78 ' CG2' HD22 ' A' ' 103' ' ' LEU . 10.8 m -51.49 -31.67 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.385 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -33.84 68.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 3.0 mt-30 -78.71 -20.09 50.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.6 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.021 HD22 HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -66.28 62.65 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 178.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 29.6 mmm-85 -56.04 158.35 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 111.303 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -46.89 161.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.13 37.29 91.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.471 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 70.4 m-20 -129.32 131.07 46.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.626 ' C ' HD23 ' A' ' 81' ' ' LEU . 54.7 m -100.55 138.78 37.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.552 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.719 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.64 159.51 41.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.298 -178.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 86' ' ' GLU . 2.8 p -124.43 130.95 53.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.726 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.015 HD12 ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -120.99 -130.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -69.6 -34.08 72.69 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.638 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 9.3 mp0 -101.02 25.23 8.31 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.007 ' O ' HG22 ' A' ' 82' ' ' THR . 10.3 pt-20 38.07 33.88 0.06 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.804 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -144.04 109.15 5.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.775 ' HE2' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -140.59 149.68 42.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.506 ' CH2' ' HA3' ' A' ' 108' ' ' GLY . 12.3 m0 -133.23 142.73 48.71 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.901 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.021 HG21 HD22 ' A' ' 75' ' ' LEU . 94.0 t -85.32 106.59 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.821 0.819 . . . . 0.0 109.511 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 7.7 t0 -87.47 -2.11 58.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.668 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.614 ' HG3' HG13 ' A' ' 90' ' ' VAL . 3.2 mmp_? . . . . . 0 C--O 1.231 0.109 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.692 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.712 0 CA-C-O 122.048 0.928 . . . . 0.0 110.129 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.507 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 2.8 t90 -99.36 122.13 42.06 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.166 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.787 HD21 ' HB2' ' A' ' 65' ' ' LEU . 3.5 mp -89.74 156.72 18.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 89' ' ' TRP . . . -133.68 110.47 0.89 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.946 173.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 1.7 mmm180 -98.91 156.02 17.1 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CH2' ' A' ' 89' ' ' TRP . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.211 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.444 -0.263 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.825 ' OG1' HD11 ' A' ' 83' ' ' ILE . 2.4 t -92.61 138.71 31.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.188 0.518 . . . . 0.0 111.824 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 75.1 m -119.91 129.76 54.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.694 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.052 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -123.87 143.6 50.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.344 0.592 . . . . 0.0 110.553 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.597 ' C ' HD13 ' A' ' 29' ' ' ILE . 4.4 m -119.66 133.71 55.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.84 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.004 HD11 HG12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -100.6 128.3 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.18 0.514 . . . . 0.0 111.397 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -133.4 98.74 4.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.438 177.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 35' ' ' SER . 1.4 p -109.88 151.97 26.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.597 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.57 -39.79 38.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.165 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -75.24 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -139.27 68.45 1.37 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 31.3 p -65.02 128.7 36.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.29 55.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.536 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.72 123.26 14.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -99.67 117.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.004 HG12 HD11 ' A' ' 29' ' ' ILE . 2.3 pp -119.33 159.76 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.688 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -104.03 149.76 24.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.839 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 148.23 146.54 4.36 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.768 ' CB ' HG21 ' A' ' 25' ' ' THR . 0.4 OUTLIER -112.41 -168.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.71 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.9 t80 . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.77 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 121.12 0.486 . . . . 0.0 111.2 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.806 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.86 139.56 49.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.241 -177.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.0 m-85 -98.71 112.69 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 65' ' ' LEU . 12.2 p -106.57 162.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.932 0.396 . . . . 0.0 111.79 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.25 -69.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.86 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.0 p -84.09 -96.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -174.99 31.98 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.292 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.666 ' OE1' HG22 ' A' ' 39' ' ' ILE . 1.9 tt0 -76.5 -46.16 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.082 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.715 ' HB ' HD22 ' A' ' 103' ' ' LEU . 17.1 m -53.55 -34.41 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.32 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -54.39 -31.22 54.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.65 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.0 mt-30 -85.1 -21.91 29.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.718 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HG21 ' A' ' 29' ' ' ILE . 3.8 mp -66.85 65.23 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.5 mmm-85 -59.15 155.26 14.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.03 136.93 13.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.316 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.46 30.18 4.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.838 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 90' ' ' VAL . 16.2 t70 -140.56 144.01 35.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 30' ' ' THR . 2.0 m -112.41 140.12 47.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.561 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.868 HD12 ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -132.16 158.52 41.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.318 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.999 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -119.29 130.66 55.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.239 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -117.55 -129.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.382 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.433 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -71.12 -40.38 61.82 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.437 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -90.47 13.32 15.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.108 -0.546 . . . . 0.0 110.099 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.999 ' O ' HG22 ' A' ' 82' ' ' THR . 12.1 mt-10 64.96 20.74 12.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.402 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.07 112.66 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.936 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -141.25 126.05 18.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.261 175.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 12.6 m95 -118.52 144.97 45.68 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.311 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 90' ' ' VAL . 11.4 p -83.8 107.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.992 0.901 . . . . 0.0 109.863 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 12.9 t70 -93.53 -5.32 49.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.94 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.609 ' HD3' HD12 ' A' ' 103' ' ' LEU . 3.6 mtm180 . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 123.409 0.683 . . . . 0.0 112.544 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HB ' ' A' ' 72' ' ' VAL . 6.5 tp . . . . . 0 N--CA 1.444 -0.766 0 CA-C-O 121.167 0.508 . . . . 0.0 109.958 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -96.6 133.93 40.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.058 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.806 HD11 ' CB ' ' A' ' 65' ' ' LEU . 1.2 mp -106.07 160.88 14.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -171.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 89' ' ' TRP . . . -137.51 102.67 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.283 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -97.07 155.8 16.64 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.194 -0.592 . . . . 0.0 110.75 -177.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.583 179.155 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.855 0.359 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.17 112.63 13.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.017 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -162.27 150.12 14.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.77 66.2 1.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.804 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -131.28 61.27 1.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.48 -76.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -163.76 -59.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.02 -174.75 4.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.5 60.12 0.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.13 -54.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.44 22.97 13.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.053 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.1 tt -117.59 -34.95 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.045 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.61 -27.4 45.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.21 27.23 3.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.17 -66.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 68.02 67.88 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.004 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -173.87 146.45 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.42 76.13 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.829 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 16.1 mm -112.5 -54.24 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.82 152.77 15.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.94 56.94 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.577 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.62 135.64 54.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.827 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.84 -176.48 4.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.71 43.75 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.368 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.927 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -93.19 138.7 31.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 111.955 -178.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 62.9 m -121.59 124.74 45.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.379 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.43 144.14 50.23 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 4.0 m -121.11 134.21 55.24 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.478 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 39' ' ' ILE . 3.1 mm -99.79 125.28 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.382 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.12 99.14 4.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.558 178.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.443 ' N ' ' HB2' ' A' ' 35' ' ' SER . 15.1 p -108.53 153.69 23.0 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.97 -18.58 26.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -89.61 -69.1 0.74 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.76 0.314 . . . . 0.0 111.38 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -128.6 71.65 1.41 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.533 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.443 ' HB2' ' N ' ' A' ' 31' ' ' SER . 8.0 t -80.59 114.04 19.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.671 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.09 46.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.373 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 121.19 18.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 38' ' ' VAL . 18.5 m -99.69 117.41 44.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 29' ' ' ILE . 2.0 pp -114.09 159.93 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.698 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.699 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 154.55 146.67 4.47 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.327 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.927 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.0 OUTLIER -115.06 174.05 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.681 0.753 . . . . 0.0 112.101 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.3 t80 -90.38 141.14 29.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.618 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 64' ' ' SER . 6.5 t0 -128.42 129.42 46.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.611 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.9 109.94 42.43 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.047 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.25 -50.33 8.81 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.355 2.037 . . . . 0.0 111.806 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' CA ' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -43.17 -40.63 3.39 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.512 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.9 -73.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 mm -71.94 90.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.207 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.77 25.32 11.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.93 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -100.85 -77.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.04 169.5 8.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.88 57.33 16.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.381 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HA ' ' NH1' ' A' ' 57' ' ' ARG . 13.8 pt20 -113.47 -172.8 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.039 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.8 21.23 58.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 57' ' ' ARG . 6.3 p -161.09 -46.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 58' ' ' VAL . 5.7 mmm180 67.76 -64.25 0.28 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.901 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 57' ' ' ARG . 8.5 p 49.29 24.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.309 -174.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 60' ' ' GLY . 13.5 pt-20 -165.09 -49.57 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.523 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.452 ' HA3' ' CA ' ' A' ' 47' ' ' GLU . . . -125.46 109.89 1.25 Allowed Glycine 0 C--N 1.329 0.186 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.541 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.5 p -114.38 -30.92 6.42 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.489 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -134.79 141.89 40.3 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.702 0.287 . . . . 0.0 111.622 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.528 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 61.2 Cg_endo -99.97 144.65 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.102 2.535 . . . . 0.0 113.845 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -106.72 161.26 14.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.209 0.528 . . . . 0.0 111.468 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.835 HD22 HD11 ' A' ' 105' ' ' LEU . 6.0 tp -116.92 140.67 49.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.728 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 15.4 t80 -100.3 123.26 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.834 0.349 . . . . 0.0 110.27 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 68' ' ' ARG . 11.2 p -112.46 164.65 8.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.542 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.796 ' O ' HG23 ' A' ' 69' ' ' THR . 0.0 OUTLIER -128.58 41.94 3.4 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -171.21 -101.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.394 178.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 t0 177.95 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.105 0 CA-C-O 120.891 0.377 . . . . 0.0 111.064 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -98.42 -34.99 10.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.986 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.757 HG21 ' CD1' ' A' ' 103' ' ' LEU . 19.4 m -62.16 -31.17 50.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.916 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -42.59 84.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.272 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.9 mt-30 -69.88 -20.62 63.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.576 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.029 HD22 HG21 ' A' ' 90' ' ' VAL . 0.3 OUTLIER -65.05 61.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.112 178.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 74' ' ' GLN . 48.8 mmm-85 -59.38 152.63 20.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 111.108 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -42.02 159.44 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.653 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.91 32.12 61.33 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.187 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 5.6 m-20 -128.62 128.4 44.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 111.015 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.747 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -99.98 140.45 34.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.444 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.883 HD13 HD11 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -135.18 159.71 40.69 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.442 -177.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -123.04 129.53 51.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.749 HD12 ' CE2' ' A' ' 88' ' ' PHE . 2.3 tt -137.88 135.47 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 43.47 -95.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.03 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.764 ' HB3' HG23 ' A' ' 109' ' ' VAL . 40.8 mm-40 -50.66 -27.35 6.78 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 98.65 31.16 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.813 1.245 . . . . 0.0 111.663 176.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.417 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -143.5 111.18 5.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.749 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -140.48 139.76 35.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.558 173.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.515 ' HD1' HG23 ' A' ' 80' ' ' THR . 7.0 t90 -134.93 142.42 46.52 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.726 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.029 HG21 HD22 ' A' ' 75' ' ' LEU . 59.8 t -84.29 108.51 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 121.874 0.845 . . . . 0.0 110.902 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 104' ' ' TRP . 11.9 t70 -85.59 -5.58 59.26 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.864 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.446 ' HG3' HG13 ' A' ' 90' ' ' VAL . 9.6 mtm-85 -44.29 174.15 0.0 OUTLIER 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.265 0.555 . . . . 0.0 111.901 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.74 153.58 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.08 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -161.61 85.02 1.7 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.004 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.43 -25.23 47.46 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.633 2.222 . . . . 0.0 112.407 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -170.72 -52.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.18 77.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.49 157.7 40.7 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.575 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.92 49.96 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.9 p -103.98 130.71 51.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 110.938 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.47 55.09 3.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.574 ' CG ' ' CZ3' ' A' ' 104' ' ' TRP . 1.6 t-80 -108.62 -41.53 4.78 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.779 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.757 ' CD1' HG21 ' A' ' 72' ' ' VAL . 0.7 OUTLIER 61.99 77.22 0.34 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.805 178.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.574 ' CZ3' ' CG ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -99.48 120.34 39.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.835 HD11 HD22 ' A' ' 65' ' ' LEU . 10.9 mt -107.75 161.19 15.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.947 0.879 . . . . 0.0 113.282 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.34 117.21 2.22 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.686 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.553 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mmm180 -98.0 156.68 16.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.448 0.642 . . . . 0.0 112.348 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.01 39.63 1.05 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.076 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.764 HG23 ' HB3' ' A' ' 85' ' ' GLU . 7.4 p -32.08 94.12 0.07 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 96.2 Cg_endo -90.37 179.34 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.057 2.505 . . . . 0.0 111.675 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.62 -67.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.536 2.157 . . . . 0.0 112.159 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.87 109.78 0.29 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.805 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.717 ' O ' HG22 ' A' ' 113' ' ' VAL . 7.5 p -141.04 25.16 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.599 . . . . 0.0 110.519 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 48.63 76.27 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.048 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.54 ' HG3' HG13 ' A' ' 113' ' ' VAL . 1.5 mtp180 -94.59 148.4 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 127.08 20.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.058 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.95 179.81 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.813 0.34 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 69.28 -68.63 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.56 45.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.023 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -108.87 -35.04 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.816 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.7 p-10 -107.18 60.75 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.812 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -82.75 62.84 6.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.9 -54.58 2.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.817 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.76 117.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -127.42 -51.51 1.39 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.94 -64.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.95 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.69 46.63 1.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.018 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 11.8 tt -179.88 161.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.371 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 72.08 23.6 3.39 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.161 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -111.33 27.69 9.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 55.02 -179.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 16' ' ' ASP . 11.0 p30 -178.6 173.01 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -122.52 42.69 3.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.918 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.1 m 52.42 91.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 19' ' ' ILE . 23.0 mt -87.87 56.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.7 tpt85 -109.67 32.5 4.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.988 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.75 92.67 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 172.28 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.1 mtt -62.87 -81.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.81 47.96 45.72 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.399 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.963 ' OG1' HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -92.89 138.49 31.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.305 0.574 . . . . 0.0 112.072 -178.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 64.8 m -118.94 124.95 48.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.166 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -124.98 138.83 54.22 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.45 ' C ' HD13 ' A' ' 29' ' ' ILE . 5.4 m -115.95 133.9 55.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.331 -177.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.965 HD11 HG12 ' A' ' 39' ' ' ILE . 1.9 mm -99.81 131.6 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.34 0.59 . . . . 0.0 111.132 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -137.35 98.96 3.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.67 178.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.441 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.0 OUTLIER -108.1 159.56 16.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.798 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.85 -43.08 70.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.18 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -75.63 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 120.886 0.374 . . . . 0.0 111.993 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -137.87 77.16 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.31 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.477 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 29.4 p -74.29 123.54 24.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.788 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.5 48.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.487 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.17 126.12 29.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 38' ' ' VAL . 13.6 p -99.71 122.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.965 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -122.01 156.98 26.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -99.07 140.38 33.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.873 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 159.15 152.57 6.5 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.068 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.957 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.6 178.64 3.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.284 0.564 . . . . 0.0 111.707 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.646 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 -89.66 140.78 29.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.254 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' SER . 3.8 t0 -127.53 139.64 52.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.711 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -116.75 106.95 47.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.092 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 13.9 Cg_exo -70.04 -38.26 7.41 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.759 2.306 . . . . 0.0 112.24 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.66 48.11 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.177 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -64.52 145.56 55.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.8 tt -79.4 143.98 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 t 59.86 27.07 16.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.75 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 10.0 t80 -68.45 63.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.178 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 51' ' ' TYR . . . 67.21 -67.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.326 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -56.52 4.61 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.646 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 69.72 136.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.754 0.311 . . . . 0.0 110.796 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.19 36.85 49.98 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.396 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.17 105.01 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -86.29 99.52 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.077 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 58' ' ' VAL . 12.4 p -94.79 37.58 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 74.96 71.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.849 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.62 163.37 24.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.443 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.99 -44.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.69 170.0 12.25 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.676 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.521 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 76.7 Cg_endo -98.98 137.99 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.936 2.424 . . . . 0.0 112.996 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -107.13 164.74 11.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.979 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -115.35 139.72 49.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.996 -177.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 6.3 m-85 -93.82 121.08 34.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.643 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 1.004 HG11 HG21 ' A' ' 72' ' ' VAL . 10.0 p -122.18 160.16 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.199 0.524 . . . . 0.0 112.15 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.534 ' C ' HG22 ' A' ' 69' ' ' THR . 1.8 mpt_? -134.41 65.29 1.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.318 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' C ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER 167.49 122.86 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.002 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -66.36 62.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.227 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' THR . 5.6 mt-10 -126.39 -45.82 1.65 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.668 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.004 HG21 HG11 ' A' ' 67' ' ' VAL . 5.2 m -57.53 -30.29 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.046 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -48.49 77.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.424 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 1.4 mt-30 -63.29 -19.76 64.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.574 176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.09 HD22 HG21 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -67.11 63.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.599 178.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.8 mmm180 -55.32 160.89 2.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -53.04 146.46 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.311 -178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 77' ' ' ARG . . . 95.88 38.51 4.62 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.304 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.695 ' CG ' HD21 ' A' ' 75' ' ' LEU . 2.5 t0 -140.36 150.59 44.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 111.305 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 30' ' ' THR . 4.9 m -118.5 142.98 47.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.688 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -136.1 158.31 44.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.384 -178.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.005 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -118.75 129.23 55.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.674 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.963 HD11 ' OG1' ' A' ' 25' ' ' THR . 0.6 OUTLIER -122.7 -136.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.858 -179.564 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.555 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -59.74 -41.12 97.39 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.592 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -91.0 15.92 10.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.041 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.005 ' O ' HG22 ' A' ' 82' ' ' THR . 4.5 mt-10 57.71 19.78 5.83 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.399 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.439 ' ND2' ' CD ' ' A' ' 110' ' ' PRO . 18.1 m120 -144.89 112.66 6.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.833 ' CD1' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -138.98 150.98 46.48 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 171.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.543 ' CE3' HG23 ' A' ' 80' ' ' THR . 30.9 t-105 -135.63 141.92 45.14 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.439 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.09 HG21 HD22 ' A' ' 75' ' ' LEU . 9.2 t -84.98 107.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.099 0.952 . . . . 0.0 110.532 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 104' ' ' TRP . 33.7 t0 -99.18 -5.89 29.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.815 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 3.7 mtm180 -20.04 115.54 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 94' ' ' SER . 1.7 p -49.69 158.17 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.705 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -67.31 160.0 74.11 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.668 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.96 -169.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.472 2.114 . . . . 0.0 112.199 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 71.24 -65.08 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -97.08 71.04 2.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -159.06 132.71 3.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.75 15.88 61.55 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.688 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.91 157.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.5 m 62.46 61.69 1.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -139.28 -48.24 0.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.788 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 50.68 100.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.49 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.8 114.15 25.76 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.833 HD13 ' CD1' ' A' ' 88' ' ' PHE . 13.2 mt -107.39 163.31 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -143.95 122.13 1.77 Allowed Glycine 0 CA--C 1.521 0.461 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.019 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 3.1 mtm180 -99.26 140.0 34.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.347 0.573 . . . . 0.0 111.828 -177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -116.69 -19.73 5.23 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.504 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 109' ' ' VAL . 7.1 p 30.09 60.93 0.93 Allowed Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 109' ' ' VAL . 36.8 Cg_endo -95.27 -179.79 0.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.325 2.683 . . . . 0.0 111.784 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.09 -68.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.545 2.163 . . . . 0.0 112.297 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.92 99.76 0.27 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.559 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 86' ' ' GLU . 84.3 t -132.83 106.64 10.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.84 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -58.06 85.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -74.21 -29.48 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.8 mmt85 54.84 104.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.818 0.342 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.51 167.11 22.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -152.88 40.95 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -139.15 149.24 44.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -162.69 70.0 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -116.47 165.37 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.43 132.2 44.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.01 79.81 2.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -104.13 82.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.24 84.34 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.88 53.97 10.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 13' ' ' ALA . 5.3 tp -161.08 -43.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.082 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -96.56 28.63 3.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -147.24 45.34 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.019 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.9 39.4 2.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -119.26 172.17 7.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.33 -174.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.04 51.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.027 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.2 pt -59.27 164.3 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.19 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.08 94.28 1.2 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.62 -122.34 2.88 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.42 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -121.65 157.77 30.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 18.5 mmm 65.27 -165.32 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.017 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.79 18.68 5.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.846 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -92.79 138.6 31.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.191 0.519 . . . . 0.0 112.062 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 83' ' ' ILE . 49.6 m -126.73 124.33 39.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.445 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.47 142.59 51.2 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 38' ' ' VAL . 3.8 m -114.34 132.88 56.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.149 -177.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 75' ' ' LEU . 4.3 mm -102.02 124.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.303 0.573 . . . . 0.0 111.856 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -128.56 99.11 5.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.363 178.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.45 ' N ' ' HB3' ' A' ' 35' ' ' SER . 0.8 OUTLIER -116.95 154.61 30.55 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.919 -179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.01 -17.7 30.75 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.823 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -88.56 -69.72 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.743 0.306 . . . . 0.0 111.316 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -127.95 72.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.166 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.45 ' HB3' ' N ' ' A' ' 31' ' ' SER . 12.9 p -84.6 146.17 27.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.94 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.14 24.73 4.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.706 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.35 129.97 56.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.945 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.507 HG22 ' OG1' ' A' ' 28' ' ' THR . 66.7 t -101.84 122.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.025 0.44 . . . . 0.0 111.315 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.775 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -116.33 160.09 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.966 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -102.94 147.07 27.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.615 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 150.83 153.32 6.1 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.014 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.8 OUTLIER -124.03 175.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.556 0.693 . . . . 0.0 112.317 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.627 ' N ' HG13 ' A' ' 42' ' ' VAL . 37.1 t80 -90.1 140.5 29.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.57 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 64' ' ' SER . 1.1 t70 -124.93 136.91 54.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.106 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 4.1 p30 -123.79 106.74 31.64 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.799 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.422 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 19.6 Cg_exo -67.94 -64.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.608 2.205 . . . . 0.0 112.461 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' O ' HG12 ' A' ' 49' ' ' ILE . 1.5 mt-10 -88.18 -68.47 0.76 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.261 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 6.7 p-10 44.85 49.58 9.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.576 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -149.51 -93.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.007 179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.403 ' H ' HD12 ' A' ' 49' ' ' ILE . 3.7 t 47.88 25.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.697 0.285 . . . . 0.0 111.351 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.12 -57.75 2.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.839 0.352 . . . . 0.0 110.992 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -51.91 -26.54 10.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.05 48.88 0.31 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -90.87 92.47 8.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.059 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -98.96 24.2 33.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.381 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.26 -29.14 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.336 . . . . 0.0 111.119 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 62.78 110.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 58' ' ' VAL . 13.9 p -94.79 31.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 74.11 37.19 0.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 46' ' ' PRO . . . -130.76 99.11 0.42 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.371 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.04 -26.97 11.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 0.0 110.983 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.41 175.33 3.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 36.8 Cg_endo -98.68 150.52 0.67 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.986 2.458 . . . . 0.0 112.644 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -128.16 165.76 19.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.956 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -113.13 141.08 47.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.067 -177.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.427 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 2.2 m-85 -103.98 115.22 30.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.046 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HG22 ' A' ' 72' ' ' VAL . 12.3 p -102.89 160.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.029 0.442 . . . . 0.0 111.523 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -79.12 -55.88 4.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.929 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.53 -90.07 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -176.42 32.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.65 0.262 . . . . 0.0 111.363 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.33 -41.93 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.057 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.829 HG11 HD21 ' A' ' 65' ' ' LEU . 33.5 m -56.57 -33.75 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.985 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -54.02 -30.78 49.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.541 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.5 mt-30 -86.36 -22.71 26.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.624 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 29' ' ' ILE . 6.5 mp -66.51 62.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 12.7 mmt-85 -60.33 158.03 12.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.793 0.33 . . . . 0.0 110.622 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -42.53 157.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.605 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.5 27.56 54.39 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.401 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -125.7 139.91 53.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.912 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.889 HG22 ' CE3' ' A' ' 89' ' ' TRP . 0.5 OUTLIER -108.31 138.87 43.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.718 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -140.26 158.58 43.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.948 -179.353 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.975 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -121.11 122.28 39.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.237 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.874 HD11 ' OG1' ' A' ' 25' ' ' THR . 6.4 tt -127.05 137.35 58.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.323 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 38.88 -92.69 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.946 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 86' ' ' GLU . 63.0 mm-40 -49.54 -26.36 3.42 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.975 ' O ' HG22 ' A' ' 82' ' ' THR . 3.0 mt-10 101.34 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.619 1.168 . . . . 0.0 111.382 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 16.4 m120 -144.28 110.81 5.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -140.83 119.51 12.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.626 173.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.889 ' CE3' HG22 ' A' ' 80' ' ' THR . 9.1 m95 -108.95 142.46 39.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.715 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.866 ' CG2' HD21 ' A' ' 81' ' ' LEU . 48.0 t -86.1 107.76 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.506 0.67 . . . . 0.0 110.348 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.487 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 16.4 t0 -89.35 -59.43 2.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.403 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.734 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.2 mtp180 44.8 -177.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.362 176.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -110.04 30.21 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.962 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.5 p 61.9 151.77 0.1 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -46.24 147.24 4.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.538 2.159 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.87 100.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.959 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -158.5 28.11 0.24 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 55.55 95.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.47 68.0 1.44 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.431 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.7 m -56.19 95.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.01 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.3 p 174.54 68.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.956 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -128.69 -56.03 1.21 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.912 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.932 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 66.09 88.44 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.953 177.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.487 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.6 t90 -98.04 128.59 44.67 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.956 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.9 mp -100.29 159.76 14.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -140.01 110.2 0.67 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.352 172.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -97.79 156.73 16.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.469 0.652 . . . . 0.0 111.843 -175.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.42 53.55 0.37 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.127 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.545 HG23 ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -29.91 143.61 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 123.589 0.756 . . . . 0.0 112.16 -178.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.545 ' HD2' HG23 ' A' ' 109' ' ' VAL . 1.3 Cg_endo -43.39 174.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.468 2.779 . . . . 0.0 112.849 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 7.0 Cg_exo -72.22 -167.96 5.18 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.663 -1.39 . . . . 0.0 112.441 0.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . 70.59 61.77 0.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.251 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 86' ' ' GLU . 86.5 t -115.14 68.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.899 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.8 m120 48.24 34.17 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.212 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -89.56 174.52 7.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -142.94 -77.67 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.927 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.844 0.354 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.26 -57.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.064 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -175.93 74.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.991 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -91.13 171.84 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -119.04 106.99 12.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -112.0 120.48 42.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.35 -55.2 2.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.058 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.13 126.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' HB2' HG22 ' A' ' 12' ' ' ILE . 12.0 m-20 -55.58 -62.58 1.59 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.912 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.94 -53.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.46 33.62 5.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.178 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.709 HG23 ' N ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -144.26 -154.31 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.988 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.709 ' N ' HG23 ' A' ' 12' ' ' ILE . . . 49.45 50.84 17.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.743 0.306 . . . . 0.0 111.208 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.43 39.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.815 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 63.11 103.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.051 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.63 -176.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.93 67.88 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 48.92 86.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.105 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.71 95.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -127.84 -175.7 3.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 148.98 -148.47 19.9 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -102.48 -179.5 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.13 -79.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.791 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 50.0 47.08 41.16 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.582 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.924 HG21 HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.19 138.93 31.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.579 . . . . 0.0 112.29 -178.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.8 m -133.07 123.96 26.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.285 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -125.76 152.43 45.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.092 0.473 . . . . 0.0 109.977 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 16.2 m -124.18 133.02 53.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.143 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD22 ' A' ' 81' ' ' LEU . 4.0 mm -100.79 122.97 53.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.345 0.593 . . . . 0.0 111.835 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.415 ' HA ' ' CB ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -126.0 98.75 5.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.106 178.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.436 ' N ' ' HB3' ' A' ' 35' ' ' SER . 98.6 p -120.06 160.4 22.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.848 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.51 -25.65 58.44 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.174 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -64.91 -75.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.091 0.472 . . . . 0.0 111.569 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 6.3 tt0 -143.44 57.02 1.37 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.04 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.436 ' HB3' ' N ' ' A' ' 31' ' ' SER . 14.0 p -49.24 118.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.176 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.71 46.73 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.478 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.84 126.06 23.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 10.9 p -99.48 132.33 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.485 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.587 HG12 HD11 ' A' ' 29' ' ' ILE . 2.2 pp -121.23 153.77 24.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.323 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 10.6 ttp180 -109.91 142.88 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.185 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' HG23 ' A' ' 25' ' ' THR . . . 121.28 149.07 8.05 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.48 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.924 HG23 HG21 ' A' ' 25' ' ' THR . 26.2 t -111.15 -120.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.658 ' N ' HG12 ' A' ' 42' ' ' VAL . 6.1 p90 -134.49 141.71 46.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 129.92 54.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -100.84 109.63 58.48 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.602 0.239 . . . . 0.0 111.01 -178.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.83 -37.99 14.51 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.912 2.408 . . . . 0.0 112.8 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.01 40.84 1.04 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.254 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.0 p-10 -103.35 32.15 3.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.813 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.3 pt -123.19 91.87 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.34 29.3 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.698 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -134.71 -66.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.084 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.38 -161.0 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.006 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -49.09 153.03 2.66 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.456 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -155.07 54.73 0.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.909 0.385 . . . . 0.0 110.997 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -116.79 63.25 0.37 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG23 ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -139.24 -89.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.525 0.202 . . . . 0.0 111.123 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.534 ' O ' HG12 ' A' ' 58' ' ' VAL . 8.9 mpt_? -71.66 -69.69 0.37 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.684 0.278 . . . . 0.0 110.811 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 58' ' ' VAL . 12.9 p 47.67 23.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.835 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER 173.89 35.46 0.0 OUTLIER 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.07 179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.65 54.87 0.27 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.305 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -79.9 123.29 27.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.05 0.452 . . . . 0.0 111.528 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 141.59 8.95 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.15 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -99.41 150.74 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.582 2.188 . . . . 0.0 113.155 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.5 OUTLIER -119.82 168.8 10.73 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.924 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -111.71 140.04 46.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.662 0.744 . . . . 0.0 111.194 -176.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.407 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 62.8 t80 -94.63 135.35 36.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.272 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.707 HG11 HG22 ' A' ' 72' ' ' VAL . 14.5 p -133.08 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.081 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HG3' ' HG2' ' A' ' 40' ' ' ARG . 17.0 mmm180 -102.76 37.31 1.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.95 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 70' ' ' ASP . 97.5 m -164.32 -103.55 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.377 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.519 ' N ' HG22 ' A' ' 69' ' ' THR . 51.0 t0 179.0 36.8 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.758 0.313 . . . . 0.0 110.879 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.24 -47.01 5.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.312 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.811 HG11 HD21 ' A' ' 65' ' ' LEU . 27.6 m -52.63 -35.16 20.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.278 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -30.59 52.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.62 176.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 76' ' ' ARG . 7.5 mt-30 -89.76 -19.17 25.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.855 HD11 HG21 ' A' ' 29' ' ' ILE . 5.6 mp -66.04 67.56 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.8 mmt85 -62.53 151.79 36.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.078 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -43.92 137.47 3.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.024 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.97 34.74 3.91 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.163 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 31' ' ' SER . 97.3 m-20 -140.55 147.79 40.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.902 0.382 . . . . 0.0 111.188 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' HD23 ' A' ' 81' ' ' LEU . 8.0 m -111.12 150.36 29.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.778 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.977 HD22 HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -145.05 152.49 40.19 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -178.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.962 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -113.23 120.68 42.02 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.672 HG21 ' CD1' ' A' ' 88' ' ' PHE . 5.3 tt -130.38 136.81 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.86 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 41.76 -92.34 0.01 OUTLIER Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.81 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.897 ' HB3' HG23 ' A' ' 109' ' ' VAL . 4.6 mm-40 -53.12 -33.49 52.56 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.962 ' O ' HG22 ' A' ' 82' ' ' THR . 3.7 mm-40 116.04 19.82 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.196 1.398 . . . . 0.0 111.745 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.474 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 26.4 t-20 -144.21 121.6 11.66 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 118.845 -1.142 . . . . 0.0 114.03 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.811 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -142.94 112.16 6.65 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.436 ' O ' ' CD2' ' A' ' 105' ' ' LEU . 8.7 t90 -104.03 141.87 35.45 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.25 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 90' ' ' VAL . 9.3 p -84.37 109.3 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.892 0.853 . . . . 0.0 111.622 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' OD2' ' CE2' ' A' ' 104' ' ' TRP . 27.8 t0 -86.93 -4.31 59.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.796 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.656 ' HD3' HD22 ' A' ' 103' ' ' LEU . 6.3 mtm180 -37.71 161.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.232 0.539 . . . . 0.0 112.333 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG12 ' H ' ' A' ' 94' ' ' SER . 1.7 t -135.38 165.45 30.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.249 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 93' ' ' VAL . 42.3 m 58.99 102.55 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.58 -27.52 53.51 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.451 2.101 . . . . 0.0 112.213 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -177.8 77.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.965 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.98 35.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.856 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -151.93 -165.66 13.3 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.549 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.15 -103.07 0.16 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.505 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 173.82 175.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 110.959 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 57.7 m 55.75 43.68 27.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.028 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.403 ' O ' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -116.98 33.99 5.33 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.559 0.695 . . . . 0.0 109.704 178.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -46.62 90.65 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.747 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.468 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 9.2 t90 -97.13 123.64 40.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.811 HD11 ' CD2' ' A' ' 88' ' ' PHE . 2.4 mt -104.92 163.3 12.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -171.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 89' ' ' TRP . . . -145.85 121.01 1.41 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.89 174.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -98.26 157.58 16.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.525 0.678 . . . . 0.0 112.217 -175.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.59 39.45 1.09 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.89 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.897 HG23 ' HB3' ' A' ' 85' ' ' GLU . 7.1 p -31.68 103.51 0.21 Allowed Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 87' ' ' ASN . 77.9 Cg_endo -91.17 171.0 3.16 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.075 2.517 . . . . 0.0 111.566 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.4 175.11 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.694 2.263 . . . . 0.0 112.049 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 51.24 97.46 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.438 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.616 HG23 ' HG2' ' A' ' 86' ' ' GLU . 2.7 p -134.51 131.24 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.515 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.86 113.0 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.025 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HD3' HG13 ' A' ' 113' ' ' VAL . 1.6 mtm180 -120.74 151.24 39.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.74 146.59 40.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.925 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.845 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.842 0.353 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.75 94.52 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -127.88 -47.38 1.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -86.23 -26.25 25.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.004 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.637 ' OD1' HD23 ' A' ' 7' ' ' LEU . 34.7 t0 -120.87 134.9 55.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -129.9 62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.077 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD23 ' OD1' ' A' ' 5' ' ' ASP . 2.2 mm? -86.1 88.92 7.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.826 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -49.58 161.48 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -133.22 114.47 13.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.963 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -165.58 -54.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.51 41.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 13' ' ' ALA . 16.6 tt -150.13 -44.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.057 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -93.88 63.26 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.101 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -103.77 58.97 0.74 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.8 69.77 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.012 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t0 63.89 110.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.64 125.82 4.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.997 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.04 164.09 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.913 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.9 mt 58.72 74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.17 -39.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.987 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.67 158.94 7.72 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.503 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -149.93 88.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.78 0.324 . . . . 0.0 111.033 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 5.9 ptm -62.08 151.78 34.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.58 45.4 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.198 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 1.005 ' OG1' HD11 ' A' ' 83' ' ' ILE . 1.1 t -92.7 133.18 36.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.135 0.493 . . . . 0.0 111.923 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 83' ' ' ILE . 70.3 m -115.45 123.32 48.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.286 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -122.71 146.94 47.03 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.229 0.538 . . . . 0.0 110.538 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 5.8 m -120.74 134.15 55.3 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.718 -178.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.977 HG23 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -104.58 125.42 59.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.168 0.509 . . . . 0.0 111.517 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -129.76 98.96 4.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.378 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 80.0 p -118.22 142.48 47.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.675 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.45 -30.07 1.28 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.855 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -72.62 -75.9 0.13 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.874 0.369 . . . . 0.0 111.627 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -126.48 64.83 1.25 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.557 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 93.8 p -77.32 127.68 33.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.675 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 135.97 48.83 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.388 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.78 132.37 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.9 p -99.72 123.41 52.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.155 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 29' ' ' ILE . 2.4 pp -119.35 157.92 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.376 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -99.96 149.74 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.081 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 83' ' ' ILE . . . 145.97 150.39 5.19 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.373 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -120.63 178.07 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.713 0.768 . . . . 0.0 112.472 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.647 ' N ' HG13 ' A' ' 42' ' ' VAL . 21.0 t80 -93.28 135.99 33.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.92 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.24 130.24 53.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.031 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -116.43 107.04 47.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.1 -33.2 95.33 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.437 2.091 . . . . 0.0 112.269 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.49 -49.29 4.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 71.86 116.85 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.791 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.12 146.95 6.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.158 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 t 59.18 30.63 20.44 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -59.06 -35.89 74.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.853 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.16 82.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.044 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.96 22.08 64.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.487 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -66.24 -77.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.24 -54.51 4.88 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 56' ' ' VAL . 15.9 m -49.34 119.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.49 103.16 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 58' ' ' VAL . 11.5 p -111.54 28.77 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.748 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 70.17 11.32 7.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.473 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 44.73 32.11 2.88 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 66.12 -74.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 0.0 110.719 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.508 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 1.5 p 172.34 131.08 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.984 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.536 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 40.5 Cg_endo -105.7 138.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.764 2.309 . . . . 0.0 113.878 -177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -108.58 164.33 12.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.87 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.899 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -114.44 139.66 49.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.098 -177.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.8 m-85 -96.38 112.74 24.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 72' ' ' VAL . 11.3 p -109.69 163.36 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.904 0.383 . . . . 0.0 111.717 -177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.522 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -93.19 -62.29 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.124 -178.022 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 70' ' ' ASP . 60.5 m -86.02 -110.33 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 121.144 -0.222 . . . . 0.0 111.415 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 69' ' ' THR . 22.5 t70 -164.82 24.95 0.06 Allowed 'General case' 0 C--O 1.231 0.117 0 O-C-N 122.071 -0.393 . . . . 0.0 111.543 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.84 -35.47 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.204 0.526 . . . . 0.0 109.76 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 67' ' ' VAL . 16.6 m -63.12 -39.07 83.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.561 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -33.08 31.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.304 0.573 . . . . 0.0 110.077 177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.7 mt-30 -81.99 -23.72 35.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.66 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.054 HD22 HG21 ' A' ' 90' ' ' VAL . 0.4 OUTLIER -63.25 75.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.663 178.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 74' ' ' GLN . 3.4 mmt180 -71.09 155.26 41.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.855 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -41.82 149.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.916 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.47 35.4 8.65 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.671 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 96.7 m-20 -140.66 150.83 44.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 111.279 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.792 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.8 m -116.88 147.36 42.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.335 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.792 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -139.22 158.94 43.29 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.802 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.977 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -124.99 132.39 53.27 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.506 -0.121 . . . . 0.0 110.903 -178.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 27' ' ' ALA . 13.7 tt -152.29 143.11 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 46.18 -94.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.475 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.655 ' CA ' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -53.44 -33.73 55.15 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.977 ' O ' HG22 ' A' ' 82' ' ' THR . 4.9 pt-20 102.56 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.412 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.426 ' OD1' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -142.44 110.19 5.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.288 178.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.626 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -136.55 138.47 41.32 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 174.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.5 t-105 -132.95 144.42 50.12 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.195 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.054 HG21 HD22 ' A' ' 75' ' ' LEU . 7.7 t -84.95 107.47 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 121.871 0.843 . . . . 0.0 110.041 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 8.1 t70 -96.73 -3.94 41.57 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.798 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.4 mtm180 -29.77 149.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.657 0.783 . . . . 0.0 112.961 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.84 -65.77 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.143 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -172.83 141.5 1.02 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.992 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.38 81.65 2.24 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.593 2.196 . . . . 0.0 112.343 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.09 -175.4 4.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -73.78 104.6 4.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 134.34 -44.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.569 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.28 35.1 4.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.49 132.75 40.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.781 0.324 . . . . 0.0 110.826 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 69.59 50.36 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CG ' ' CZ3' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -119.35 -40.96 2.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.666 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.851 HD12 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 49.97 97.89 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.884 -177.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.525 ' CZ3' ' CG ' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -98.34 136.88 37.87 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.899 HD11 ' CB ' ' A' ' 65' ' ' LEU . 3.5 mp -110.03 161.09 15.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -169.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -147.99 110.52 0.5 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 112.99 -1.914 . . . . 0.0 109.814 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.524 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 2.4 mtm180 -97.98 130.39 44.83 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 117.765 0.782 . . . . 0.0 111.796 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.38 -19.13 75.83 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.152 175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.534 HG13 ' HD2' ' A' ' 110' ' ' PRO . 61.9 t -123.5 138.11 29.63 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-O 120.703 0.287 . . . . 0.0 110.915 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.534 ' HD2' HG13 ' A' ' 109' ' ' VAL . 28.0 Cg_endo -62.4 165.97 14.16 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.59 2.193 . . . . 0.0 112.32 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.18 -154.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.956 2.437 . . . . 0.0 112.185 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 62.95 64.94 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.032 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.655 HG21 ' CA ' ' A' ' 85' ' ' GLU . 59.5 t -117.97 -21.38 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.573 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.93 -54.18 50.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 50.85 -168.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.96 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -106.72 20.53 18.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.163 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.982 -179.776 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.801 0.334 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.12 -177.18 4.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.033 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -147.12 161.52 40.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 52.07 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -176.29 148.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -97.68 -29.91 13.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.73 -28.86 23.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -126.39 146.94 49.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.27 86.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -164.51 73.76 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.176 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.8 30.95 16.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.187 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.52 HG23 ' N ' ' A' ' 13' ' ' ALA . 6.5 tp -134.24 -47.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.52 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -99.75 91.39 4.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.023 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.42 47.13 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.59 57.26 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -135.23 86.74 2.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.951 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.99 130.2 53.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -38.31 -33.49 0.1 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.229 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.501 HG22 ' CG ' ' A' ' 20' ' ' ARG . 40.6 mt -55.44 136.9 17.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.015 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' CG ' HG22 ' A' ' 19' ' ' ILE . 11.8 mtm-85 66.2 76.17 0.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.85 -148.56 8.74 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.532 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -149.62 85.92 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.79 0.328 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.62 -75.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.702 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.91 19.56 63.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.932 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -92.41 130.1 38.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.206 0.526 . . . . 0.0 111.706 -179.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 69.1 m -115.05 123.24 48.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.633 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.941 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.01 145.94 48.86 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.155 0.503 . . . . 0.0 110.326 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 8.4 m -121.13 134.35 55.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.205 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.861 HD12 HD11 ' A' ' 75' ' ' LEU . 8.9 mm -102.48 125.33 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.452 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -132.81 99.22 4.54 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.813 178.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 35' ' ' SER . 20.1 m -98.07 157.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.49 -18.66 23.55 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.669 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -126.1 -40.71 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.615 0.245 . . . . 0.0 111.385 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -112.19 63.82 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.791 0.329 . . . . 0.0 111.494 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.435 ' HB2' ' N ' ' A' ' 31' ' ' SER . 17.8 t -104.78 120.3 41.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.654 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.15 42.3 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.35 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.48 127.02 16.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.119 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 19.2 m -99.3 130.53 48.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.799 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.743 HG12 HD11 ' A' ' 29' ' ' ILE . 1.9 pp -125.57 155.9 34.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 41' ' ' GLY . 0.3 OUTLIER -100.81 144.59 29.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.071 178.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 155.45 154.79 7.06 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.664 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.932 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -128.3 169.87 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.779 0.799 . . . . 0.0 111.901 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.561 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.4 t80 -89.93 127.73 36.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.119 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' O ' ' CB ' ' A' ' 63' ' ' PRO . 1.6 t0 -113.98 144.57 42.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.609 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -121.75 108.23 35.25 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.155 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HG2' ' O ' ' A' ' 62' ' ' SER . 3.3 Cg_exo -74.35 -29.23 9.65 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.64 2.226 . . . . 0.0 112.029 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.66 25.88 2.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.237 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -68.38 -33.14 73.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.887 0.375 . . . . 0.0 110.86 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.669 ' O ' HG23 ' A' ' 49' ' ' ILE . 13.8 tt -143.19 95.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.049 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.0 27.94 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 70.11 -78.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.43 -48.35 70.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.0 106.85 1.49 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -95.63 149.06 21.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 0.0 110.85 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.59 55.93 15.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.418 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 m -151.49 121.18 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.015 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -99.0 87.71 3.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.667 ' O ' HG22 ' A' ' 58' ' ' VAL . 11.6 p -95.03 38.37 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 68.84 41.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.775 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.43 -83.88 0.97 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.711 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 62' ' ' SER . 24.3 m -114.08 -30.0 6.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.735 0.302 . . . . 0.0 111.252 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 61' ' ' SER . 0.3 OUTLIER 75.48 166.7 0.12 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.896 -178.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.544 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 37.5 Cg_endo -98.33 150.68 0.74 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.217 1.945 . . . . 0.0 112.888 -177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -128.26 165.97 19.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.78 179.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.08 HD23 HD13 ' A' ' 103' ' ' LEU . 2.9 tp -112.43 139.51 47.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.687 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.776 ' N ' HD12 ' A' ' 65' ' ' LEU . 6.3 m-85 -101.53 112.84 25.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.184 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.913 HG11 HG22 ' A' ' 72' ' ' VAL . 11.4 p -102.87 157.97 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.959 0.409 . . . . 0.0 111.577 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -67.49 -31.55 71.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.433 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.53 -96.12 0.16 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.577 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -155.57 19.7 0.4 Allowed 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.674 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -61.15 -48.29 82.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 109.974 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.913 HG22 HG11 ' A' ' 67' ' ' VAL . 16.0 m -53.78 -35.56 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.469 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -31.96 47.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.4 mt-30 -82.96 -20.93 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.686 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.993 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.2 64.21 0.06 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.188 0.518 . . . . 0.0 110.664 178.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 74' ' ' GLN . 16.2 mmm180 -55.1 160.74 1.96 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.1 ttt-85 -52.87 145.43 12.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.407 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.35 32.97 6.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.845 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 92.8 m-20 -140.55 150.53 43.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.835 0.35 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.671 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 m -116.29 145.29 43.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.235 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.818 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.2 159.62 40.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.99 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.998 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.94 129.85 52.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.793 -0.185 . . . . 0.0 110.58 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.941 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.8 tt -126.08 -127.59 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 83' ' ' ILE . . . -58.45 -71.32 0.77 Allowed Glycine 0 CA--C 1.5 -0.9 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.853 -176.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.824 ' HG3' HG11 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -55.32 -23.96 26.47 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 171.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.998 ' O ' HG22 ' A' ' 82' ' ' THR . 1.3 pt-20 89.99 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.342 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -142.15 109.83 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.699 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.753 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -138.02 136.55 37.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.767 176.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 106' ' ' GLY . 7.8 m95 -130.43 143.31 50.68 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.646 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.993 ' CG2' HD22 ' A' ' 75' ' ' LEU . 33.7 t -85.29 107.11 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.96 0.886 . . . . 0.0 109.905 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.516 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 27.0 t0 -90.35 -3.67 57.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.89 -1.504 . . . . 0.0 110.71 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HG3' HD23 ' A' ' 103' ' ' LEU . 5.4 mtm180 -34.7 156.16 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.196 0.599 . . . . 0.0 112.58 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -106.3 -170.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.584 -178.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.56 ' H ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -111.6 91.08 13.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.668 0.271 . . . . 0.0 110.937 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 54.2 Cg_exo -52.52 175.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.715 2.276 . . . . 0.0 112.416 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.04 78.84 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.903 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.2 t0 64.91 87.98 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.75 137.22 7.98 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.468 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' O ' ' CG ' ' A' ' 95' ' ' PRO . . . 95.92 112.58 2.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.549 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 p -169.9 36.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 110.928 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.88 43.3 1.71 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.967 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -136.55 64.52 1.55 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.287 178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.08 HD13 HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -55.87 111.5 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.899 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.516 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 8.1 t90 -97.56 127.9 43.87 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.0 mp -100.77 160.77 14.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -171.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.47 ' O ' ' CD1' ' A' ' 89' ' ' TRP . . . -149.0 107.63 0.37 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.054 173.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.857 ' HB3' HG12 ' A' ' 109' ' ' VAL . 4.4 mtm180 -97.25 131.45 43.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 117.684 0.742 . . . . 0.0 111.392 -177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.2 -17.48 52.47 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.387 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 107' ' ' ARG . 14.8 p -74.92 141.34 74.97 Favored Pre-proline 0 N--CA 1.455 -0.219 0 CA-C-O 120.71 0.29 . . . . 0.0 111.331 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.479 ' CB ' ' CD ' ' A' ' 111' ' ' PRO . 52.2 Cg_exo -54.72 -172.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.483 2.122 . . . . 0.0 111.828 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 110' ' ' PRO . 11.6 Cg_exo -68.38 -41.99 6.0 Favored 'Trans proline' 0 CA--C 1.518 -0.304 0 C-N-CA 122.573 2.182 . . . . 0.0 111.873 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.36 77.94 0.1 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.667 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.786 HG13 ' CD ' ' A' ' 85' ' ' GLU . 88.3 t -93.68 48.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.555 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 45.5 69.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.336 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -113.02 141.29 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -152.76 -73.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.898 0.38 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.69 33.94 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 t0 69.84 89.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.99 91.21 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.954 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -146.95 43.04 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.818 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 t30 70.29 171.33 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.975 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.98 127.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.26 127.22 53.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.577 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 15.5 t70 68.44 -67.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 9' ' ' ASP . . . 78.23 19.49 1.01 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.151 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 13.98 2.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.324 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 13' ' ' ALA . 8.0 tp -124.89 -40.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.772 0.32 . . . . 0.0 111.062 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -79.15 120.57 23.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.5 ptt180 -133.04 31.13 3.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.981 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 14' ' ' ARG . . . 177.58 -71.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.84 -60.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.04 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 65.76 122.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.83 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.74 154.14 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.816 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.1 tt -145.68 144.69 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -96.4 -62.66 1.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.848 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.17 110.12 2.69 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.411 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -57.02 123.2 14.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.782 0.325 . . . . 0.0 111.04 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.51 102.92 14.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.761 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -135.17 38.51 1.79 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.815 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.88 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -91.89 138.1 31.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.3 0.572 . . . . 0.0 112.262 -178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 67.8 m -117.61 123.79 47.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.239 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HB2' HG13 ' A' ' 83' ' ' ILE . . . -126.0 141.24 52.05 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 82' ' ' THR . 4.5 m -118.16 132.18 56.35 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.216 -177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.876 HD12 HD11 ' A' ' 75' ' ' LEU . 5.3 mm -103.52 126.9 57.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.238 0.542 . . . . 0.0 111.359 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -133.5 99.22 4.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.282 178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.456 ' N ' ' HB3' ' A' ' 35' ' ' SER . 3.0 p -115.31 156.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.05 -18.58 27.51 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.621 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -86.38 -70.46 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.697 0.284 . . . . 0.0 111.247 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -130.65 71.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.456 ' HB3' ' N ' ' A' ' 31' ' ' SER . 66.3 p -81.4 134.55 35.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.666 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.94 49.75 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.479 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.04 127.7 16.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 111.111 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.8 p -99.51 122.56 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.241 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' OE1' ' A' ' 71' ' ' GLU . 2.3 pp -112.05 157.88 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.368 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 68' ' ' ARG . 12.1 ttp180 -100.64 133.15 45.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.887 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.608 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 157.24 158.75 9.09 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.144 -1.026 . . . . 0.0 112.789 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.88 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.3 t -129.11 167.53 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 121.828 0.823 . . . . 0.0 111.918 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' HB2' HD22 ' A' ' 105' ' ' LEU . 4.8 t80 -89.22 120.72 30.84 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.999 -1.455 . . . . 0.0 110.954 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.53 137.32 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -124.67 107.1 29.24 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.81 -45.87 15.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.459 2.106 . . . . 0.0 111.895 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.05 49.23 0.81 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.565 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -46.06 122.4 3.86 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.425 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.4 pt -103.89 25.82 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 m -111.25 27.52 9.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.34 172.53 7.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.93 94.51 8.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.139 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.74 83.08 1.01 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.459 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -82.2 64.33 6.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.45 51.82 1.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.526 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -141.03 136.44 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.83 0.348 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.65 108.14 11.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.003 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.675 ' O ' HG22 ' A' ' 58' ' ' VAL . 13.0 p -105.21 29.11 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.045 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 67.16 24.8 9.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.05 155.19 16.8 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 53.5 p -158.07 33.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 111.03 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.79 154.32 0.28 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.265 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 39.2 Cg_endo -99.14 150.91 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.242 2.628 . . . . 0.0 112.47 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -130.09 164.65 23.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.997 0.427 . . . . 0.0 111.338 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.013 HD23 HD12 ' A' ' 103' ' ' LEU . 3.5 tp -113.7 140.93 47.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.674 ' N ' HD12 ' A' ' 65' ' ' LEU . 3.7 m-30 -108.49 113.03 25.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.387 -178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.791 HG11 HG22 ' A' ' 72' ' ' VAL . 12.6 p -98.46 149.54 5.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.165 -178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.428 ' CG ' ' HG2' ' A' ' 40' ' ' ARG . 8.7 mmm180 -96.44 23.69 6.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.794 -177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.46 HG22 ' N ' ' A' ' 70' ' ' ASP . 43.9 m -163.44 -112.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.816 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' N ' HG22 ' A' ' 69' ' ' THR . 6.3 m-20 -161.59 26.25 0.12 Allowed 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.021 0.373 . . . . 0.0 110.922 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.768 ' OE1' HG22 ' A' ' 39' ' ' ILE . 42.5 mt-10 -81.35 -43.35 19.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.531 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.791 HG22 HG11 ' A' ' 67' ' ' VAL . 29.6 m -54.12 -37.94 36.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.297 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.87 -36.58 59.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.884 177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 76' ' ' ARG . 2.9 mt-30 -77.73 -25.39 49.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.409 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.948 HD22 ' CG2' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -67.18 62.85 0.06 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.667 178.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 1.5 mmt-85 -56.74 158.83 4.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.002 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -49.48 149.76 2.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.149 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.04 37.27 7.28 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.472 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 8.3 m-20 -136.03 148.42 48.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.757 ' C ' HD23 ' A' ' 81' ' ' LEU . 6.8 m -113.55 135.1 54.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.815 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -133.89 160.09 38.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.839 -179.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.995 HG22 ' O ' ' A' ' 86' ' ' GLU . 1.2 p -123.03 129.0 50.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.291 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.859 HD12 ' CE2' ' A' ' 88' ' ' PHE . 3.9 tt -129.71 -139.07 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 83' ' ' ILE . . . -51.64 -44.68 54.47 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 119.198 0.908 . . . . 0.0 111.628 -177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 87' ' ' ASN . 1.0 OUTLIER -96.57 28.99 3.11 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 173.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.995 ' O ' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER 34.54 33.49 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.808 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -141.85 109.87 5.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.221 0.534 . . . . 0.0 111.923 177.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.859 ' CE2' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -140.95 142.17 34.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.734 176.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 2.0 t-105 -134.79 142.62 46.74 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.818 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.948 ' CG2' HD22 ' A' ' 75' ' ' LEU . 59.5 t -85.56 107.44 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.126 -178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.496 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 21.4 t0 -90.24 -56.75 3.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.684 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.768 ' HD3' HD22 ' A' ' 103' ' ' LEU . 5.4 mmm180 42.97 -176.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.726 175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 m -63.16 173.51 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.767 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.29 151.69 93.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.735 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -47.16 -33.69 16.14 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.525 2.15 . . . . 0.0 112.365 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.1 76.13 1.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.908 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -148.86 158.95 44.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.17 109.0 3.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.541 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.15 -64.03 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.443 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.1 p 65.64 130.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.906 0.384 . . . . 0.0 111.016 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.6 m 61.92 46.18 6.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.1 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -128.11 44.35 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.326 0.584 . . . . 0.0 110.297 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.013 HD12 HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -46.77 93.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.806 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 7.8 t90 -98.63 128.75 45.03 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.985 HD11 ' CB ' ' A' ' 65' ' ' LEU . 4.5 mp -103.1 160.69 14.42 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -171.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -139.08 103.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 113.094 -1.867 . . . . 0.0 109.749 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.514 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 4.0 mtm180 -97.46 142.71 28.98 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.306 0.553 . . . . 0.0 111.17 -176.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.47 -16.64 63.77 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.01 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.6 t -135.36 75.31 58.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.696 0.284 . . . . 0.0 110.896 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 67.9 Cg_exo -47.97 -44.26 28.07 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.482 2.121 . . . . 0.0 112.618 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 110' ' ' PRO . 6.8 Cg_exo -73.87 -153.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.704 2.269 . . . . 0.0 112.02 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 49.35 98.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.298 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -171.42 129.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.976 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -75.36 122.36 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.0 111.06 20.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.73 168.04 15.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.02 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.818 0.342 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.7 27.52 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.992 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -166.41 135.75 3.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.7 170.92 0.22 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -123.87 -69.08 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 m120 177.45 158.54 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.46 76.76 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -110.24 -22.22 11.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.6 t70 71.3 51.88 0.26 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.89 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.81 -44.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.054 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.83 50.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.029 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -159.08 -42.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' N ' HG23 ' A' ' 12' ' ' ILE . . . -76.85 -59.17 2.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.03 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 51.74 31.0 7.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.02 -171.08 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.008 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 67.23 152.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.52 102.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.2 m 55.78 77.77 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.23 56.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.078 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.32 117.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.94 -176.98 15.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.565 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -91.12 -45.19 8.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.859 0.361 . . . . 0.0 110.946 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -49.31 -77.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.08 41.49 47.52 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.759 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.937 ' CB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -92.72 138.52 31.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.37 0.605 . . . . 0.0 111.922 -179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 44.0 m -122.9 128.52 50.43 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.559 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . -124.8 139.99 53.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.53 ' OG1' HG22 ' A' ' 38' ' ' VAL . 4.9 m -114.56 130.89 56.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.01 HG23 HD11 ' A' ' 75' ' ' LEU . 4.2 mm -100.06 128.65 51.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -136.88 99.18 3.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.857 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.454 ' N ' ' HB3' ' A' ' 35' ' ' SER . 4.8 m -95.68 159.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.842 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -14.6 39.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.969 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -119.9 -48.04 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -120.68 68.75 0.87 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.854 0.359 . . . . 0.0 111.849 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 31' ' ' SER . 40.9 p -98.73 122.69 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.594 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.82 41.77 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.491 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.424 ' CB ' ' OE2' ' A' ' 71' ' ' GLU . . . -140.72 121.74 14.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.339 . . . . 0.0 110.799 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG22 ' OG1' ' A' ' 28' ' ' THR . 77.5 t -99.5 119.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.148 0.499 . . . . 0.0 111.442 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.652 HG12 HD11 ' A' ' 29' ' ' ILE . 2.5 pp -112.33 159.8 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.374 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.45 146.31 27.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.061 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 66' ' ' PHE . . . 153.0 148.86 4.99 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.703 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.937 HG23 ' CB ' ' A' ' 25' ' ' THR . 1.2 t -119.11 171.98 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 0.0 111.689 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' HD2' HD22 ' A' ' 105' ' ' LEU . 36.7 t80 -90.02 132.91 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -119.4 136.31 54.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.008 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -123.24 106.76 33.05 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.754 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.41 -45.86 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.669 2.246 . . . . 0.0 112.26 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -75.75 -83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.053 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.0 t30 64.37 112.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.942 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.6 mt -84.74 63.04 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -108.95 28.97 7.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -137.01 172.13 13.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . . . -92.8 140.59 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.73 -75.24 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.369 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 52' ' ' ALA . 0.5 OUTLIER 58.34 89.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 0.0 111.017 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -67.32 -28.43 73.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.294 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 m -52.74 -173.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.047 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -73.0 122.21 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.966 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 58' ' ' VAL . 12.7 p -92.98 21.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.943 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 173.24 38.51 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.949 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.48 -32.26 3.73 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.429 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.08 168.15 9.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.939 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -134.8 179.09 1.47 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.542 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 32.5 Cg_endo -98.28 150.71 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.119 2.546 . . . . 0.0 112.374 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -129.32 165.57 21.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.048 HD23 HD13 ' A' ' 103' ' ' LEU . 4.9 tp -112.42 138.67 48.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.598 ' N ' HD12 ' A' ' 65' ' ' LEU . 27.1 m-85 -101.3 113.3 26.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.921 0.391 . . . . 0.0 110.838 -177.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.81 HG11 ' CG2' ' A' ' 72' ' ' VAL . 9.1 p -107.38 161.28 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.294 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -127.87 46.43 2.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.568 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 70' ' ' ASP . 87.7 m -163.97 -108.31 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.056 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' N ' HG22 ' A' ' 69' ' ' THR . 48.1 t0 179.75 36.6 0.0 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.887 0.375 . . . . 0.0 110.739 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 37' ' ' ALA . 1.5 tt0 -104.71 -43.4 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.232 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.81 ' CG2' HG11 ' A' ' 67' ' ' VAL . 9.9 m -56.88 -37.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.25 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -41.77 68.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.814 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -73.9 -18.76 60.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.006 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.01 HD11 HG23 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -67.07 65.13 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 0.0 110.926 179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.439 ' HA ' ' NH2' ' A' ' 92' ' ' ARG . 4.1 mmt180 -58.54 156.1 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.716 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.03 141.03 6.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.273 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.38 29.78 5.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.453 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 75.2 m-20 -140.37 150.47 43.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.119 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -115.7 145.05 43.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.349 -179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -136.27 160.26 39.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.133 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -122.96 135.8 54.62 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.735 HG21 ' CD1' ' A' ' 88' ' ' PHE . 3.0 tt -137.58 89.09 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.9 -68.78 0.19 Allowed Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.754 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.6 mm-40 -62.1 -16.74 54.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.386 172.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.002 ' O ' HG22 ' A' ' 82' ' ' THR . 0.0 OUTLIER 84.19 19.13 0.17 Allowed 'General case' 0 C--N 1.343 0.318 0 C-N-CA 123.051 0.54 . . . . 0.0 111.081 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.509 ' HB2' ' HA ' ' A' ' 109' ' ' VAL . 0.2 OUTLIER -142.94 119.05 10.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.735 ' CD1' HG21 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -149.44 130.57 14.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.358 -1.292 . . . . 0.0 107.865 169.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.544 ' CD2' HG23 ' A' ' 80' ' ' THR . 0.8 OUTLIER -128.49 143.63 51.01 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.518 179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.99 HG21 HD22 ' A' ' 75' ' ' LEU . 6.3 t -85.2 108.5 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.664 0.745 . . . . 0.0 110.922 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 9.8 t0 -92.04 -5.43 52.93 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.506 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.537 ' HG3' HD23 ' A' ' 103' ' ' LEU . 4.8 mtm-85 -37.96 161.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.229 0.537 . . . . 0.0 112.347 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.81 -37.0 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.0 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t 68.16 81.68 0.2 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.059 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.79 -167.45 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.651 2.234 . . . . 0.0 112.321 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -128.65 29.55 5.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -162.65 -177.84 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -48.88 113.64 1.7 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.98 108.91 0.31 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.434 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 173.72 -169.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.738 0.304 . . . . 0.0 110.867 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.2 t 76.76 26.9 0.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -115.92 -39.74 3.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.055 0.455 . . . . 0.0 110.141 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.048 HD13 HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 52.13 106.39 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.604 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.493 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 6.5 t90 -96.62 126.55 41.87 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.973 HD11 ' CB ' ' A' ' 65' ' ' LEU . 5.3 mp -97.22 160.06 14.56 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -171.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 89' ' ' TRP . . . -140.86 99.09 0.24 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' ASN . 6.5 ttp180 -99.22 156.77 16.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.72 44.81 0.81 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.231 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.848 HG13 ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -25.04 -67.8 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.096 0.958 . . . . 0.0 113.017 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.848 ' CD ' HG13 ' A' ' 109' ' ' VAL . 96.1 Cg_endo -79.46 151.32 22.62 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 121.782 1.655 . . . . 0.0 112.437 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -93.72 -158.77 0.75 Allowed 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.584 -1.006 . . . . 0.0 112.213 0.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 42.16 98.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.102 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 85' ' ' GLU . 94.6 t -139.31 152.61 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.414 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 76.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 113' ' ' VAL . 1.1 mtm-85 -82.43 99.16 9.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.942 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -71.41 163.45 27.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.93 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.826 0.346 . . . . 0.0 111.225 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 71.55 -77.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.229 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -119.51 177.25 5.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.029 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 68.29 -165.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 t70 69.87 42.76 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 67.45 175.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.4 mt -67.94 -173.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -142.13 142.74 32.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.561 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -169.03 175.75 5.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.967 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 9' ' ' ASP . . . 77.58 -59.2 0.46 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.936 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.26 30.21 3.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.895 0.379 . . . . 0.0 110.926 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 19.9 tt -171.68 161.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.423 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . 74.72 92.23 0.08 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.035 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 97.2 mtt180 -102.01 -50.81 3.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' ARG . . . 178.4 49.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -134.48 106.35 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.28 122.75 1.54 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.846 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 m 61.7 99.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.789 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.7 tt -89.91 -19.97 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.521 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.44 50.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.821 0.343 . . . . 0.0 111.046 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.07 -108.82 0.42 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.5 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 67.0 135.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.748 0.309 . . . . 0.0 111.171 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.572 ' SD ' HG11 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.69 -82.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.747 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 40' ' ' ARG . . . 67.61 62.53 4.27 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.717 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.746 ' OG1' HD11 ' A' ' 83' ' ' ILE . 14.9 t -93.01 138.7 31.25 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 54.6 m -105.04 122.97 46.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.573 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.015 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -124.85 145.56 49.72 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.885 0.374 . . . . 0.0 110.061 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 2.5 m -120.59 133.74 55.35 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 -178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.581 HD12 HD11 ' A' ' 75' ' ' LEU . 8.1 mm -103.63 122.26 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.098 0.475 . . . . 0.0 111.289 -178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -126.91 99.44 5.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.505 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' HB3' ' A' ' 35' ' ' SER . 6.5 p -115.17 157.98 22.88 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.078 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -17.34 32.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.758 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -86.64 -71.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.723 0.297 . . . . 0.0 111.275 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -132.53 69.16 1.48 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.464 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 68.6 p -73.99 167.04 22.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.76 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.84 50.76 2.8 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.597 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.58 132.37 38.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.923 0.392 . . . . 0.0 110.963 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.6 p -99.88 118.28 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.45 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.666 HG22 ' CD ' ' A' ' 71' ' ' GLU . 2.1 pp -123.52 154.63 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.368 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 24' ' ' GLY . 0.1 OUTLIER -100.3 125.39 46.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA3' HD11 ' A' ' 65' ' ' LEU . . . -176.91 143.32 6.25 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.385 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 25' ' ' THR . 0.0 OUTLIER -119.26 -162.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.29 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.518 ' CZ ' ' CB ' ' A' ' 63' ' ' PRO . 6.6 t80 -122.16 110.15 15.4 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.432 -177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.83 129.24 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.512 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -106.36 108.7 62.27 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.14 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.67 -57.17 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.479 2.119 . . . . 0.0 112.269 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -73.27 -25.62 60.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.96 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 68.03 86.32 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 50' ' ' SER . 53.7 mt -76.0 157.55 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.086 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.491 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER 61.27 27.59 17.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -106.98 154.22 21.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.22 131.15 32.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.013 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.22 -77.14 0.87 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.439 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.81 30.15 12.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.62 49.62 2.06 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.393 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.72 149.52 17.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.152 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -127.9 99.0 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.663 ' O ' HG22 ' A' ' 58' ' ' VAL . 13.7 p -94.05 24.55 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.16 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 61.2 49.34 5.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.986 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.1 -66.71 0.33 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.383 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.7 p 48.78 25.76 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.703 0.287 . . . . 0.0 111.209 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.29 156.29 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.241 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 37.6 Cg_endo -98.3 139.94 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.086 2.524 . . . . 0.0 113.162 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.48 165.32 12.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.847 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.823 ' CD2' HD21 ' A' ' 103' ' ' LEU . 2.3 tt -114.49 139.46 49.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.789 0.328 . . . . 0.0 110.425 -177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.438 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 84.3 t80 -97.84 111.15 23.56 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 72' ' ' VAL . 10.6 p -100.68 163.48 3.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' N ' HG22 ' A' ' 67' ' ' VAL . 4.2 tpt85 -71.96 -36.62 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.114 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.63 -96.49 0.16 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.616 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -152.47 17.64 0.62 Allowed 'General case' 0 C--O 1.232 0.138 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.666 ' CD ' HG22 ' A' ' 39' ' ' ILE . 6.8 tt0 -61.56 -46.81 88.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.977 0.418 . . . . 0.0 109.877 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.78 ' CG2' HD22 ' A' ' 103' ' ' LEU . 10.8 m -51.49 -31.67 12.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.385 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -33.84 68.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 3.0 mt-30 -78.71 -20.09 50.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.6 178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.021 HD22 HG21 ' A' ' 90' ' ' VAL . 0.2 OUTLIER -66.28 62.65 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.466 178.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 29.6 mmm-85 -56.04 158.35 3.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.955 0.407 . . . . 0.0 111.303 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -46.89 161.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.336 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.13 37.29 91.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.426 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.471 ' CB ' ' CD2' ' A' ' 75' ' ' LEU . 70.4 m-20 -129.32 131.07 46.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.893 0.378 . . . . 0.0 111.15 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.626 ' C ' HD23 ' A' ' 81' ' ' LEU . 54.7 m -100.55 138.78 37.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.552 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.719 HD21 HG23 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -134.64 159.51 41.01 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.298 -178.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 1.007 HG22 ' O ' ' A' ' 86' ' ' GLU . 2.8 p -124.43 130.95 53.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.726 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.015 HD12 ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -120.99 -130.23 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -69.6 -34.08 72.69 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.638 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.773 ' HA ' HG23 ' A' ' 113' ' ' VAL . 9.3 mp0 -101.02 25.23 8.31 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 172.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.007 ' O ' HG22 ' A' ' 82' ' ' THR . 10.3 pt-20 38.07 33.88 0.06 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.804 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' O ' ' CD ' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -144.04 109.15 5.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.775 ' HE2' HD13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -140.59 149.68 42.66 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.506 ' CH2' ' HA3' ' A' ' 108' ' ' GLY . 12.3 m0 -133.23 142.73 48.71 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.901 177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.021 HG21 HD22 ' A' ' 75' ' ' LEU . 94.0 t -85.32 106.59 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.821 0.819 . . . . 0.0 109.511 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 104' ' ' TRP . 7.7 t0 -87.47 -2.11 58.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.668 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.614 ' HG3' HG13 ' A' ' 90' ' ' VAL . 3.2 mmp_? -36.79 163.78 0.0 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.692 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.5 t -131.1 -51.01 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.909 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.9 p 50.42 67.83 3.99 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.283 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.63 -28.71 37.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.641 2.227 . . . . 0.0 111.905 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.0 p30 176.68 176.69 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.769 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -70.16 143.6 52.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.978 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.18 -99.36 0.18 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.39 -91.86 0.75 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.467 ' O ' ' CE1' ' A' ' 102' ' ' HIS . 0.2 OUTLIER 59.49 -163.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 110.951 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.6 m 77.34 32.49 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.278 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.468 ' O ' HD23 ' A' ' 103' ' ' LEU . 0.4 OUTLIER -123.64 -47.67 1.95 Allowed 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.151 0.5 . . . . 0.0 110.479 178.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.823 HD21 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 60.12 114.94 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.048 0.928 . . . . 0.0 110.129 -177.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.507 ' CG ' ' HB3' ' A' ' 91' ' ' ASP . 2.8 t90 -99.36 122.13 42.06 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.166 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.787 HD21 ' HB2' ' A' ' 65' ' ' LEU . 3.5 mp -89.74 156.72 18.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 89' ' ' TRP . . . -133.68 110.47 0.89 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.946 173.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 1.7 mmm180 -98.91 156.02 17.1 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.506 ' HA3' ' CH2' ' A' ' 89' ' ' TRP . . . -145.94 42.93 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.825 -1.079 . . . . 0.0 111.211 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 109' ' ' VAL . 7.4 p -35.62 100.8 0.2 Allowed Pre-proline 0 N--CA 1.465 0.325 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HB2' ' CD ' ' A' ' 111' ' ' PRO . 93.5 Cg_endo -83.46 -179.04 3.99 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.711 2.274 . . . . 0.0 111.598 177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 110' ' ' PRO . 12.1 Cg_exo -69.91 -39.85 5.76 Favored 'Trans proline' 0 CA--C 1.519 -0.251 0 C-N-CA 122.481 2.121 . . . . 0.0 112.199 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.5 93.23 6.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.871 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.773 HG23 ' HA ' ' A' ' 85' ' ' GLU . 3.5 p -112.79 -21.32 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.817 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 58.42 69.69 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 110.898 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 117' ' ' ARG . 0.6 OUTLIER -67.83 96.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.831 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -63.26 120.92 12.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 115' ' ' ARG . 2.8 ptp180 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.823 0.344 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.74 113.34 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.84 -63.02 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -75.99 140.53 42.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -178.28 122.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.806 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -100.04 -63.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.163 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.4 mp -118.22 47.14 1.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.152 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.12 -73.36 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.137 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -158.5 -83.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.939 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -83.98 57.71 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.133 0.492 . . . . 0.0 111.134 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.23 21.68 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.286 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.701 HD13 ' O ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -179.35 -41.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 111.218 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 12' ' ' ILE . . . 169.96 170.32 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.956 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.9 37.84 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.38 -171.49 2.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.183 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -131.04 179.95 5.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -100.11 166.28 11.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.826 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.08 24.54 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' ILE . 2.9 tt -173.32 69.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.64 -62.95 1.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 129.71 8.78 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.622 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.51 169.88 9.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.834 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.0 71.67 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.995 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -117.32 42.04 1.94 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.444 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.825 ' OG1' HD11 ' A' ' 83' ' ' ILE . 2.4 t -92.61 138.71 31.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.188 0.518 . . . . 0.0 111.824 -178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 75.1 m -119.91 129.76 54.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.694 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.052 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -123.87 143.6 50.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.344 0.592 . . . . 0.0 110.553 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.597 ' C ' HD13 ' A' ' 29' ' ' ILE . 4.4 m -119.66 133.71 55.53 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.84 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.004 HD11 HG12 ' A' ' 39' ' ' ILE . 0.9 OUTLIER -100.6 128.3 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.18 0.514 . . . . 0.0 111.397 -178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -133.4 98.74 4.31 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.438 177.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.439 ' N ' ' HB3' ' A' ' 35' ' ' SER . 1.4 p -109.88 151.97 26.37 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.597 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.57 -39.79 38.39 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.165 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -75.24 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -139.27 68.45 1.37 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.262 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.452 ' CB ' ' HA ' ' A' ' 30' ' ' THR . 31.3 p -65.02 128.7 36.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.29 55.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.536 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.72 123.26 14.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 111.053 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -99.67 117.51 44.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.195 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.004 HG12 HD11 ' A' ' 29' ' ' ILE . 2.3 pp -119.33 159.76 19.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.688 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 -104.03 149.76 24.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.839 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.485 ' O ' HD11 ' A' ' 83' ' ' ILE . . . 148.23 146.54 4.36 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.768 ' CB ' HG21 ' A' ' 25' ' ' THR . 0.4 OUTLIER -112.41 -168.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.71 ' N ' HG13 ' A' ' 42' ' ' VAL . 1.9 t80 -115.53 125.05 52.53 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.77 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.26 137.72 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -115.87 106.81 49.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.798 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 25.2 Cg_exo -63.77 -36.96 48.48 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.46 42.92 1.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.979 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -84.15 53.0 2.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.031 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG22 ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER 47.63 -171.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.093 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 49' ' ' ILE . 2.2 p 65.88 33.1 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.03 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' GLY . 2.5 m-30 -81.2 61.9 4.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.973 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 53.69 -87.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.299 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 51' ' ' TYR . . . -109.23 -4.12 31.01 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.979 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 71.02 -170.62 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.935 0.367 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.73 32.06 5.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.412 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 58' ' ' VAL . 2.5 p -159.41 113.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 110.808 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.581 ' O ' HG12 ' A' ' 58' ' ' VAL . 6.7 mmt180 62.76 -70.79 0.06 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.476 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 57' ' ' ARG . 8.2 p 48.37 26.38 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.771 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.418 ' OE2' ' NH1' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -128.32 -42.79 1.48 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.878 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.28 131.42 2.75 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.663 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -100.88 -68.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.689 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.539 ' HB2' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER 176.84 138.96 0.22 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.801 179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 43' ' ' PHE . 42.4 Cg_endo -100.85 139.93 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.763 2.309 . . . . 0.0 114.414 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -107.31 164.19 12.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.2 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.806 ' CB ' HD11 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.86 139.56 49.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.241 -177.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.0 m-85 -98.71 112.69 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.585 ' HB ' HD21 ' A' ' 65' ' ' LEU . 12.2 p -106.57 162.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.932 0.396 . . . . 0.0 111.79 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' N ' HG22 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -87.25 -69.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.86 -178.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.0 p -84.09 -96.06 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -174.99 31.98 0.01 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.692 0.282 . . . . 0.0 111.292 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.666 ' OE1' HG22 ' A' ' 39' ' ' ILE . 1.9 tt0 -76.5 -46.16 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.974 0.416 . . . . 0.0 110.082 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.715 ' HB ' HD22 ' A' ' 103' ' ' LEU . 17.1 m -53.55 -34.41 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.32 178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -54.39 -31.22 54.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.65 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 76' ' ' ARG . 4.0 mt-30 -85.1 -21.91 29.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.718 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.807 HD11 HG21 ' A' ' 29' ' ' ILE . 3.8 mp -66.85 65.23 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.776 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 74' ' ' GLN . 15.5 mmm-85 -59.15 155.26 14.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.993 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.03 136.93 13.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.316 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 107.46 30.18 4.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.838 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 90' ' ' VAL . 16.2 t70 -140.56 144.01 35.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.844 0.354 . . . . 0.0 110.846 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 30' ' ' THR . 2.0 m -112.41 140.12 47.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.561 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.868 HD12 ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -132.16 158.52 41.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.318 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.999 HG22 ' O ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -119.29 130.66 55.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.239 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.052 HD12 ' HB2' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -117.55 -129.5 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 120.078 -0.649 . . . . 0.0 112.382 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.433 ' H ' ' CG1' ' A' ' 83' ' ' ILE . . . -71.12 -40.38 61.82 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 120.098 -1.049 . . . . 0.0 111.437 -177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.864 ' HB3' HG23 ' A' ' 109' ' ' VAL . 19.7 mm-40 -90.47 13.32 15.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.108 -0.546 . . . . 0.0 110.099 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.999 ' O ' HG22 ' A' ' 82' ' ' THR . 12.1 mt-10 64.96 20.74 12.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.402 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.448 ' ND2' ' HD3' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -145.07 112.66 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.936 ' CE2' HD13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -141.25 126.05 18.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.261 175.094 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 12.6 m95 -118.52 144.97 45.68 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.311 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 90' ' ' VAL . 11.4 p -83.8 107.63 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.992 0.901 . . . . 0.0 109.863 -178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 104' ' ' TRP . 12.9 t70 -93.53 -5.32 49.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.128 -1.396 . . . . 0.0 110.94 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.609 ' HD3' HD12 ' A' ' 103' ' ' LEU . 3.6 mtm180 -33.86 157.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.409 0.683 . . . . 0.0 112.544 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.0 128.35 4.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.159 -176.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 t 54.27 76.64 0.5 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.36 -39.2 86.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.617 2.211 . . . . 0.0 112.255 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.9 141.67 32.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.043 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.46 105.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.023 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.31 -83.34 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.507 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.4 -39.22 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 102' ' ' HIS . 0.0 OUTLIER 50.77 -166.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 72.58 25.88 2.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.046 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' CD2' ' C ' ' A' ' 100' ' ' SER . 1.9 m-70 -119.92 -45.82 2.46 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.304 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.715 HD22 ' HB ' ' A' ' 72' ' ' VAL . 6.5 tp 53.16 101.4 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.958 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.539 ' CD1' ' HB2' ' A' ' 62' ' ' SER . 0.1 OUTLIER -96.6 133.93 40.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.058 -178.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.806 HD11 ' CB ' ' A' ' 65' ' ' LEU . 1.2 mp -106.07 160.88 14.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -171.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 89' ' ' TRP . . . -137.51 102.67 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.283 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER -97.07 155.8 16.64 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 122.194 -0.592 . . . . 0.0 110.75 -177.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -142.05 1.8 1.76 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.583 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.864 HG23 ' HB3' ' A' ' 85' ' ' GLU . 7.8 p 26.04 59.99 0.48 Allowed Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 109' ' ' VAL . 72.6 Cg_endo -94.93 157.54 1.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.217 2.611 . . . . 0.0 112.171 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.79 -67.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.422 2.082 . . . . 0.0 112.203 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -53.13 92.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.884 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' 86' ' ' GLU . 47.7 t -158.2 -38.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.862 178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -66.28 67.61 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.973 0.416 . . . . 0.0 110.695 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -141.1 120.3 12.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.086 -179.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -102.8 -179.4 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.877 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.959 -179.908 . . . . . . . . 1 1 . 1 stop_ save_